Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,-0.138495551336853,0.00282577989250463,-0.144034079926162,-0.132957022747543,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39477,0.488471955250833,0.010972027691421,0.466966780975647,0.509977129526018,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,39858,0.198840811785922,0.00384434328586101,0.191305898945634,0.206375724626209,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,-0.123223094636057,0.00272235708226844,-0.128558914517303,-0.11788727475481,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,0.132708169028573,0.00365255298901637,0.125549165170101,0.139867172887045,6.33580940698985e-276
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37437,0.269430101247662,0.00748732633890801,0.254754941623403,0.284105260871922,6.20620529894687e-271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40058,0.170190191737236,0.00489532786457772,0.160595349122664,0.179785034351808,1.77309245622366e-255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40030,0.209958475375502,0.00606448879803879,0.198072077331346,0.221844873419658,1.98352739435532e-253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37021,0.2854088107449,0.00842214446185422,0.268901407599666,0.301916213890135,2.02041143022277e-241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,39788,0.267843091776944,0.008191177550588,0.251788383777792,0.283897799776097,4.82101617750213e-227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,-0.0828661175592259,0.00258866794037574,-0.0879399067223624,-0.0777923283960895,5.04172990775952e-218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,0.148606890885239,0.00483948775802117,0.139121494879517,0.15809228689096,2.95706924546873e-201
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,39805,0.112256651240769,0.00369310887536968,0.105018157845045,0.119495144636494,2.50684471517208e-197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9,Complement component C9,37445,-0.145912208866025,0.00488751816249149,-0.155491744464509,-0.136332673267542,9.7402573563825e-190
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,0.152689578273132,0.00513032127765494,0.142634148568929,0.162745007977336,1.37705162644279e-188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,0.0748858370269263,0.0026965450951562,0.0696006086404202,0.0801710654134325,8.61102266096343e-166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.309252331482483,0.0114046215006091,-0.331605389623677,-0.286899273341289,2.16851532984861e-158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,39854,0.199874578883166,0.00738352771687447,0.185402864558092,0.21434629320824,7.76459253431916e-158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37445,-0.0642367143662814,0.00240043515241312,-0.0689415672650111,-0.0595318614675517,8.73461808942749e-154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,0.158475781165969,0.00596229372584697,0.146789685463309,0.170161876868629,2.64659456766787e-152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,39758,0.187761563809419,0.00709558682199637,0.173854213638306,0.201668913980532,4.8953527254296e-151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,0.336683441991869,0.0128787328116628,0.31144112568101,0.361925758302728,1.38468507845112e-147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,39826,0.232075786116711,0.0093132926309227,0.213821732560103,0.25032983967332,1.70782889918473e-134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,39868,-0.108851747580578,0.00440350709650764,-0.117482621489733,-0.100220873671423,1.99195063620903e-132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37039,0.180731306604606,0.00743552130323022,0.166157684850274,0.195304928358937,1.06132847959367e-127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,39868,0.140029558384645,0.00582775225437633,0.128607163966067,0.151451952803222,2.32602902233142e-125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,0.116907453393957,0.00493218110289697,0.107240378432279,0.126574528355635,4.22643662486387e-122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.146328881537694,0.00620940558406409,0.134158446592928,0.15849931648246,1.00020098757557e-120
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,39868,0.13556018081174,0.00575891302466272,0.124272711283401,0.146847650340079,1.7878739882539e-120
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,0.0942620072354493,0.00407164386725646,0.0862815852556267,0.102242429215272,2.9252722740722e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40030,-0.0739900576503483,0.00327938497537047,-0.0804176522020744,-0.0675624630986222,5.24242963413162e-111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,0.0972389152295218,0.004417462368055,0.088580688988134,0.10589714147091,7.950690321767e-106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,0.0592624290425701,0.00270154408251966,0.0539674026408316,0.0645574554443087,4.12458908761155e-105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.295987440574617,0.0135439896110488,0.269441220936962,0.322533660212273,2.53965013469784e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FURIN,Furin,39913,0.0690770042732914,0.00316400272381065,0.0628755589346226,0.0752784496119603,3.74436577377391e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,0.101686968698031,0.00465803634120228,0.0925572174692746,0.110816719926788,4.17043002807879e-104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,-0.108568009253016,0.00503818618930899,-0.118442854184062,-0.0986931643219705,1.56334849418613e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,39587,0.159371623737398,0.00740692914195372,0.144854042619169,0.173889204855628,3.12476980578989e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40052,0.104569858911713,0.00488001225138969,0.095005034898989,0.114134682924437,1.80577596311367e-100
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,0.0638277349801715,0.00298876283460994,0.057969759824336,0.069685710136007,1.75405420548663e-99
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,39899,0.0597159432499426,0.00280325404418782,0.0542215653233345,0.0652103211765507,2.55524230741656e-99
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39489,0.10077051966298,0.00474323246538505,0.0914737840308257,0.110067255295135,9.07804404991892e-99
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0628489335091304,0.00296742722892066,0.0570327761404459,0.0686650908778149,3.34029289499112e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,39862,0.102777352286531,0.00493513653480428,0.0931044846783145,0.112450219894747,4.60809606085794e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,38721,0.076437690254868,0.00368038640005536,0.0692241329107595,0.0836512475989765,1.80803983210937e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40011,0.229776647660077,0.0111645454491537,0.207894138579736,0.251659156740418,6.3166072625716e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0631420284366926,0.00308138672175839,0.0571025104620462,0.0691815464113391,3.89428350606025e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0647255369124834,0.00317475730462328,0.0585030125954218,0.070948061229545,3.01867740316079e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,0.142995972213379,0.00705835151950318,0.129161603235153,0.156830341191606,4.1863995480003e-90
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.061647957895685,0.00306306862539399,0.0556443433899128,0.0676515724014572,5.33982703037224e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,37453,-0.124560342475522,0.00619403793480795,-0.136700656827746,-0.112420028123299,1.1756043041109e-88
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40052,0.0789979573046907,0.00397729706832091,0.0712024550507817,0.0867934595585997,9.30465631400153e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,39858,0.0771158531164581,0.0038867459915789,0.0694978309729635,0.0847338752599527,1.45332225758291e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37124,0.076690445659527,0.00387620635389809,0.0690930812058868,0.0842878101131673,6.92018193660738e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,39919,0.108495914660772,0.00550984294404205,0.0976966224904496,0.119295206831094,2.59403106808866e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.155704993296421,0.00791086689566372,0.140199694180921,0.171210292411922,4.72344294642605e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.115031107553798,0.00585441809510239,0.103556448087397,0.126505767020199,6.29173997341122e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,0.0939388269473721,0.00479064018727147,0.0845491721803201,0.103328481714424,1.34815824056566e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,0.0683945297890079,0.00349357121835594,0.0615471302010303,0.0752419293769855,2.28760859718414e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0783562219694906,0.00400369732819878,0.070508975206221,0.0862034687327602,2.58740600791451e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.108577070411055,0.00555161752036817,0.0976959000711332,0.119458240750976,3.5950442026809e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.154324112027677,0.00791561956571957,0.138809497678866,0.169838726376487,1.14852682559392e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0681474455873668,0.0034926116136038,0.0613019268247033,0.0749929643500302,1.28801109077539e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,39933,0.117100684546792,0.00604550027660356,0.105251504004649,0.128949865088935,1.21050624208705e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37437,0.167087680300954,0.00863270899679523,0.150167570667235,0.184007789934672,2.36361790228229e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0627506277749563,0.00326429223304211,0.0563526149981938,0.0691486405517188,1.93899580167322e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.0963264789670065,0.00501093286299916,0.0865050505555281,0.106147907378485,1.96575259884166e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,0.152958462640975,0.00796830682750739,0.137340581259061,0.16857634402289,3.28421785154295e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,39908,-0.0480307539289663,0.00250224934164726,-0.0529351626385949,-0.0431263452193377,3.30680080352249e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,-0.056611913745076,0.0029517915499157,-0.0623974251829108,-0.0508264023072412,4.52223941953097e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MME,Neprilysin,39788,0.141371391078995,0.00738719471244064,0.126892489442611,0.155850292715379,9.92343144536875e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37382,0.1280543332499,0.00671753827383706,0.11488795823318,0.141220708266621,5.75039133180618e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.141644792990973,0.00745921085860503,0.127024739708107,0.156264846273839,1.58058926956172e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,39949,0.0550987371485165,0.00292048768308331,0.0493745812896732,0.0608228930073598,1.51950619201163e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,39931,0.0724743508801739,0.0038586912908538,0.0649113159501005,0.0800373858102474,7.20803226791811e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,39955,0.0606151919242472,0.0032340433296918,0.0542764669980513,0.0669539168504431,1.48081795669762e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,39949,-0.0486668980998585,0.00260308209553066,-0.0537689390070986,-0.0435648571926184,3.51256112644956e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37043,0.0916015567275942,0.00489846716352618,0.0820005610870829,0.101202552368106,4.89341767982674e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,0.102834236270211,0.00552160401156326,0.0920118924075473,0.113656580132875,1.30197485849246e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40058,0.044984541277205,0.00241606379528066,0.0402490562384549,0.0497200263159551,1.41983858162026e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40003,0.0333681378077608,0.00181434154265608,0.0298120283841548,0.0369242472313667,8.94137001218414e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40058,0.0477145530478022,0.00260244370732875,0.0426137633814379,0.0528153427141666,2.47691460259772e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,39839,0.0833085301523279,0.00455532391254309,0.0743800952837434,0.0922369650209123,5.83670237631753e-74
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.0796375192255652,0.00436631018154438,0.0710795512697382,0.0881954871813922,1.43181396132764e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,0.0435282098261429,0.00240441820541275,0.0388155501435339,0.0482408695087519,2.17914170420499e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40052,0.0734897323542484,0.00407456307166041,0.065503588733794,0.0814758759747028,5.12675152272481e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.12998995072517,0.00720510729831336,0.115867940420475,0.144111961029864,6.41176057680543e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,0.0509903579459763,0.00283723064335508,0.0454293858850003,0.0565513300069523,1.63116546186649e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,39908,0.0307349040761191,0.00171092593126626,0.0273814892508372,0.034088318901401,1.87052686197762e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,39840,-0.0752538962295037,0.0042505001672202,-0.0835848765572553,-0.0669229159017521,1.77563013088306e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0660519137956203,0.00373067004313411,0.0587398005110774,0.0733640270801631,1.8071855483136e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40030,0.055066190627692,0.00311394638910829,0.0489628557050397,0.0611695255503442,2.51392719202222e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0477254365677582,0.00270694963103237,-0.0530310578445816,-0.0424198152909348,6.38823612706765e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0837185483270986,0.00476618803955005,0.0743768197695805,0.0930602768846167,1.9978956855888e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,39788,0.0585192312937809,0.00337805764925065,0.0518982383012496,0.0651402242863122,1.27864567794258e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.0884307554551787,0.00511667051615375,0.0784020812435174,0.09845942966684,2.54811792469775e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.134015223392122,0.00777015248570885,0.118785724520132,0.149244722264111,4.78282032722771e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40058,0.0483535117062543,0.00281622482494069,0.0428337110493706,0.0538733123631381,1.70238959537678e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0872440562848591,0.00508266947094148,0.0772820241218138,0.0972060884479044,1.88832419814899e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,-0.0343201919122263,0.00200439566298737,-0.0382488074116816,-0.0303915764127711,3.7916970349311e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37124,0.0463784128647195,0.00271021032391959,0.0410664006298371,0.0516904250996019,5.95591357272722e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,0.0533052731134552,0.00313706619113649,0.0471566233788277,0.0594539228480827,3.42347310594087e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.145409946690039,0.00855897126099792,0.128634363018484,0.162185530361595,3.68765892835283e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,0.121967366760889,0.00719206864663377,0.107870912213487,0.136063821308291,6.20655710609685e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37382,0.176072683228014,0.0103884534618242,0.155711314442839,0.19643405201319,8.92258444071138e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,39858,-0.0424876216391418,0.00251026184722793,-0.0474077348597085,-0.037567508418575,1.04444533079706e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELE,E-selectin,40052,0.0789500316069224,0.00468549112444373,0.0697664690030127,0.0881335942108321,3.62796197890211e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0491316807276837,0.00292630187915589,0.0433961290445381,0.0548672324108292,9.92767674250202e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37088,0.0595128871881589,0.00356009480228581,0.0525351013756787,0.0664906730006391,4.29319978130926e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.166407204172404,0.0100306273878593,0.1467471744922,0.186067233852609,2.69367132276924e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0468861211019708,0.00283411567041528,-0.0524409878159847,-0.0413312543879568,7.25632906085294e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,39846,0.0438786039008081,0.00265570259396579,0.0386734268166351,0.049083780984981,8.0797102856827e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.134645658521392,0.00817582283246207,0.118621045769766,0.150670271273017,1.94301205116154e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,0.125996327541326,0.00765873678029163,0.110985203451954,0.141007451630697,2.57932752949938e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40012,-0.0809355005463014,0.00496053061362754,-0.0906581405490114,-0.0712128605435915,2.26997528010297e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40052,0.0879774097328091,0.00540779044972826,0.0773781404513417,0.0985766790142765,4.84223092110248e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,-0.0498727939795361,0.00308139442927334,-0.0559123270609118,-0.0438332608981603,1.86082493636928e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,39868,-0.0563500034917716,0.00348979183785939,-0.063189995493976,-0.0495100114895672,3.43004694619405e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.09807650292509,0.00607747147251468,0.0861646588389613,0.109988347011219,4.80102409816497e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELN,Elastin,37437,0.0509198216810825,0.00316288769981938,0.0447205617894366,0.0571190815727285,8.85519783520876e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,39788,0.0707582998157786,0.00440584416954415,0.062122845243472,0.0793937543880851,1.37577705823804e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,39879,-0.0294023733547401,0.00183963913614719,-0.0330080660615886,-0.0257966806478916,4.65817391541016e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40058,0.0507315990671393,0.00320004105482522,0.0444595185996819,0.0570036795345968,3.52120502117596e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0336528835995595,0.00212461028686063,0.0294886474373127,0.0378171197618063,4.41891002219973e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,39858,0.0352759721525145,0.0022343406838225,0.0308966644122224,0.0396552798928066,9.90002409561024e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,39984,0.0729469512284802,0.00463199836464407,0.0638682344337778,0.0820256680231826,1.822033434319e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFM,Afamin,37453,0.0281475689355446,0.00178837566640725,0.0246423526293864,0.0316527852417029,2.50789283492612e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.0510728628593849,0.00325204819882257,0.0446988483896927,0.0574468773290771,3.60726101180706e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37411,0.0658138955576927,0.00418798584469949,0.0576054433020817,0.0740223478133037,3.66557654124946e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,39788,0.0827670528933702,0.0052744303057501,0.0724291694941,0.0931049362926404,4.42552758975586e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0499751598371111,0.00318813440608979,0.0437264164011751,0.0562239032730471,5.66684640996786e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,39908,0.0496977833426648,0.00317487705343804,0.0434750243179262,0.0559205423674033,8.00331050982178e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0411219727041752,0.00263813843291061,0.0359512213756704,0.04629272403268,2.2142536813561e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,0.0411874428745669,0.0026476389632062,0.0359980705066828,0.0463768152424511,3.56105514976902e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0612933327266943,0.00394293938978083,0.0535651715227239,0.0690214939306648,4.33868951219379e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,0.14572466492641,0.00944162144534076,0.127219086893542,0.164230242959278,2.39959727216129e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0700126977050787,0.00455640497043152,-0.0789432514471245,-0.0610821439630329,7.74238270117578e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39464,0.0853063661460711,0.00555679575685282,0.0744150464626396,0.0961976858295026,8.38678734947511e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,39974,0.0367043503420253,0.00240264455394758,0.0319951670162881,0.0414135336677625,2.54517544239747e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0285149580819954,0.00186674745456145,-0.0321737830929359,-0.024856133071055,2.62658263695401e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,39868,0.0366919001957133,0.00240531031655503,0.0319774919752654,0.0414063084161611,3.57435147985386e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0487359012231264,0.00320148820352639,-0.0550108181020381,-0.0424609843442147,5.70751790931386e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,0.0455390388210861,0.00299102218700642,0.0396766353345535,0.0514014423076187,6.45062744809404e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0520031736165628,0.0034205993005635,0.0452987989874583,0.0587075482456672,7.70557024242463e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,39931,-0.0616758811348085,0.0040948852490613,-0.0697018562229687,-0.0536499060466483,6.43927541500561e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,0.182928215349492,0.0121487889932576,0.159116588922707,0.206739841776277,6.83933996528591e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,-0.0520169598344854,0.00345455279937942,-0.0587878833212691,-0.0452460363477018,7.95117520495288e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,0.0399842280861681,0.00266282616714244,0.0347650887985689,0.0452033673737673,1.47442355636017e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0774122077932107,0.00516180439124068,0.067295071186379,0.0875293444000424,1.71259262538012e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,39976,-0.0506634366356204,0.00338424004841986,-0.0572965471305233,-0.0440303261407175,2.49772104574858e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,0.0389774173700668,0.00260604792108367,0.0338695634447429,0.0440852712953908,3.57590179890062e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,39865,0.0436931658978736,0.00292592190151442,0.0379583589709053,0.0494279728248419,4.36149969999211e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40009,0.0519868435707932,0.00350555063248163,0.0451159643311292,0.0588577228104572,1.98588918921229e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37043,0.0906046660458057,0.00611696074542578,0.0786154229847712,0.10259390910684,3.04566966272967e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0419842333028048,0.00283984239574249,0.0364181422071495,0.0475503243984601,3.9324997206138e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POSTN,Periostin,37437,-0.0510889054945003,0.00350237052846496,-0.0579535517302916,-0.0442242592587089,7.82071728768651e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0527844720201224,0.00362984690694919,0.045669972082502,0.0598989719577429,1.31471620907326e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,0.0485575615686845,0.00334272545023484,0.0420058196862243,0.0551093034511448,1.66053432494844e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0786901125225876,0.00542200444333759,0.0680629838136459,0.0893172412315293,2.31928161285669e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,39931,0.0701986133472842,0.00484736346065164,0.0606977809644069,0.0796994457301614,3.13122223127943e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0543528824085867,0.00378385878381416,0.0469365191923109,0.0617692456248624,1.68462681789019e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.0668579883822841,0.00468735712271941,0.0576707684217541,0.0760452083428142,7.07247664539345e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,39858,0.0759832591511739,0.00533591350941443,0.0655248686727216,0.0864416496296262,9.84787823628632e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,39585,0.0706222065609378,0.00495920225196945,0.0609021701470777,0.080342242974798,9.86424453733815e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,39866,0.0613158219550631,0.00431142924519079,0.0528654206344892,0.0697662232756371,1.27441542609123e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0327682946813945,0.00230422487990356,-0.0372845754460054,-0.0282520139167835,1.27827346383013e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,39868,0.0470497673420816,0.00331027702830642,0.040561624366601,0.0535379103175622,1.43568804425884e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37124,0.0363699060403781,0.00256041846092977,0.0313514858569557,0.0413883262238004,1.84575685739454e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,0.0287270413487469,0.0020317726216621,0.0247447670102892,0.0327093156872047,4.07863264928239e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0511294206652739,0.00363029104333349,-0.0582447911102076,-0.0440140502203403,8.78146111099717e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,-0.0486708603816625,0.00345572063655022,-0.0554440728293009,-0.0418976479340241,8.80199676765733e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAST,Gastrin,37388,0.154177958853647,0.0109587661657535,0.13269877716877,0.175657140538524,1.21661838632657e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.079921526997412,0.00572346381567749,-0.0911395160761399,-0.0687035379186841,5.32986437974677e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,39866,0.100923902768073,0.00728503359922421,0.0866452369135934,0.115202568622552,2.15402743368834e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.0811643742079582,0.00585935170494673,-0.0926487035496538,-0.0696800448662626,2.18719850759398e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,39913,0.0527205207949817,0.00381131361480173,0.0452503461099703,0.060190695479993,2.86861981151038e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,36780,-0.0565364163259175,0.00409818113734001,-0.0645688513551039,-0.048503981296731,5.47069438443684e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.03489305534108,0.00253202914934058,-0.0398558324737875,-0.0299302782083724,5.86017491093652e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.0888605729118665,0.0064519811140625,0.076214689928304,0.101506455895429,7.38382561799888e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,0.0471924496756201,0.00343110133470202,0.0404674910596041,0.0539174082916361,8.45994396622297e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0467902468147581,0.00340710425117544,0.0401123224824543,0.053468171147062,1.11479647753991e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,39858,0.0466335764079753,0.0033994868389008,0.0399705822037297,0.0532965706122209,1.3831126230405e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,39979,0.0765517546913594,0.00558848203281335,0.0655983299070452,0.0875051794756736,1.80131384576202e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OCLN,Occludin,37411,0.0553351780498893,0.00406041228254887,0.0473767699760935,0.0632935861236851,5.16516186517529e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0447356499701279,0.00328566713807972,0.0382957423794916,0.0511755575607641,5.55732394274677e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0535557356706523,0.00395151068266161,0.0458107747326356,0.0613006966086691,1.2863634368638e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.0627784610867612,0.00463011765921507,0.0537034304746997,0.0718534916988227,1.33165027296549e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0470216903338142,0.00347231583673791,0.0402159512938079,0.0538274293738205,1.4988697318644e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0606201759059832,0.00448313760048068,0.0518332262090411,0.0694071256029253,2.18663215032927e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,0.072031305784005,0.00535548679293707,0.0615345516698484,0.0825280598981617,5.63157593812665e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,39749,-0.0422236601864154,0.00314217540972489,-0.0483823239894762,-0.0360649963833547,6.08228045769459e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,0.0454326769728962,0.00338814978586372,0.0387919033926033,0.0520734505531891,8.88860210858956e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0494931069376206,0.00369658006849433,0.0422478100033717,0.0567384038718695,1.1649672736961e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0327693044777487,0.00244923694173713,0.0279688000719439,0.0375698088835535,1.44502155012104e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40008,0.0735692569089956,0.00551279006349653,0.0627641883845424,0.0843743254334488,2.06832620066888e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40052,0.0742883707630872,0.00558384271567171,0.0633440390403706,0.0852327024858038,3.5579560237128e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37124,0.0664057709466703,0.00499443681393934,0.0566166747913492,0.0761948671019914,4.4101907972931e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40058,0.0570000130811744,0.0042927162589518,0.0485862892136289,0.06541373694872,5.00719001367371e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0714657551649153,0.00538458781250361,0.0609119630524082,0.0820195472774224,5.96219507749857e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,0.0407583744848767,0.00307287494392764,0.0347355395947785,0.0467812093749749,6.05454790562054e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,0.0330722864546076,0.00249454218568115,0.0281829837706726,0.0379615891385427,6.58703241804455e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39315,0.0503764452691075,0.00380900567457804,0.0429107941469346,0.0578420963912805,1.02593786586152e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,-0.0332135206496278,0.0025222769201503,-0.0381571834131224,-0.0282698578861333,2.14763115422218e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.0649741082120962,0.00493485140495265,0.0553017994583891,0.0746464169658034,2.18625372484825e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40030,0.0326847093908857,0.00248410749825188,0.0278158586943121,0.0375535600874594,2.45343418978276e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40009,-0.0455369705121158,0.0034638775990549,-0.0523261706062634,-0.0387477704179682,2.84560070546543e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.0838943170150708,0.00638209172783174,0.0713854172285206,0.096403216801621,2.92760130355876e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.0677651559116503,0.00515823087378261,0.0576550233990364,0.0778752884242642,3.25539523371912e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.0878548358607789,0.00671295014146828,0.0746974535835011,0.101012218138057,6.68581116700329e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40030,-0.0557006279759043,0.00425969105286551,-0.0640496224395207,-0.0473516335122879,7.09149448429614e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.0889144559811422,0.0068002329424335,0.0755859994139725,0.102242912548312,7.24997031618153e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,39897,0.0327137200557848,0.00251018580326984,0.0277937558813759,0.0376336842301936,1.25784557057599e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,39885,-0.0477813310373936,0.00366836484079381,-0.0549713261253495,-0.0405913359494377,1.38051432345715e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,0.0321602554913806,0.00247138515894011,0.0273163405798579,0.0370041704029032,1.61469829118491e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37383,-0.0229071091250766,0.0017643670104209,-0.0263652684655016,-0.0194489497846516,2.58179307925493e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,39866,0.0397454746615037,0.00306582545565869,0.0337364567684127,0.0457544925545947,3.04834049127395e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40052,-0.0195884942500102,0.00151448488077611,-0.0225568846163314,-0.016620103883689,4.46167212725688e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.106131764925403,0.00820818251313712,0.0900437271996542,0.122219802651152,4.78536049486254e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0257684078649369,0.00199923081841569,0.0218499154608422,0.0296869002690317,7.9607970885857e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,0.0490988409191313,0.00381869435150518,0.0416141999901812,0.0565834818480815,1.19895861388324e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,0.147003587870903,0.0114271113820754,0.124606449562036,0.169400726179771,1.20092764517161e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,0.0571958361825548,0.00444726286364569,0.0484792009698093,0.0659124713953004,1.24084888758849e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.100623677616635,0.0078396479714154,0.0852579675926603,0.115989387640609,1.61090685395634e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.0634477222837211,0.00494306090102773,0.0537593229177068,0.0731361216497355,1.71296289391018e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,0.0930077674854788,0.00725016637286497,0.0787974413946635,0.107218093576294,1.73148257426405e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37445,-0.0625406295866952,0.00487510200711687,-0.0720958295206442,-0.0529854296527461,1.87088723002255e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0336805500454187,0.00262732794501586,0.0285309872731877,0.0388301128176498,1.9532614271361e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37043,0.0731986782966434,0.00571596040447406,0.0619953959038742,0.0844019606894125,2.53173025216493e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,0.067424495273909,0.00527581685095487,0.0570838942460375,0.0777650963017805,3.22754758245239e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0464182255229494,0.00363091250014304,0.0393016370226691,0.0535348140232298,3.29930359324631e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXN,Paxillin,39489,0.0622524619808524,0.00488556065208838,0.0526767631027591,0.0718281608589456,5.26895720681713e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37420,-0.0407480280774778,0.00320605145236507,-0.0470318889241133,-0.0344641672308422,8.46600819003888e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37309,0.0302575807914765,0.00238163149285247,0.0255895830654857,0.0349255785174674,9.07248680739662e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37124,-0.0265947451124444,0.00210271679593607,-0.0307160700324791,-0.0224734201924097,1.86755528627253e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,0.131049224803617,0.0104020452871098,0.110661216040882,0.151437233566352,3.23214388602829e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,39846,0.0343979069250879,0.0027354694195318,0.0290363868628056,0.0397594269873703,4.30709310423376e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,0.114155698905843,0.00916148789311626,0.0961991826353351,0.132112215176351,1.92156727405692e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37437,0.0310016425283446,0.002488452188537,0.0261242762388121,0.0358790088178771,1.97078883367585e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,0.0612183249768999,0.00491771794510997,0.0515795978044843,0.0708570521493154,2.08363762238818e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,0.0324083366289811,0.00260564553440647,0.0273012713815444,0.0375154018764178,2.38471245070602e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,39713,0.0715003288390369,0.0057581377296345,0.0602143788889533,0.0827862787891205,3.07188593887607e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0349374825909818,0.00281308106489726,0.0294238437037831,0.0404511214781804,3.19351394289031e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,0.0740150702658623,0.0059724452037789,0.0623090776664557,0.085721062865269,4.14442587569552e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40052,-0.0311821432480101,0.00251711887882797,-0.036115696250513,-0.0262485902455073,4.37516844046088e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0299831764998133,0.00241966427923319,-0.0347257184871103,-0.0252406345125162,4.49674071342835e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,39866,-0.0397910172545148,0.00321338244799803,-0.0460892468525909,-0.0334927876564387,4.68054842067991e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37424,0.0329466459938553,0.00266458145550891,0.0277240663410579,0.0381692256466528,6.25993757482256e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,39868,0.0739650407720004,0.00598489973393778,0.0622346372934823,0.0856954442505184,6.31560001641474e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,0.0678244370564375,0.00549103324911387,0.0570620118881743,0.0785868622247007,7.33098236469752e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0653509387630405,0.00530641841843226,0.0549503586629132,0.0757515188631677,1.16060299411985e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,0.0370650055335132,0.0030098846080416,0.0311656317017517,0.0429643793652747,1.1653015345094e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,39866,0.0620349967941425,0.00504122547008731,0.0521541948727713,0.0719157987155136,1.21288842939939e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,39906,-0.0447663758572915,0.00364337718619446,-0.0519073951422326,-0.0376253565723503,1.52005237528511e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,0.0660497522645113,0.00538435022556077,0.0554964258224122,0.0766030787066104,1.93968592911737e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPN,Asporin,37437,-0.0312336294708093,0.00255004306505576,-0.0362317138783185,-0.0262355450633,2.60361137074395e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,39730,-0.0325691820801904,0.00266332786788353,-0.0377893047012421,-0.0273490594591387,3.11203672503034e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.0819945313379869,0.00670492018863081,0.0688528877682705,0.0951361749077033,3.12014356730845e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,-0.029988272490393,0.00245490531139459,-0.0347998869007264,-0.0251766580800596,3.6249619506396e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.0795615889228645,0.00655200611932653,0.0667196569289845,0.0924035209167445,9.35852420689029e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0314888141560951,0.00259468652995134,0.0264032285573905,0.0365743997547997,9.59161666634355e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,39660,0.042970307399781,0.00354804234439707,0.0360161444047628,0.0499244703947993,1.301573861101e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,0.0673712263885395,0.00557749125305393,0.0564393435325538,0.0783031092445253,1.90811130052684e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0356156529233282,0.00294931110296489,-0.0413963026851394,-0.029835003161517,1.97697745649853e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,0.0679801110855774,0.00564041871883291,0.0569248903966649,0.0790353317744899,2.63274435960894e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0304990585295175,0.00253710361471189,0.0255263354446822,0.0354717816143528,3.81393703478931e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37051,0.029540681236461,0.00245994570798937,0.0247191876488018,0.0343621748241202,4.7572479195588e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.0680021403920632,0.00566568696445121,0.0568973939417389,0.0791068868423876,4.76865668085625e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,0.0372267990341374,0.00310493839175297,0.0311411197863016,0.0433124782819733,5.56551089891496e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37437,-0.0655694545820904,0.00549519068130399,-0.0763400283174462,-0.0547988808467346,1.17178165538486e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0224572264615129,0.00188286764738946,0.0187668058726296,0.0261476470503962,1.17644079707941e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.0833909396514478,0.00700112338236441,0.0696687378220135,0.097113141480882,1.42600898936718e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37437,0.125348333214345,0.0105252169310286,0.104718908029529,0.145977758399161,1.53661509051303e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40058,0.0461809747699091,0.00389220765677286,0.0385522477626342,0.0538097017771839,2.44950343354159e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37437,0.102386267361935,0.0086308334747995,0.0854698337513277,0.119302700972542,2.66513260725618e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,0.139488275831506,0.0117714640593657,0.116416206275149,0.162560345387862,2.9505935556182e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,39868,-0.0573449584968864,0.00483985444207469,-0.0668310732033527,-0.04785884379042,2.98842719025104e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,0.0746404428681691,0.00630826484214314,0.0622762437775685,0.0870046419587696,3.61462016880158e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0431973273572593,0.00365421099553711,0.0360350738060066,0.0503595809085121,4.39678942355698e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,0.0326387580347282,0.00276750568462659,0.0272144468928601,0.0380630691765964,5.74164541827796e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,0.0958795044792514,0.00814608159785543,0.0799131845474547,0.111845824411048,8.03589513405265e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,39995,0.0416588442620336,0.003541789461261,0.034716936917962,0.0486007516061051,8.25403300531673e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0325500672908465,0.0027707334325212,0.0271194297631049,0.0379807048185881,9.77937913160979e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0484044934304135,0.00412614625644221,0.0403172467677868,0.0564917400930403,1.19091100352377e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0838723466512912,0.00715736437600841,0.0698439124743147,0.0979007808282677,1.45693249176434e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0562085928433177,0.00480494655141935,0.0467908976025358,0.0656262880840996,1.76425446321269e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,0.125860877540752,0.0107806462114797,0.104730810966252,0.146990944115253,2.3036807972767e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,-0.0330822549240055,0.00283524687417948,-0.0386393387973973,-0.0275251710506137,2.4784581868757e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40030,-0.0181809117459876,0.0015624668035893,-0.0212433466810226,-0.0151184768109525,3.59806139421708e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,39866,0.0503514522919962,0.00433868317506502,0.0418476332688687,0.0588552713151236,5.15894838552974e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0482612589514347,0.00416528711664926,0.0400972962028022,0.0564252217000672,6.41557486300757e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0491189282769612,0.00423881175041195,0.0408108572461538,0.0574269993077686,6.69725481893798e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,0.0994289459761147,0.00861911804937966,0.0825354745993306,0.116322417352899,1.14943697747472e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLN,Promotilin,39866,0.0971154146853575,0.00842153158051513,0.0806092127875478,0.113621616583167,1.20548756487666e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40030,0.0499055009205126,0.00433566661695148,0.0414075943512877,0.0584034074897375,1.53691896275231e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,39963,0.0744828344027521,0.00647442755878355,0.0617929563875363,0.0871727124179678,1.65423537957859e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,0.0824026855003423,0.00717793073209196,0.068333941265442,0.0964714297352425,2.31308006820534e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,0.0400347450910378,0.00349362018387189,0.0331872495306489,0.0468822406514267,2.77550237774417e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,-0.0274331443778644,0.00239803822375495,-0.032133299296424,-0.0227329894593047,3.46669536768465e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,39875,0.0509706699588094,0.00445626291655679,0.0422363946423581,0.0597049452752607,3.53727186635499e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,0.115129173082964,0.010066870196768,0.0953981074972984,0.134860238668629,3.78254790346905e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,39858,-0.0308186279725403,0.00269579777108732,-0.0361023916038714,-0.0255348643412091,3.78446591773056e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0359134974330935,0.00314207204032342,-0.0420719586321274,-0.0297550362340596,3.88001726504343e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,0.084107518825077,0.00736297105155027,0.0696760955640385,0.0985389420861156,4.19625068515594e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40030,0.0701758708015955,0.00614443463399527,0.0581327789189648,0.0822189626842262,4.28143566159307e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0293505204575914,0.00257427199773991,0.0243049473420211,0.0343960935731616,5.40051121659698e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,39720,0.0298115335133983,0.00261643840059363,0.0246833142482348,0.0349397527785618,5.86209709241324e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37056,0.0911164845956475,0.00800784160921638,0.0754211150415834,0.106811854149712,7.37979705157145e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,39788,0.078431999263008,0.0068998796884424,0.0649082350736609,0.0919557634523551,7.9407189252199e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0640594673963392,0.00564742972482465,0.0529905051356829,0.0751284296569955,1.09267625633386e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0414086841831012,0.00366866635933875,0.0342180981187972,0.0485992702474051,1.96648633764699e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37382,0.104676006758955,0.00927295773358476,0.0865010096011289,0.122851003916781,2.02943677508868e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,39788,0.0733928695149423,0.00651165665254613,0.0606300224759519,0.0861557165539327,2.35711067879554e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0652733173309061,0.00580246577906006,0.0539004844039484,0.0766461502578638,3.01142279695891e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37124,0.0674033584208241,0.00601563345582865,0.0556127168474,0.0791939999942483,5.21899065000184e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,0.116048260766129,0.0103661295548408,0.0957306468386412,0.136365874693617,5.78642528982635e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,0.0471841338042569,0.00421745955435716,0.0389179130777169,0.055450354530797,6.31308417045927e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,0.0842697270931335,0.00753510883311151,0.069500913780235,0.0990385404060321,6.56114330265876e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37445,0.0280698596013303,0.00251057013869396,0.0231491421294901,0.0329905770731704,6.77896556494901e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.103035418960974,0.00923604365981102,0.0849327733877441,0.121138064534203,8.57765600146306e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0410697405758161,0.00368481490530977,0.0338475033614089,0.0482919777902232,1.00837622070296e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,-0.0664960692561177,0.00598646845239393,-0.0782295474228098,-0.0547625910894256,1.46486524523158e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,0.0551682640743947,0.00496964368748206,0.0454277624469299,0.0649087657018596,1.57596176396112e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,0.0715396613990065,0.0064683484781795,0.0588616983817746,0.0842176244162383,2.48774866638706e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,-0.0752968075207178,0.0068173187396994,-0.0886587522505286,-0.061934862790907,3.06106524047673e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0432575400639848,0.00392655687256755,0.0355614885937524,0.0509535915342172,4.00462917506144e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0680753221099047,0.00618407846581279,0.0559545283169116,0.0801961159028978,4.40345449630975e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,39749,-0.0263677428044657,0.00240024539778498,-0.0310722237841243,-0.0216632618248072,5.66187806892167e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.0565808166599942,0.00515255319962593,0.0464818123887274,0.066679820931261,5.95103432418701e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37043,0.0628621738077003,0.00574008086998827,0.0516116153025233,0.0741127323128773,8.61524634159372e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,39803,0.0309952123653117,0.00283445975139144,0.0254396712525845,0.0365507534780389,9.82177359634751e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,0.0679368978397604,0.00622673958609069,0.0557324882510226,0.0801413074284981,1.28334789142561e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37124,0.0475323023850594,0.00435555137874464,0.0389954216827199,0.0560691830873989,1.30839628156616e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0268101172419861,0.00246001047126672,0.0219884967183033,0.0316317377656689,1.46858938740963e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,-0.0329550900256677,0.00302288353852959,-0.0388799417611857,-0.0270302382901497,1.47978695591729e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,0.0323236809553894,0.00297009174473203,0.0265023011357146,0.0381450607750642,1.81657245482117e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37386,0.0284388239877593,0.00261719423538538,0.023309123286404,0.0335685246891147,2.1683527835498e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,39749,0.0915161620127034,0.00843533554890036,0.0749829043368588,0.108049419688548,2.50987843330259e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,39749,0.0536773502925027,0.00495371070220141,0.043968077316188,0.0633866232688175,2.90140198548793e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.0871090052693033,0.00805040892599812,0.071330203774347,0.10288780676426,3.58236901802322e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.019669954193758,0.00182154917485608,0.01609971781104,0.0232401905764759,4.36791689271673e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0514409857071539,0.00478013800303517,0.042071915221205,0.0608100561931029,6.50681712466419e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0285197639918087,0.00265067559708118,0.0233244398215296,0.0337150881620878,6.6194654258622e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37368,0.101394191937629,0.00943336668634779,0.0829047932323875,0.119883590642871,7.73613776808341e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,0.0291844626612475,0.00272199949549697,0.0238493436500734,0.0345195816724215,9.97248553549564e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,0.0362072625442403,0.0033772559765756,0.0295878408301521,0.0428266842583284,1.03854777297125e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,39785,0.072416034103054,0.00675946301471904,0.0591674865942047,0.0856645816119034,1.08718009401753e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0299291381349373,0.00279348496581844,0.0244539076019331,0.0354043686679414,1.12771667783759e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0782323133476145,0.00732392945793991,0.0638774116100523,0.0925872150851767,1.58081761445159e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,0.0442748497837228,0.00415168951563158,0.0361375383330849,0.0524121612343607,1.90505627885081e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.0826532544837283,0.0077639425469172,0.0674359270917706,0.097870581875686,2.32066517323857e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,39836,0.0922966258869317,0.00867763963909066,0.075288452194314,0.109304799579549,2.47829200321643e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0495129368675535,0.00466500547532908,0.0403695261359085,0.0586563475991985,3.1616674736676e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37411,0.0513983367864682,0.00484484483716065,0.0419024409056334,0.0608942326673031,3.43316168427681e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0708782411705974,0.00668411874838376,0.0577773684237652,0.0839791139174296,3.63909274687743e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,39858,0.0450132953361925,0.00425391988256035,0.0366756123663742,0.0533509783060108,4.42326208955526e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,0.085350072846414,0.00806998675542798,0.0695328988057751,0.101167246887053,4.69819111939713e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0292966470668222,0.00277149455558157,0.0238645177378823,0.034728776395762,5.14191513509026e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,39788,0.0509726262382209,0.00483679143833682,0.0414925150190808,0.0604527374573611,6.98333437692207e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40009,0.0417526803312187,0.00396330250183582,0.0339846074276204,0.0495207532348169,7.24214784848575e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37124,-0.0503087947803297,0.00477717609743208,-0.0596720599312966,-0.0409455296293629,7.85534058150813e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0867556568535209,0.00824063865868237,0.0706040050825035,0.102907308624538,8.0955269326731e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.069809201647915,0.00664036639886717,0.0567940835061354,0.0828243197896947,9.52985261146804e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASN,Vasorin,39642,-0.0271945829114276,0.00259050502900309,-0.0322719727682737,-0.0221171930545816,1.07458429472809e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.0511588777091472,0.00488158232969195,0.041590976342951,0.0607267790753434,1.29826432614588e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0623444206940938,0.00595214169910076,0.0506782229638564,0.0740106184243313,1.41987467005079e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,0.019384490225588,0.00185236161156725,0.0157538614669162,0.0230151189842598,1.51701277972695e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.103311854190111,0.00988504402351333,0.083937167904025,0.122686540476197,1.74738885936527e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,0.0599137539494231,0.00573307231163941,0.0486769322186099,0.0711505756802364,1.7595881881896e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,39858,0.0320724003470126,0.00308877440155027,0.0260184025199741,0.0381263981740512,3.54247321380238e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EZR,Ezrin,40009,0.0234988419824432,0.00227185761421828,0.0190460010585754,0.0279516829063111,5.36334347873589e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,0.02099352755105,0.00203237634100915,0.0170100699226721,0.024976985179428,6.19146066208938e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,0.0220132532611854,0.00213037531430527,0.0178377176451471,0.0261887888772237,6.21019382895026e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.0778673415863961,0.00756583695179125,0.0630383011608852,0.0926963820119069,9.45383112777936e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,0.0485458095805071,0.004719788617682,0.0392950238898504,0.0577965952711638,9.78451242285609e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40058,0.048484994791734,0.00471671938983709,0.0392402247876533,0.0577297647958147,1.03951476656459e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,0.0391245524647848,0.00380655799473355,0.031663698795107,0.0465854061344625,1.05243750174443e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37445,0.0217638576955043,0.00212502292668269,0.0175988127592063,0.0259289026318024,1.58324006077009e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0257485906433142,0.00251604609246595,0.0208171403020809,0.0306800409845474,1.66578812133959e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,0.0618126392051153,0.0060441585258589,0.0499660884944318,0.0736591899157987,1.79574997094062e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40030,0.0528642994334486,0.00518674614820951,0.042698276982958,0.0630303218839392,2.54511901884212e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0226237208450937,0.00222151246309526,0.018269556417427,0.0269778852727604,2.77434927045911e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,39908,0.0549084641125808,0.005394377749612,0.0443354837233413,0.0654814445018203,2.92097669444526e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REN,Renin,39868,0.0634068818015146,0.00623754659438804,0.051181290476514,0.0756324731265152,3.35291246860556e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,39984,0.0226821360430865,0.0022317265418434,0.0183079520210735,0.0270563200650996,3.41308412134448e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0305142030102172,0.00300647289889331,0.0246215161283863,0.0364068898920481,3.93998681233208e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,0.0365574540476361,0.0036041673654712,0.0294932860113126,0.0436216220839597,4.20734619442057e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRN,Agrin,39931,0.0312610396275551,0.00308341882357683,0.0252175387333445,0.0373045405217657,4.40754556073588e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,0.0764225222642319,0.00753849568238244,0.0616470707267623,0.0911979738017015,4.60706606630346e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.055079826164264,0.00544179577014779,0.0444139064547743,0.0657457458737537,5.22589233895738e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.0857407701532966,0.00847168428725026,0.0691362689502861,0.102345271356307,5.28065831670873e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,0.0587156388305516,0.00580386134372451,0.0473400705968516,0.0700912070642516,5.52574725660907e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,39871,-0.0260460268765429,0.00257820412317734,-0.0310993069579705,-0.0209927467951153,6.3589672623387e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0585716819141859,0.00581069690919627,0.0471827159721613,0.0699606478562106,7.98137618066769e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39477,0.0704001871101404,0.00699104720523014,0.0566977345878893,0.0841026396323914,8.85728830817958e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,0.0447354064349691,0.00444359102850134,0.0360259680191065,0.0534448448508317,9.05907776624248e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37241,0.0223322618904358,0.00221928607674054,0.0179824611800244,0.0266820626008473,9.79640384998435e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37437,0.0419178998245047,0.00416658067991538,0.0337514016918705,0.0500843979571388,9.99931428890788e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0266266654734932,0.00265072714715952,0.0214312402650605,0.0318220906819259,1.13542093803922e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFI,Complement factor I,37453,0.019005035971404,0.00189170538599348,0.0152972934148568,0.0227127785279512,1.15109612026591e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39489,0.0616903357402023,0.0061480329171887,0.0496401912225124,0.0737404802578921,1.27184158860506e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.0709523035852849,0.00709000184004248,0.0570558999788016,0.0848487071917681,1.7162672608469e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,-0.0270785021553335,0.00270722429119025,-0.0323846617660664,-0.0217723425446006,1.74183857704198e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.0613709847530896,0.00613542345602901,0.0493455547792728,0.0733964147269065,1.74455736357205e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,0.0338331272757265,0.00338391210165799,0.0272006595564769,0.0404655949949762,1.81799879996194e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,0.0219802290231336,0.00219969428642413,0.0176688282217423,0.0262916298245249,1.98247468893898e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,39866,0.0376651874202869,0.00377372788425357,0.0302686807671499,0.0450616940734239,2.16300045878446e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37437,0.0648616410302572,0.00650275545017143,0.0521162403479212,0.0776070417125932,2.3718108972866e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_E,,39866,0.02584100639732,0.00259182255106829,0.0207610341972261,0.0309209785974138,2.40733227833654e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH1,Somatotropin,39846,-0.170196123568352,0.0170856179402485,-0.203683934731239,-0.136708312405464,2.63036212149709e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,39749,0.0397395862872574,0.00398957091720114,0.0319200272895431,0.0475591452849716,2.64607169573539e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,39973,0.0504375095811831,0.00507058749327203,0.0404991580943699,0.0603758610679963,3.03043318909013e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40030,0.0376130898311575,0.00378939694953012,0.0301858718100785,0.0450403078522365,3.74186625484071e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37169,0.121069746135007,0.0121975672062128,0.0971625144108298,0.144976977859184,3.8716574121299e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.102668098416077,0.0103442833617949,0.0823933030269589,0.122942893805195,3.88573798749945e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0581408444915872,0.00587612234429457,0.0466236446967698,0.0696580442864045,5.12455521180633e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37430,0.0526416592514176,0.00533433053341466,0.0421863714059248,0.0630969470969103,6.81037711758258e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,39897,-0.0335749688807355,0.00340335798201418,-0.0402455505254833,-0.0269043872359877,6.84241673212783e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.0914466447764476,0.00927615444933953,0.0732653820557421,0.109627907497153,7.53646857371217e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,0.112974500370984,0.0114658702277266,0.0905013947246395,0.135447606017328,7.96851163816271e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,39749,0.0339687704722414,0.00345571134390356,0.0271955762381904,0.0407419647062924,9.73287865628596e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,0.0629388872914229,0.00640450847477678,0.0503860506808604,0.0754917239019854,9.94527143437553e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40009,0.055489330215867,0.00564766388019977,0.0444199090106755,0.0665587514210586,1.0156984474967e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39455,0.0364797498637027,0.00371756345819527,0.02919332548564,0.0437661742417654,1.15340572453123e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0466678071999597,0.00476145604382801,0.0373353533540568,0.0560002610458626,1.2886954524269e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.0784242374878405,0.0080035176604235,0.0627373428734105,0.0941111321022706,1.32089797683389e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,39798,0.0281963107053407,0.00288039089465122,0.0225507445518243,0.033841876858857,1.45246771179957e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,39931,0.0361684696820553,0.00370052356782234,0.0289154434891236,0.0434214958749871,1.68396800703875e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.0655456652295632,0.00670745599019966,0.0523990514887718,0.0786922789703545,1.71969117888618e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,0.0522724037154371,0.00535505403227716,0.0417764978121739,0.0627683096187004,1.90583439668572e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0358580163084556,0.00367444200904396,-0.0430599226461818,-0.0286561099707295,1.95419382887844e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD248,Endosialin,37437,-0.0366161794700605,0.00375298796768455,-0.0439720358867222,-0.0292603230533988,2.04911072327539e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39477,0.057547088711642,0.00590376950266056,0.0459757004864273,0.0691184769368567,2.18960792175612e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.054352088024303,0.00558095674623902,0.0434134128016745,0.0652907632469315,2.43619638594253e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,0.0885982342496049,0.00911033248542639,0.0707419825781692,0.106454485921041,2.71509775618084e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,0.0564661594531255,0.0058114872372193,0.0450756444681757,0.0678566744380753,3.05184829238482e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0549451453195417,0.0056582923443256,0.0438548923246635,0.0660353983144198,3.13888498660902e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0395590647812713,0.00407968689927909,-0.0475552511038583,-0.0315628784586843,3.58539709994944e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,0.0680413000742364,0.00701820412610812,0.0542856199870645,0.0817969801614083,3.64448750769363e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,0.0782109796715587,0.00807782320800458,0.0623784461838698,0.0940435131592477,4.14138765165601e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,0.0453803112374877,0.0046912002725409,0.0361855587033075,0.0545750637716679,4.48606847688892e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,0.0156656727796283,0.00161904844296631,0.0124923378314143,0.0188390077278422,4.49905866452601e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37388,0.0346345048232124,0.00358465069178481,0.0276085894673142,0.0416604201791106,5.15575627617824e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,0.0396928595110478,0.00411192748391536,0.0316334816425737,0.0477522373795219,5.47465358263023e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,0.0787505725235338,0.008171380825442,0.0627346661056675,0.0947664789414001,6.37666828571353e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,-0.0476812037320317,0.00496381822684206,-0.0574102874566421,-0.0379521200074213,8.65606332279936e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0196680735932061,0.00205023916027655,0.015649604839064,0.0236865423473481,1.00578444411614e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.055788037973386,0.00582858750627287,0.0443640064610911,0.0672120694856808,1.20850129070995e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,0.0608886274534397,0.00637908675491762,0.0483856174138012,0.0733916374930782,1.59725830188829e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37348,0.0395880986805226,0.00416180098907764,0.0314309687419304,0.0477452286191148,2.17730141157078e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0433149775105685,0.00455672428983532,0.0343837979024912,0.0522461571186457,2.26723502271023e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,39587,0.0428338556092567,0.0045141614243078,0.0339860992176134,0.0516816120009,2.66545639839376e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40030,0.0341870990680591,0.00360421021362839,0.0271228470493475,0.0412513510867707,2.74477611970038e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,0.0680858052611218,0.00718143119241848,0.0540102001239816,0.0821614103982621,2.86474524248352e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39504,0.0444960380156174,0.00469629197514859,0.0352913057443261,0.0537007702869086,3.0496583877023e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0372248221423513,0.00393104218346028,0.0295199794627692,0.0449296648219335,3.19713945922552e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.126400672564959,0.0133572403823742,0.100220481415506,0.152580863714413,3.47693647291773e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0230466640754945,0.00244743860698239,-0.02784364374518,-0.018249684405809,5.39687738914657e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39314,0.0818591879556467,0.0086971207005418,0.0648128313825848,0.0989055445287086,5.52844260164387e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,39931,0.0680501069722038,0.00723675143016417,0.053866074169082,0.0822341397753255,5.9793745425832e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40058,0.0300518043192537,0.00320095764617173,0.0237779273327572,0.0363256813057503,6.88484310671277e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0366451401973196,0.00390447311425986,0.0289923728933702,0.0442979075012689,7.25135088335409e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,0.0736666281007275,0.00785147295796503,0.058277741103116,0.0890555150983389,7.28406834789381e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0452709189749663,0.00483451249746852,0.035795274479928,0.0547465634700046,8.90149472436885e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.032919667077693,0.00353004160088641,0.0260007855399556,0.0398385486154303,1.24773991430883e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,0.0295726299187939,0.00317624117132224,0.0233471972230023,0.0357980626145855,1.43426771399264e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,0.0261406387718301,0.00281706286685273,0.0206191955527987,0.0316620819908614,1.91736680439544e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.038074540641918,0.00410896275692709,0.0300209736383409,0.0461281076454951,2.22089870146622e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEP,Leptin,39868,0.0593834809456676,0.0064151004288685,0.0468098841050853,0.0719570777862498,2.36715166824207e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0325113192608903,0.00351282332354746,0.0256261855467373,0.0393964529750433,2.4582108168685e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,0.0279675542576807,0.00303084002645206,0.0220271078058346,0.0339080007095267,3.10066640247198e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,-0.034151504891668,0.00370261966259711,-0.0414086394303583,-0.0268943703529777,3.23033466102017e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37043,0.0651246812185125,0.00708371184594139,0.0512406060004674,0.0790087564365577,4.36236440763007e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0244170985069518,0.00265846613823933,0.0192065048760027,0.0296276921379009,4.62398448206984e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0463029742553716,0.0050533238280356,0.0363984595524219,0.0562074889583214,5.77212001002848e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0355926525287529,0.00388660554055663,0.0279749056692619,0.0432103993882439,5.92352982039742e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40058,0.0819462567937916,0.0089672082865948,0.0643705285520657,0.0995219850355174,7.07175328788254e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,0.0255588379281933,0.00280015761387329,0.0200705290050016,0.0310471468513849,7.81611424237039e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,-0.0259470494648706,0.00284278904414,-0.031518915991385,-0.0203751829383562,7.85872666922153e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37437,0.0255108104864079,0.00279483909991316,0.0200329258505781,0.0309886951222377,7.96170326892632e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0508962003950919,0.00558315374377971,0.0399532190572837,0.0618391817329002,8.72363065791029e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,39858,0.0460908368331556,0.00505948377621533,0.0361742486317736,0.0560074250345377,9.21229448222984e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,39880,0.0504157913404204,0.00553458778570608,0.0395679992804365,0.0612635834004043,9.25900378303056e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,39913,0.0334693858108685,0.00367875028448384,0.0262590352532802,0.0406797363684568,1.02566081937712e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,-0.0340972856429578,0.00374996681574674,-0.0414472206018214,-0.0267473506840942,1.07706706267442e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANG,Angiogenin,39843,0.0290889924291643,0.00319956069439668,0.0228178534681468,0.0353601313901818,1.08879720498053e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.0626983672654078,0.00690477484222895,0.0491650085746391,0.0762317259561766,1.23337817800247e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,-0.0206326401888912,0.00227491160580074,-0.0250914669362607,-0.0161738134415218,1.33076907901824e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.097660573657885,0.0107674611609566,0.0765563497824101,0.11876479753336,1.35528944178749e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,39585,-0.0200575763856124,0.00221357353313848,-0.0243961805105638,-0.015718972260661,1.43971569433518e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.0297931429899808,0.00329559306057321,0.0233337805912573,0.0362525053887043,1.73813810447313e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTD,Biotinidase,37453,0.0175996812224972,0.00194636822529153,0.0137847995009259,0.0214145629440686,1.73883759401923e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORT1,Sortilin,39846,0.0319232679604759,0.00353205566006806,0.0250004388667425,0.0388460970542093,1.77250260524292e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0228665089816659,0.0025324709352814,0.0179028659485144,0.0278301520148174,1.92183399029824e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,39931,0.0863834694158625,0.0095696027080145,0.0676270481081541,0.105139890723571,1.96315216667147e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,0.0539755495448092,0.00598040127806142,0.0422539630398088,0.0656971360498096,2.02891865184038e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.0837801321929083,0.00929118863491006,0.0655694024684846,0.101990861917332,2.14491780241636e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,39795,0.0388040074116879,0.00430508995879851,0.0303660310924428,0.047241983730933,2.21803932479703e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0364337478251643,0.00405586862961374,-0.0443832503392072,-0.0284842453111214,2.92547367496128e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0442134840128388,0.00492483076872846,0.034560815706131,0.0538661523195466,3.06685503574151e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,39859,0.0267134368333911,0.00297736533263251,0.0208778007814314,0.0325490728853508,3.22396470002423e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.023596791681528,0.00263177986482016,0.0184385031464805,0.0287550802165755,3.47878315706598e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,39866,0.0532543512475115,0.00594617585788495,0.041599846566057,0.064908855928966,3.72834493115676e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,39866,0.0808949604529954,0.00903797655880586,0.0631805263977359,0.0986093945082549,3.91813601158374e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.042834616954225,0.00479058732386412,0.0334450657994513,0.0522241681089987,4.33493351329387e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.0646867187241918,0.00723511684440144,0.050505889709165,0.0788675477392187,4.36226048730084e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,0.0360939955498252,0.00404472497008882,0.0281663346084511,0.0440216564911993,4.98923110615245e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0462526246523349,0.00518483952580513,0.0360903391817568,0.0564149101229129,5.1241867705757e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,0.0672005568261248,0.00754368379347661,0.0524149365909107,0.081986177061339,5.74957818792229e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,0.0776974871727421,0.0087264855484092,0.0605935754978601,0.0948013988476241,5.97457828540683e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0288265174100343,0.00323818911294079,0.0224796667486703,0.0351733680713982,6.07555430244312e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,0.0392116198839272,0.00440523978685049,0.0305773499017002,0.0478458898661542,6.11429288767801e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.0895114842848352,0.0100682518866384,0.0697777105870239,0.109245257982647,6.72314838140097e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.0729450126106141,0.00822615512921837,0.0568217485573461,0.0890682766638821,8.25822721012045e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40058,-0.00755545132294656,0.000852850435074301,-0.00922703817569219,-0.00588386447020093,8.8927521235084e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40009,0.0485340056993023,0.00548712588862566,0.037779238957596,0.0592887724410086,1.0077441824468e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDK,Midkine,39843,0.0423205315727874,0.00478533005090899,0.0329412846730058,0.051699778472569,1.02016843502832e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,0.0224844867847463,0.00254569971222675,0.0174949153487818,0.0274740582207107,1.12869270396932e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,0.0331403284303099,0.00375373535215867,0.0257830071400789,0.0404976497205409,1.19118421482915e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0256127082686916,0.0029041231639479,0.0199206268673537,0.0313047896700295,1.28966349323389e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37437,0.0234050690175423,0.0026545544370658,0.0182021423208933,0.0286079957141913,1.3178420816523e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.0640656365488897,0.00727197918772406,0.0498125573409505,0.0783187157568288,1.37931232745912e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,39913,0.0447697149595073,0.00509544773808758,0.0347826373928557,0.054756792526159,1.70076923144848e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39476,0.0580378605627453,0.00661681313590052,0.0450689068163803,0.0710068143091103,1.94634489418655e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0250457743467064,0.00285601161680523,0.0194479915777681,0.0306435571156446,1.97100452256815e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0305390758665233,0.00348368245870828,0.0237110582474551,0.0373670934855916,2.07023992697343e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40030,0.0310826971740351,0.00354788579773909,0.0241288410104665,0.0380365533376037,2.1259395777182e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,39789,0.0623697014589494,0.00712234082080095,0.0484099134501796,0.0763294894677193,2.20537480907617e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBIN,Erbin,39788,0.085193620290017,0.00973471788485499,0.0661135732357012,0.104273667344333,2.31272634091137e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.0685101187908369,0.00784553738975897,0.0531328655069093,0.0838873720747645,2.78959486171949e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.0351368290324397,0.00403119193317361,0.0272356928434194,0.0430379652214599,3.15264698409705e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0195936664805385,0.00225138246111304,-0.0240063761043201,-0.015180956856757,3.54318448826949e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.0572708910986773,0.0065794580126676,0.0443751533938488,0.0701666288035058,3.55525294333906e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,0.0450502955784695,0.00518101426986086,0.0348955076095422,0.0552050835473968,3.79977250391759e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,39866,0.0691712914422096,0.00796518119175526,0.0535595363063693,0.0847830465780499,4.17679313129997e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40052,0.0445646017821517,0.00514539662076984,0.0344796244054429,0.0546495791588606,5.10846141419069e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39489,0.0284084662271883,0.00328067912005623,0.021978335151878,0.0348385973024985,5.2031396504262e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,0.0712401829747721,0.00823785312746406,0.0550939908449425,0.0873863751046016,5.7357638258556e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.067326478225889,0.00779187369542044,0.0520544057828649,0.0825985506689131,6.10809243575369e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0534498256581926,0.00618922666019254,0.0413189414042152,0.0655807099121699,6.49058899264907e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREH,Trehalase,37437,0.0615612820945463,0.00713726660114267,0.0475722395563067,0.0755503246327859,7.09307058635266e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40009,0.0499237602317435,0.00578967696000141,0.0385759933901407,0.0612715270733463,7.12613008027049e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.046366399013817,0.00537753199201582,0.035826436309466,0.056906361718168,7.17185223428254e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,0.0432227420938218,0.0050382398726355,0.0333477919434562,0.0530976922441873,1.04338720102934e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37437,0.0186079640807105,0.00217032512165267,0.0143541268422713,0.0228618013191498,1.10844382084568e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,0.0528074596109879,0.00616604848264189,0.0407220045850098,0.064892914636966,1.18534850601356e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,39749,0.0526247739043676,0.00615283857798108,0.0405652102915246,0.0646843375172105,1.30813235033079e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0443179687921941,0.00518428248733688,0.0341567751170139,0.0544791624673744,1.35845702685853e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0496834449658218,0.00581122083017349,0.0382934521386817,0.0610734377929618,1.3662766083962e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,0.0696458418264504,0.00815585633345687,0.0536603634128749,0.0856313202400259,1.49248428396856e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,0.0713558469771342,0.00836213021931404,0.0549660717472786,0.0877456222069897,1.5735417071906e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0252528651234932,0.00296092763657313,0.0194494469558099,0.0310562832911765,1.60917396885514e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,-0.031668588125571,0.00371523970094658,-0.0389504579394263,-0.0243867183117157,1.67771154985941e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0239117781520112,0.00280886268071462,0.0184064072978105,0.0294171490062119,1.87245477389926e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.0875592675413209,0.0102886054926787,0.0673936007756706,0.107724934306971,1.91560924537457e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.0430229118438545,0.00506067295999947,0.0331039928422556,0.0529418308454535,2.03734819461194e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,37453,0.0584082054986584,0.00687673973709843,0.0449297956139455,0.0718866153833713,2.20981643153387e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0625488155399558,0.00737213687990289,-0.0769982038245654,-0.0480994272553461,2.35399745492535e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,39713,0.0638551204669204,0.00756164427120253,0.0490342976953634,0.0786759432384773,3.31198956155647e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,0.100806250575689,0.0119514032647188,0.0773815001768404,0.124231000974538,3.60025125422472e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.0597526578146991,0.00708256318861893,0.045870833965006,0.0736344816643922,3.60526453937048e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0354460902743169,0.00420801390471024,0.0271983830210848,0.043693797527549,3.96399480990239e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,39868,0.0529759737449517,0.00629200314315882,0.0406436475843604,0.0653082999055429,4.09515289208188e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.025414973309236,0.00302023753675193,0.0194953077372022,0.0313346388812697,4.2584113446096e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.0794019300412105,0.00943624277186179,0.0609068942083614,0.0978969658740596,4.26889115428226e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,0.044918743838639,0.00534495314897287,0.0344426356666522,0.0553948520106258,4.68481253560395e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.0390734849457538,0.00465172800767672,0.0299560980507075,0.0481908718408002,4.84337605484446e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,0.109375314479125,0.0130436256140265,0.0838098082756328,0.134940820682616,5.47650827760089e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,0.0665806608948033,0.00794544705115404,0.0510075846745414,0.0821537371150652,5.82465829277728e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37437,0.0595504602075095,0.00711763437456234,0.0455998968333673,0.0735010235816517,6.50454975104111e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,0.033957953292022,0.00406514562575285,0.0259902678655464,0.0419256387184975,7.16148345812174e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39489,0.0481766182261638,0.00577603444728002,0.036855590709495,0.0594976457428326,7.99021058138775e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.05434316726045,0.00651542636789922,0.0415729315793675,0.0671134029415325,8.11440774878211e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COCH,Cochlin,37437,0.0361354481813623,0.00433531124988021,0.0276382381315971,0.0446326582311275,8.47867174668833e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,39931,0.0382746034614496,0.00459292337064822,0.0292724736549791,0.0472767332679201,8.48463343744921e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0407877674667247,0.00490404655192606,0.0311758362249497,0.0503996987084998,9.88662001602139e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37411,0.0830170394777697,0.0100123460805927,0.0633928411598079,0.102641237795731,1.22322753668408e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0295666260266621,0.00356905191925522,0.0225712842649218,0.0365619677884023,1.28264517924929e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37382,0.0818096991284137,0.00988021403150755,0.0624444796266589,0.101174918630168,1.34482859864003e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0280774742898604,0.00339265844961432,0.0214278637286163,0.0347270848511045,1.37962996915726e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.0569991742803341,0.00689575340669603,0.0434834976032098,0.0705148509574583,1.51571068075566e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.0739889555312641,0.00895457893854403,0.0564379808117178,0.0915399302508104,1.53433937159451e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37124,0.0228470206766359,0.00276585008061448,0.0174259545186315,0.0282680868346403,1.58861875606857e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNST,Consortin,39868,0.0844555056696069,0.010232933031572,0.0643989569277258,0.104512054411488,1.65969508357455e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.0550607308609234,0.00667257867961971,0.0419824766488688,0.0681389850729781,1.6829694275405e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,37453,0.0276405228332872,0.00335735216534131,0.0210601125892182,0.0342209330773562,1.99391706458788e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELP,P-selectin,39931,0.0447079580516707,0.0054402719778298,0.0340450249751243,0.0553708911282171,2.22625985654384e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,0.0463622206559535,0.00564453475752599,0.0352989325312026,0.0574255087807045,2.3393101801701e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.0890667777223583,0.0108482144610494,0.0678042773787015,0.110329278066015,2.40579540112178e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.0735046218816747,0.00896069855231073,0.0559416527191457,0.0910675910442038,2.52249703258374e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37368,0.0166100677306047,0.00202547268927702,0.0126401412596217,0.0205799942015876,2.60667680802037e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,39866,0.0666959553025143,0.00814632409541512,0.0507291600755007,0.082662750529528,2.87243039106853e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37043,0.0396613599210096,0.00484454712453681,0.0301660475569174,0.0491566722851017,2.92759816595776e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0339552919938655,0.00414921182734899,0.0258228368122614,0.0420877471754695,3.00492821236954e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.0560671276729796,0.00685849814833208,0.0426244713022488,0.0695097840437105,3.18091098697919e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37056,0.0350089854907404,0.0042900772559525,0.0266004340690735,0.0434175369124074,3.63821718305584e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.0802453967132973,0.00984381243509498,0.0609515243405112,0.0995392690860835,3.84672031027163e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0359263707282001,0.0044100446538167,0.0272826832067193,0.0445700582496808,4.02093098696241e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0261034954541265,0.00320924170723428,0.0198133817079473,0.0323936092003057,4.46895486691201e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0560869971831882,0.00690582784237972,0.042551574612124,0.0696224197542525,5.00390695263965e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,39913,0.0436625383501801,0.00537867713589775,0.0331203311638205,0.0542047455365397,5.09243785807654e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40058,0.029353046545228,0.00361615061089727,0.0222653913478694,0.0364407017425867,5.11026198265415e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.032877086594006,0.00405918272278871,-0.0408330847306718,-0.0249210884573401,5.9165231408289e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,39847,-0.0392733977739444,0.0048603263349632,-0.0487996373904723,-0.0297471581574166,6.91303077761347e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.0196942199532718,0.00243830122347115,-0.0244732903512753,-0.0149151495552683,7.19403109535823e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,39843,0.0297184496522394,0.0036865364868301,0.0224928381380524,0.0369440611664264,8.07592860026364e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0538976260854715,0.00668661551296913,0.040791859680052,0.067003392490891,8.13350819261202e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,0.0337475426990649,0.00418921954519649,0.0255366723904798,0.04195841300765,8.44904040938288e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.022895501545905,0.00284391088236502,0.0173214362164695,0.0284695668753404,8.80612531557747e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,39715,0.0554021287837958,0.00688696178487971,0.0419036836854315,0.06890057388216,9.26843150019416e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.028328347091822,0.00353533121363368,0.0213990979131,0.035257596270544,1.21381286576763e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,0.0588838167297198,0.00736889874351784,0.0444407751924249,0.0733268582670148,1.42991041717126e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,0.0416641292705607,0.00521959068484502,0.0314337315282645,0.0518945270128569,1.5360907245102e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,39866,0.0617213843316889,0.00773537341129657,0.0465600524455477,0.0768827162178302,1.57310634274159e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,0.029748485978758,0.00373515741020187,0.0224275774547623,0.0370693945027537,1.77323191892236e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0493433056251975,0.00619755161050707,0.0371961044686036,0.0614905067817913,1.83358248516581e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,39868,0.0424466487914237,0.00533602743942819,0.0319880350101445,0.052905262572703,1.91452725954705e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,39866,0.0692813745528962,0.00871017998033924,0.0522094217914313,0.0863533273143611,1.92472132132435e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,39866,0.0437981985574662,0.005522913658903,0.0329732877860163,0.0546231093289161,2.33019113502546e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.0505092585632205,0.00637095594088106,0.0380221849190937,0.0629963322073474,2.37579795368113e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,0.0622962100022844,0.00786804173539592,0.0468748482009084,0.0777175718036604,2.57896184084988e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37056,0.0695066996756894,0.00878197443925793,0.0522940297747439,0.0867193695766349,2.67542018729828e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0313455370343572,0.00396588244369673,0.0235724074447117,0.0391186666240028,2.87829686757718e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,39866,0.0608126805836356,0.00769447390310944,0.0457315117335411,0.0758938494337301,2.8891049789554e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39405,0.0886518583320497,0.0112227952021728,0.0666551797357911,0.110648536928308,2.9922133178233e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0276164554942373,0.00350255059665051,0.0207514563248023,0.0344814546636723,3.35584667263107e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37056,-0.0222211147856128,0.00281857466877748,-0.0277455211364167,-0.016696708434809,3.42371514316873e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,39788,0.0548418049620915,0.00698166375262894,0.0411577440069388,0.0685258659172442,4.24733439085376e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,0.0571553457709778,0.00728175976777559,0.0428830966261376,0.0714275949158179,4.50373079914705e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,0.030926344697417,0.00394153844680526,0.0232009293416787,0.0386517600531554,4.61316656753814e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSG,Basigin,40040,0.0144467788295055,0.00184265511241913,0.010835174809164,0.018058382849847,4.77712409492488e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0299658559637869,0.00383494091413255,0.0224493717720871,0.0374823401554867,5.89334500825539e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0335178970453047,0.00429465672800768,0.0251003698584097,0.0419354242321998,6.34770907622265e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RETN,Resistin,39790,0.0301270979985453,0.00386374599378125,0.0225541558507341,0.0377000401463566,6.70974177029544e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,39788,0.0241577518718616,0.00309843065810209,0.0180848277819814,0.0302306759617417,6.74218831379728e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37368,0.061309150873871,0.00786205495284239,0.0458995231662999,0.0767187785814421,6.74302695954031e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,0.0165541855493766,0.00212550915894066,0.0123881875978529,0.0207201835009003,7.27986293457972e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0396860702160219,0.00510065841806893,0.0296887797166068,0.049683360715437,7.74971756453431e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0186994599611628,0.00240393585660423,0.0139877456822185,0.0234111742401071,7.7731587279525e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39477,0.0300182233168314,0.00386064377104661,0.0224513615255801,0.0375850851080828,7.98539476664606e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0357515079098262,0.00459883002184401,0.026737801067012,0.0447652147526405,8.05669298624016e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0422998444950263,0.0054452993883505,0.0316270576938593,0.0529726312961933,8.44906242577225e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.0823035648871877,0.010612208319188,0.0615036365815792,0.103103493192796,9.32839433085158e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,-0.0215194629607604,0.00278071068573066,-0.0269696559047925,-0.0160692700167283,1.07424699788526e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,39720,0.0377268101202713,0.00487640767476759,0.0281690510777269,0.0472845691628158,1.0823085517154e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0157042142476343,0.00203029052095872,-0.0196835836687134,-0.0117248448265552,1.09684265514675e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,0.077735118227026,0.0100541517994632,0.0580289807000782,0.0974412557539738,1.12427150363373e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0465283294358346,0.00602191360580287,0.034725378768461,0.0583312801032082,1.1706881819431e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0275142153263466,0.00356297424676461,0.020530785802688,0.0344976448500052,1.21021884379626e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.0547053954726608,0.00709275639411827,0.040803592940189,0.0686071980051326,1.30298832326655e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,39669,0.0337723700663531,0.00438175966728055,0.0251841211184832,0.042360619014223,1.35914412045235e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0248025014078073,0.0032182727392503,0.0184946868388767,0.0311103159767379,1.36556868503794e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBN,Nibrin,39587,0.0376241838962533,0.00488411528464087,0.0280513179383572,0.0471970498541494,1.40388154813921e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,39788,0.0516560323279938,0.00671306264421133,0.0384984295453396,0.064813635110648,1.49925535784499e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0352873072050109,0.0045866517787721,0.0262974697186175,0.0442771446914042,1.53082481072304e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.0480300962983368,0.00625022571212287,0.035779653902576,0.0602805386940976,1.6407657323681e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,0.0380912821706135,0.00495950247498982,0.0283706573196335,0.0478119070215936,1.67539083345607e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,0.0622563799596995,0.00810997885366896,0.0463608214065083,0.0781519385128906,1.72838685482385e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0185145655139169,0.00241551241034766,0.0137801611896355,0.0232489698381983,1.89230250253292e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0295087245040631,0.00385153637740207,-0.0370577358037711,-0.021959713204355,1.9424475161926e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0223687973617567,0.00292108634117153,-0.0280941265904529,-0.0166434681330605,1.99949781165308e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,0.0402658827209085,0.00526962474252826,0.0299374182255531,0.0505943472162639,2.29750717982798e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37306,0.0681748814065601,0.00892499288217759,0.050681895357492,0.0856678674556282,2.34319103166031e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,-0.0295006740568702,0.0038650467960752,-0.0370761657771776,-0.0219251823365628,2.42803701118464e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPTC,Opticin,39788,-0.0318832097832564,0.00418188546009965,-0.0400797052850517,-0.0236867142814611,2.59515640523716e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0407730908602015,0.00535968682578714,0.0302681046816587,0.0512780770387443,2.95540292142484e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,37453,0.0222169895361195,0.00292147479849036,0.0164908989310784,0.0279430801411606,3.04229739083687e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0271509089107493,0.00357275464874027,0.0201483097992183,0.0341535080222802,3.16984243683349e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,39794,0.0607516023865076,0.00799816583010747,0.045075197359497,0.0764280074135183,3.23104764004002e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.0492940097803739,0.00649020137826842,0.0365732150789678,0.06201480448178,3.24239087788315e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,0.0522966929063307,0.00689344491151222,0.0387855408797668,0.0658078449328947,3.50216046288793e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,0.0260076323361015,0.00343030032467789,0.0192842436997328,0.0327310209724702,3.59856505440548e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,39788,0.0942158288112981,0.0124479140826641,0.0698179172092765,0.11861374041332,3.97243223410398e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,0.0559483758997789,0.00739884484040624,0.0414466400125826,0.0704501117869751,4.19154001375744e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,39788,-0.0547076697599082,0.00724448229635443,-0.0689068550607629,-0.0405084844590535,4.53092854928783e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,0.026936360851654,0.00356805052972471,0.0199429818133936,0.0339297398899145,4.61628722767898e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0202989473674333,0.00268942097920613,0.0150276822481893,0.0255702124866773,4.6696622891329e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.0692487369085822,0.00917605812857317,0.0512636629765787,0.0872338108405856,4.70922465742539e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,0.0209545005461764,0.00278726606353054,0.0154914590616566,0.0264175420306963,5.87092332236254e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.0239530664070338,0.00318632672641776,0.017707866023255,0.0301982667908126,5.88070202161516e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.0553536178932721,0.00736339262531199,0.0409213683476606,0.0697858674388836,5.93769443871407e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,36543,0.0174770176795113,0.00232765133447991,0.0129148210639306,0.0220392142950919,6.38358769514532e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,0.0555372896742166,0.00740277062051187,0.0410278592580134,0.0700467200904199,6.67300442366076e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.0572910891688373,0.00763845446611011,0.0423197184152615,0.0722624599224131,6.76017309615656e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,0.0209787316297551,0.00279806808342184,0.0154945181862483,0.0264629450732619,6.90501027519395e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37424,-0.0266432509958258,0.00355434614459198,-0.0336097694392261,-0.0196767325524256,6.98882221718845e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37249,0.0783850838411383,0.0104615924887755,0.0578803625631384,0.0988898051191383,7.17232667354656e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,-0.0199722314183908,0.00266949529905478,-0.0252044422045381,-0.0147400206322434,7.72027027279973e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,0.0455952660652225,0.0060974680055085,0.0336442287744258,0.0575463033560191,8.02539071665139e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TF,Serotransferrin,37453,0.0154806647108448,0.0020721982422923,0.0114191561559519,0.0195421732657377,8.46642944359864e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.04595590691715,0.00615484506442147,-0.0580194032434161,-0.033892410590884,8.6532600852893e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,0.0660437562502814,0.0088647901611472,0.0486687675344329,0.0834187449661299,9.80104088344865e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,-0.0240089460049623,0.0032260438993604,-0.0303319920477087,-0.017685899962216,1.04030194988117e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,0.0342776472173938,0.00460858902224447,0.0252448127337946,0.043310481700993,1.07587621328426e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,0.0596959722353994,0.00802611721831734,0.0439647824874975,0.0754271619833014,1.07655502686651e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39477,0.0328993336378916,0.00442368008566438,0.0242289206699894,0.0415697466057937,1.08265853601432e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39489,0.0503696191900242,0.00677626279494228,0.0370881441119373,0.0636510942681111,1.11450967619071e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37382,0.0501746403140606,0.00675689740904279,0.0369311213923367,0.0634181592357844,1.18900737731535e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39489,-0.0517241819875598,0.00698085190797864,-0.0654066517271979,-0.0380417122479216,1.33318243759889e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0243885064593068,0.0032938170189151,-0.0308443878163804,-0.0179326251022332,1.38370250697407e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,39720,0.0362493034984588,0.00489567537729997,0.0266537797589508,0.0458448272379667,1.38408599006727e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,37453,0.0291380845372936,0.00393488643004801,0.0214257071343995,0.0368504619401877,1.38797501387409e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0361694518557872,0.00488919114693034,0.0265866372078037,0.0457522665037707,1.45279282226761e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.0152360720395617,0.00206150665693825,-0.0192766250871607,-0.0111955189919628,1.5453821920715e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37422,0.0325219980693687,0.00440203308414365,0.0238940132244471,0.0411499829142903,1.57819136047694e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,0.0361125983881696,0.00488984462573985,0.0265285029217195,0.0456966938546197,1.59691529942597e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37124,0.0354730932606244,0.004806916808372,0.0260515363162153,0.0448946502050335,1.68216967203962e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,0.0387740681558391,0.00525917226610413,0.028466090514275,0.0490820457974032,1.75413352908928e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37411,-0.0314818542464203,0.00426980320077556,-0.0398506685199404,-0.0231130399729002,1.76319088147413e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.0405160549053534,0.00550011636390374,0.0297358268321021,0.0512962829786047,1.83901932712321e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,39809,0.0190916997082458,0.00259394694256737,0.0140075637008138,0.0241758357156779,1.92732102312986e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,0.054333295741957,0.00738370237649009,0.0398612390840364,0.0688053523998775,1.9662212119439e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,39868,0.0855205412737752,0.0116271667729108,0.06273129439887,0.10830978814868,1.99819103502994e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.0679472004435846,0.0092441341077977,0.0498286975923011,0.0860657032948681,2.09403819522072e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39477,0.0686388586331504,0.00934026756751545,0.0503319342008201,0.0869457830654806,2.10040276457756e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,0.0503228776471766,0.00685578387303651,0.036885541256025,0.0637602140383281,2.25382806942249e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37368,0.0275643362522654,0.00375675208172967,0.0202011021720752,0.0349275703324556,2.30413908665141e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,0.0570818218740602,0.00778143787435881,0.0418302036403169,0.0723334401078035,2.3317495700917e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37368,0.0250897301743657,0.00342044386263664,0.0183856602035979,0.0317938001451335,2.33957897260031e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37124,0.0480555448021154,0.0065533533114891,0.0352109723115968,0.0609001172926341,2.38157881504819e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.0467996114203164,0.00638422914077495,0.0342865223043975,0.0593127005362353,2.40513286006369e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,0.0341300824606884,0.00466437415610802,0.0249879091147167,0.0432722558066601,2.67879666399953e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0216171172590499,0.00295507252309524,0.0158251751137832,0.0274090594043165,2.71341630830424e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,0.0321858812936368,0.00440375008352473,0.0235545311299284,0.0408172314573453,2.82703223616232e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0250984765185778,0.00343903038927118,0.0183579769556063,0.0318389760815493,3.08487185374923e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,36879,0.0483391051334371,0.00662643475639607,0.0353512930109008,0.0613269172559734,3.16202568652593e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,-0.0207597003852412,0.00285265651282265,-0.0263509071503736,-0.0151684936201088,3.56123569897122e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0431574223455381,0.00594396263860183,0.0315072555738786,0.0548075891171977,4.06068882628167e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,-0.0300353765077191,0.00414125342675634,-0.0381522332241615,-0.0219185197912766,4.2766538822243e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,39747,0.0156696873073468,0.00216278152672007,0.0114306355149755,0.0199087390997182,4.51781551021264e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37371,0.058328364371662,0.00806686613798536,0.0425173067412107,0.0741394220021133,5.0667661064939e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,0.0469847703458741,0.00650368725683082,0.0342375433224857,0.0597319973692625,5.26302112185824e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,0.0526088583621526,0.00728389001921371,0.0383324339244937,0.0668852827998115,5.37115144552653e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0355704880950752,0.0049328359742729,-0.04523884660465,-0.0259021295855003,5.80441155136675e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37186,-0.120486686277179,0.0167064467469945,-0.153231321901288,-0.0877420506530696,5.81163094059303e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,0.0292629512428907,0.00406077231533668,0.0213038375048308,0.0372220649809506,6.06457143634536e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37388,0.0518186072418631,0.00719291487893962,0.0377204940791414,0.0659167204045847,6.15112636420009e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.0705564960383026,0.00979695114042606,0.0513544718030675,0.0897585202735377,6.26083792322307e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.0436969720959089,0.00607023340932526,0.0317993146136314,0.0555946295781864,6.40465045973909e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,0.0489691475993447,0.00680782189681415,0.035625816681589,0.0623124785171004,6.61219042546258e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,0.0153082579426924,0.00212918406223986,0.0111350571807023,0.0194814587046825,6.77960531463461e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,0.0218409825748338,0.00303867148188046,0.0158851864703481,0.0277967786793195,6.94474038439261e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.05436552821005,0.00759073583984584,0.0394876859639522,0.0692433704561479,8.36776686922478e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.0637485660120708,0.00890516390945511,0.0462944447495388,0.0812026872746029,8.5696785352277e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.0697514638302169,0.0097674271238635,0.0506073066674445,0.0888956209929894,9.64485593086459e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NADK,NAD kinase,39868,0.0361061265146262,0.00506006170746729,0.0261884055679903,0.046023847461262,1.00561845220204e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.065826646389694,0.00923504444444386,0.0477259592785841,0.083927333500804,1.06254954466926e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37124,0.0195750532476403,0.00274733454610287,0.0141902775372787,0.0249598289580019,1.09369836788951e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELL,L-selectin,37453,-0.0152878227353207,0.00214773908783874,-0.0194973913474846,-0.0110782541231568,1.14913286060842e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0394392523210584,0.00554276901493284,0.02857542505179,0.0503030795903267,1.17283538940414e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0520259326811259,0.00731441394524352,0.0376896813484486,0.0663621840138032,1.19583287041177e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,0.0531685716589795,0.00747832665678237,0.0385110514116861,0.067826091906273,1.2229018428461e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,0.0226931409333137,0.00319276117319618,0.0164353290338492,0.0289509528327782,1.24070930966513e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,39829,0.0447395695541852,0.006308692057196,0.032374533122081,0.0571046059862893,1.37994470312009e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37124,0.0781287532723909,0.0110267258705498,0.0565163705661132,0.0997411359786686,1.45644263935174e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,0.0637900151346903,0.0090065796443102,0.0461371190318423,0.0814429112375383,1.47360024863941e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39453,0.0301629461679434,0.00426930873469117,0.0217951010479487,0.0385307912879381,1.67333608734664e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0336112562904052,0.00475779587870851,0.0242859763681365,0.0429365362126739,1.68025951517587e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,0.0385916486005722,0.00547069827624955,0.0278690799791231,0.0493142172220213,1.80581732067344e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,39868,0.0233792913211434,0.00331440107360955,0.0168830652168687,0.0298755174254181,1.81157328305403e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.068537143731369,0.00972199263339374,0.0494820381699173,0.0875922492928208,1.88000565620767e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,0.0156652154105741,0.00222652418383317,0.0113012280102611,0.0200292028108871,2.0616434602945e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37377,0.0503088257599291,0.00715750157764894,0.0362801226677372,0.0643375288521211,2.18268335076158e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,-0.0164781366312218,0.00234623448276772,-0.0210767562174465,-0.0118795170449971,2.2542360477051e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0159911018594667,0.00227674703553015,0.0115286776698276,0.0204535260491058,2.26414597021234e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0245427454882676,0.0034964752859017,0.0176896539279002,0.0313958370486349,2.32126496208178e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,39913,-0.0178676374299006,0.0025487676646806,-0.0228632220526746,-0.0128720528071266,2.47269992269258e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,39749,0.0411943296422846,0.00587776791846817,0.0296739045220869,0.0527147547624822,2.5057240160655e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.042305919683107,0.00604485397125416,0.0304580058994488,0.0541538334667651,2.68922473775203e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.0602514623936166,0.00860853067697021,0.043378742266755,0.0771241825204782,2.69860198210771e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0347737903167285,0.00497630101747442,0.0250202403224787,0.0445273403109784,2.90356559044478e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40030,0.0738098089232128,0.0105661377882128,0.0531001788583157,0.0945194389881098,2.94895284566148e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37385,0.0640148416399969,0.00916324211753102,0.0460548870896361,0.0819747961903577,2.95962241049499e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37388,0.0438338016491866,0.00627989922035166,0.0315251991772974,0.0561424041210759,3.08897486939415e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37043,-0.0433893121549448,0.00622129409937585,-0.0555830485897214,-0.0311955757201681,3.22003899876175e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,0.022124106465971,0.00318344276159523,0.0158845586532443,0.0283636542786976,3.82650305289592e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0276091756018982,0.00397420633604206,0.0198197311832558,0.0353986200205407,3.87171406193326e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37368,0.0421852369486319,0.00607998816652342,0.030268460142246,0.0541020137550178,4.14707320582036e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37138,-0.0139693602976412,0.00201370117631957,-0.0179162146032275,-0.0100225059920548,4.18607196894285e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0126355734458796,0.00182483494873986,0.00905889694634944,0.0162122499454097,4.55085828680999e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0402674422394188,0.00582233598831431,0.0288556637023227,0.0516792207765148,4.82004348326229e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,0.049742856142484,0.00719121281022508,0.0356480790344429,0.0638376332505252,4.82042804216195e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37445,0.0475375508725843,0.006881247531277,0.0340503057112814,0.0610247960338872,5.12420819490333e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.0597332931945609,0.0086507484022945,0.0427778263260637,0.0766887600630581,5.2506436391661e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,39796,0.0210495576566085,0.00305531036752059,0.0150611493362682,0.0270379659769489,5.80849457643542e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0310195458455271,0.00450189136936707,0.0221958387615677,0.0398432529294866,5.81244133337612e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0391962595796635,0.00569441404315637,0.028035208055077,0.05035731110425,6.11349659265875e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,0.0341912874293117,0.00496935088684932,0.024451359691087,0.0439312151675363,6.18585466693192e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,39788,0.0617970411131961,0.00899411014566315,0.0441685852276963,0.0794254969986958,6.61920751003434e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0310980539860888,0.00453591103738001,0.022207668352824,0.0399884396193536,7.38985485748318e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40009,0.0750222399242788,0.0109575335017931,0.0535454742607644,0.0964990055877932,7.83304111366667e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.021291941367955,0.00311023987134587,0.0151958712201171,0.0273880115157929,7.88371068246669e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,39862,-0.0141032507691461,0.00206021179358542,-0.0181412658845735,-0.0100652356537187,7.89592437795619e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,-0.0187139105848553,0.002734188530396,-0.0240729201044314,-0.0133549010652791,7.95451196962616e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,36991,0.0256639006195341,0.0037518489240234,0.0183102767284483,0.03301752451062,8.25086238384493e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,0.0321806633951089,0.00471149760230796,0.0229461280945853,0.0414151986956326,8.78242271264493e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37388,0.0397345217064389,0.0058185840754577,0.0283300969185418,0.051138946494336,8.92216792729223e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,39882,0.0402277782293444,0.00589774581539786,0.0286681964311646,0.0517873600275242,9.37253828780864e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGN,Biglycan,39448,-0.0770296864768937,0.0113068520302038,-0.0991911164560931,-0.0548682564976943,9.93208059399169e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0290113503695422,0.00426096399305612,0.0206598609431522,0.0373628397959322,1.02049062142451e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,0.043394309117087,0.00637499325368093,0.0308993223398723,0.0558892958943016,1.04004569586612e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,0.0253598094380444,0.00372639331157564,0.0180560785473562,0.0326635403287327,1.0430085808248e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,-0.0184274779705905,0.0027107040316899,-0.0237404578727027,-0.0131144980684783,1.09799891851939e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37043,0.026129338259434,0.00384747767448169,0.0185882820174499,0.0336703945014181,1.15899259193701e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0363305340650608,0.0053556454441406,0.0258334689945452,0.0468275991355764,1.2143153281291e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37445,0.0400503593939257,0.00590722776466507,0.0284721929751822,0.0516285258126693,1.25233723887189e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,0.0514260205209876,0.00759237561336799,0.0365449643187864,0.0663070767231889,1.31149238859476e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,0.0496221284186228,0.00732697431130544,0.0352612587684642,0.0639829980687815,1.31918139011514e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40009,0.0213230696270186,0.00315048439352206,0.0151481202157154,0.0274980190383218,1.34892210185112e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.028562052011411,0.00422299996372548,-0.0368391319403129,-0.0202849720825091,1.39366262146423e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,-0.0214622060809201,0.00317537877337965,-0.0276859484767442,-0.0152384636850959,1.43751679036419e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,39749,-0.0268181076266874,0.0039766232869797,-0.0346122892691676,-0.0190239259842072,1.59463739625524e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0436215064246505,0.00646765676548925,0.0309448991642916,0.0562981136850095,1.59851517465665e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.0502526835982442,0.00745383635189349,0.0356431643485329,0.0648622028479554,1.61762555783904e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37382,0.0214533096553697,0.00318907554798317,0.0152027215813227,0.0277038977294167,1.80008422412105e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAYN,Layilin,39713,0.0205397497107703,0.0030573007008193,0.0145474403371645,0.0265320590843761,1.90163792654206e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37388,0.0135928333241961,0.00202407238555932,0.00962565144849979,0.0175600151998923,1.94790341258121e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0267047139034581,0.00397856593946646,0.0189067246621039,0.0345027031448124,1.99438490285617e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,37453,-0.0193090232687041,0.00287824389478599,-0.0249503813024847,-0.0136676652349236,2.04258466341135e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0334268722560603,0.00498910692967299,0.0236482226739012,0.0432055218382193,2.16875148968936e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.0687891483086445,0.0102785010990071,0.0486432861545906,0.0889350104626984,2.2799190351618e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0333349343091678,0.0049828814525415,0.0235684866621865,0.0431013819561492,2.32103876770588e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,-0.00916807754180333,0.00137393258611339,-0.0118609854105856,-0.00647516967302109,2.60593987853607e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0205923494937628,0.00309062129424511,0.0145347317570424,0.0266499672304833,2.77369196933209e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARC,SPARC,39913,0.0444050244110138,0.00667681249073737,0.0313184719291686,0.0574915768928591,3.01258406542675e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,0.0408094163263093,0.00613678528780961,0.0287813171622025,0.0528375154904161,3.02672807965694e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0353036726292969,0.00531183549865883,0.0248924750519256,0.0457148702066682,3.10292710610374e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37056,0.0288309122972325,0.00434082975455789,0.020322885978299,0.0373389386161659,3.2202351614014e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0254813260494053,0.00383962404858781,0.0179556629141732,0.0330069891846374,3.33652283984726e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.0590791201895848,0.00891070104806801,0.0416141461353715,0.0765440942437981,3.46309866899555e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,0.0715471290266431,0.0108007620169088,0.0503776354735019,0.0927166225797844,3.60142227587696e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,39858,0.0241204351793678,0.00364713924529135,0.0169720422585967,0.0312688281001388,3.8717320501785e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,-0.0238410418032884,0.00360565831672443,-0.0309081321040683,-0.0167739515025085,3.90998087502941e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,39858,-0.0160832559107744,0.00243714891048914,-0.0208600677753331,-0.0113064440462157,4.26341075594729e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,39931,-0.0401921689767695,0.0060951895448886,-0.0521387404847512,-0.0282455974687878,4.41238813796434e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39477,0.0361561663974496,0.00548629016686586,0.0254030376703925,0.0469092951245067,4.53065742999227e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,-0.0148746069013052,0.00225728994615257,-0.0192988951957643,-0.0104503186068462,4.54805151654485e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37437,0.0250818311596156,0.00380689283300173,0.0176203212069322,0.032543341112299,4.60576038575346e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.016778218709422,0.00254844388998486,0.0117832686850517,0.0217731687337924,4.75714983601744e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37357,0.0199060562586894,0.00302421190045839,0.0139786009337909,0.0258335115835878,4.80569424962557e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40009,-0.0141730591278021,0.00215402956452056,-0.0183949570742624,-0.00995116118134179,4.8560623103962e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,39991,0.0239612551433867,0.00364306885205954,0.01682084019335,0.0311016700934234,4.94069345618416e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,0.0658621117908213,0.0100143517211949,0.0462339824172793,0.0854902411643633,4.95735950262071e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37382,0.0520902439216428,0.00792260568911014,0.036561936770987,0.0676185510722987,5.04775080006155e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0291369263924896,0.00443639540474686,0.0204415913991857,0.0378322613857934,5.26715330484979e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,39788,0.0558426710590891,0.00851143663130471,0.0391602552617318,0.0725250868564463,5.51335972145198e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37388,0.0672319277953934,0.0102493980337562,0.0471431076492313,0.0873207479415556,5.59148812130618e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,0.038660051825061,0.00589673394801686,0.0271024532869479,0.050217650363174,5.72597474933076e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,39555,0.0235523236740627,0.00359534239802149,0.0165054525739406,0.0305991947741848,5.90147806268964e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0442988248100007,0.00676436746537136,0.0310406645778728,0.0575569850421286,5.9743726163545e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.0485778021387772,0.00741888970723311,0.0340367783126003,0.063118825964954,6.01915343605208e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,0.0453623421996289,0.00693749381824264,0.0317648543158733,0.0589598300833845,6.3959011271125e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39477,0.0605318979100327,0.00925914755893935,0.0423839686945116,0.0786798271255538,6.44853540331616e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0249135014674717,0.003811771793447,0.0174424287523155,0.0323845741826278,6.54790272764092e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,37453,0.0340856987677569,0.00522518364045139,0.0238443388324722,0.0443270587030417,7.11879803064362e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,39866,-0.026467140584003,0.00406014486587149,-0.0344250245211111,-0.0185092566468949,7.30073491841489e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37382,0.0419626079321209,0.00644946474115084,0.0293216570394653,0.0546035588247765,7.9699422811835e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,39790,0.0267742524558637,0.00412027918952199,0.0186985052444006,0.0348499996673268,8.37185928150814e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0225088046474876,0.00346382097389417,0.0157197155386551,0.0292978937563202,8.41738400145677e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,0.0399709806669838,0.00615689474396066,0.027903466968821,0.0520384943651467,8.71346895499829e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,0.0466378356144323,0.00718494523034509,0.0325553429629559,0.0607203282659086,8.7792269753561e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.020330129816663,0.00313456548912095,0.0141863814579859,0.02647387817534,9.08293443390735e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,-0.0199298170448114,0.0030745440553606,-0.0259559233933181,-0.0139037106963046,9.35169511868175e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,0.0255708981845132,0.00394543707736815,0.0178378415128716,0.0333039548561548,9.42562655628066e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.0129038329001116,0.00199140758568364,-0.0168069917680516,-0.00900067403217172,9.51380509470859e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,39749,0.05965476646053,0.00921277840969613,0.0415977207775256,0.0777118121435344,9.74515400631674e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40052,0.0341733709189681,0.00528637000084207,0.0238120857173176,0.0445346561206185,1.04588472620034e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37411,0.0337316799034922,0.00522030023568132,0.0234998914415568,0.0439634683654276,1.07118308177043e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,39587,0.0698130528744671,0.0108449997761567,0.0485568533132,0.0910692524357342,1.2509917277198e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0133705839128486,0.00207708400655879,0.00929949925999343,0.0174416685657039,1.25794277180199e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40009,0.0134846935906631,0.00209748960329651,0.0093736139682019,0.0175957732131242,1.32077112693231e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,39713,0.0392493887194349,0.0061052729242116,0.0272830537879801,0.0512157236508896,1.32317979914593e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,0.0353317711323776,0.0055022010129005,0.0245474571470927,0.0461160851176626,1.38934230156701e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,-0.0266099547604422,0.00414530613368143,-0.0347347547824578,-0.0184851547384266,1.40756495555124e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,39985,0.043567665057307,0.00679126254349055,0.0302567904720655,0.0568785396425485,1.44506040717987e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0441866142639298,0.00689481202391982,0.030672782697047,0.0577004458308127,1.50891850094825e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0376204327769101,0.00587352026241543,0.0261083330625759,0.0491325324912444,1.55249957726871e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0261573663086314,0.00408461731331126,0.0181515163745414,0.0341632162427215,1.5578301852435e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37415,0.0271242173877707,0.0042416183491469,0.0188106454234428,0.0354377893520987,1.66051461728961e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,0.0413205216499251,0.00648022991536402,0.0286192710158116,0.0540217722840385,1.87171047546062e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.062833692073078,0.00985785985589414,0.0435122867555255,0.0821550973906305,1.89216881589929e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37382,0.0409750230905062,0.00643540825267207,0.028361622915269,0.0535884232657435,1.98833936904698e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,0.0374631292441933,0.00588393442583062,0.0259306177695653,0.0489956407188213,1.98934957612375e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,39858,-0.014369487954251,0.00226172189107787,-0.0188024628607636,-0.00993651304773839,2.16383186005446e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,0.0589171046415664,0.00927399970595457,0.0407400652178954,0.0770941440652373,2.18183344137989e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,0.0364615300346438,0.00574219903297706,0.0252068199300088,0.0477162401392788,2.21485396997275e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.031689870354309,0.00499514178655607,0.0218993924526591,0.0414803482559589,2.29789472382003e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,39882,0.0553876731255354,0.00873188123995992,0.0382731858952139,0.0725021603558568,2.3114297041868e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0358203217996818,0.0056511305601982,0.0247441059016933,0.0468965376976702,2.38161287065688e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,-0.0170636535226897,0.0026923455622459,-0.0223406508246917,-0.0117866562206878,2.40439302317367e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,39788,0.0331636021495045,0.00524208335614153,0.0228891187714671,0.0434380855275419,2.57617769157178e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,39788,0.0174266854108835,0.00275540465074606,0.0120260922954213,0.0228272785263458,2.6074833876637e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,0.0373983574270123,0.00593174008695547,0.0257721468565795,0.049024567997445,2.97541057259778e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.0437727056182668,0.00694438882511124,0.0301617035210488,0.0573837077154848,2.9896335014063e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40024,0.0411030519573532,0.00652473550707832,0.0283145703634797,0.0538915335512268,3.0618368797411e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,0.032041192066529,0.00508573567213864,0.0220731501491373,0.0420092339839208,3.0669921320393e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.014891060272279,0.00236488258899204,0.0102558903978546,0.0195262301467034,3.11855018903866e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.019616744884619,0.00311508666718542,-0.0257223147523024,-0.0135111750169355,3.12135330043583e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37437,0.0385837995123625,0.00612947970281379,0.0265700192948475,0.0505975797298775,3.1728079359114e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0176000612324877,0.002796880697743,0.0121181750649114,0.023081947400064,3.20007719887575e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,0.0351158798863179,0.00558152924991078,0.0241760825564928,0.046055677216143,3.22904723625439e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,0.0213421889122652,0.00339286483196954,0.0146921738416049,0.0279922039829255,3.26575956291351e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,39866,0.039425054375039,0.00627137668892611,0.0271331560647438,0.0517169526853341,3.33098948401048e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.0503267656231565,0.00803960529837643,0.0345691392383387,0.0660843920079743,3.96952049985165e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37056,0.0248762150554159,0.00398128759063205,0.017072891377777,0.0326795387330547,4.27745267980523e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,0.0325015807218021,0.00520306022887426,0.0223035826732085,0.0426995787703956,4.32289595050389e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,0.0284293108737298,0.00455468423870799,0.0195021297658621,0.0373564919815974,4.455576757633e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,-0.011137117177303,0.00178673458584212,-0.0146391169655535,-0.00763511738905243,4.70463588494879e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.0156391556540512,0.0025134357224412,-0.020565489670036,-0.0107128216380665,5.02414537337898e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,0.0150261276556424,0.00241734590732191,0.0102881296772915,0.0197641256339934,5.2271575943204e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0154724836358841,0.00248929264111547,0.0105934700592978,0.0203514972124704,5.23852985488052e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0223200428633292,0.00359503201677685,0.0152737801104465,0.0293663056162118,5.47786232650529e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0368326017147009,0.0059332852085854,0.0252033627058735,0.0484618407235283,5.53484940155348e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37039,0.0776521393366259,0.0125284724974322,0.0530963332416587,0.102207945431593,5.88702751606579e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,0.0417043271523748,0.00673742088481241,0.0284989822181425,0.0549096720866072,6.16482027381418e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40031,-0.0239405874770952,0.003872536699346,-0.0315307594078133,-0.016350415546377,6.47534718493978e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,-0.0208161399392627,0.0033688039680249,-0.0274189957165915,-0.0142132841619339,6.60173234257215e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,0.014869214773098,0.00240732978845112,0.0101508483877338,0.0195875811584621,6.70489699949402e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,0.0308413344286179,0.00499931167734586,0.0210426835410201,0.0406399853162158,7.03539116886742e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37056,0.0262745343424066,0.00426136231723967,0.0179222642006168,0.0346268044841963,7.21917455135965e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,-0.0149149347903534,0.00242251984418336,-0.0196630736849528,-0.010166795895754,7.60071850474653e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,0.0396354573971598,0.00644713980766498,0.0269990633741364,0.0522718514201832,8.07914357400234e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,0.0175665846693239,0.00286155383219978,0.0119579391582123,0.0231752301804355,8.54457039181377e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,0.0280785125301323,0.00457527310664245,0.0191109772411131,0.0370460478191515,8.64438968884362e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37257,-0.0626853727062334,0.0102164423248604,-0.0827095996629598,-0.0426611457495071,8.71552967952045e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,0.0285626592235473,0.0046561669144861,0.0194365720711545,0.0376887463759401,8.78708980100061e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,39931,0.0242566354285232,0.00395679172556957,0.0165013236464068,0.0320119472106395,8.97176167448567e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0206016470622695,0.00336539410628707,0.0140054746139468,0.0271978195105921,9.47964213430519e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0447291491504604,0.00731045729038227,-0.0590576454396097,-0.0304006528613112,9.66436520413976e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,-0.0353903625103151,0.00578561335755362,-0.0467301646911202,-0.02405056032951,9.79954687534702e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,0.0213912309829202,0.00349853080042265,0.0145341106140918,0.0282483513517486,9.92446161783915e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,0.0328122781346725,0.00536895129137931,0.0222891336035691,0.043335422665776,1.01487029144014e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0377692595602599,0.00618245982748561,0.0256516382983881,0.0498868808221317,1.02944185260376e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37388,0.026657286207155,0.00437123884128698,0.0180896580782325,0.0352249143360775,1.10096747505938e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39477,0.0218217994384026,0.00357943860621786,0.0148060997702156,0.0288374991065896,1.1101459529988e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0391362075740327,0.00641999783712709,0.0265530118132636,0.0517194033348018,1.11321994050578e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,39868,0.0247902608599114,0.00407201753319295,0.0168091064948533,0.0327714152249696,1.16971493264651e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,0.0349568304886583,0.00574145681490285,0.0237035751314487,0.0462100858458679,1.17056165751206e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,-0.0140549407308947,0.00231060823939002,-0.0185837328800991,-0.00952614858169023,1.207982273944e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,0.0584273162595456,0.00961602790282499,0.0395799015700087,0.0772747309490826,1.26485786367495e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40052,-0.0175633909590633,0.00289113413489325,-0.023230013863454,-0.0118967680546725,1.26829146572452e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40009,0.0199158952994925,0.00328233556414541,0.0134825175937675,0.0263492730052175,1.3273500496683e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,39673,0.0191370648999517,0.00315659962733878,0.0129501296303677,0.0253240001695357,1.37019163548069e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,0.0287290862031403,0.00474129670661573,0.0194361446581735,0.0380220277481072,1.40410754281635e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37388,0.0318143250742789,0.00525738795859698,0.0215098446754288,0.042118805473129,1.47425950926316e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,-0.0137675169614201,0.00227696341754175,-0.0182303652598019,-0.00930466866303828,1.51357137357197e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,39587,0.0247072766023798,0.00408761852404927,0.0166955442952432,0.0327190089095163,1.53336391393537e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37340,0.0271066565453887,0.00448790114061099,0.0183103703097911,0.0359029427809862,1.58227771636015e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37124,0.0329768700371421,0.00546808567012405,0.022259422123699,0.0436943179505853,1.6749936990456e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0320675731911042,0.00531766799149421,0.0216449439277756,0.0424902024544329,1.67904833038698e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37437,0.0174270338844105,0.00289100966065284,0.011760654949531,0.0230934128192901,1.70293874139397e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0487214653234144,0.00808590789681138,0.0328730858456641,0.0645698448011647,1.72311823466145e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37411,0.0382368882816877,0.00634767206056429,0.0257954510429817,0.0506783255203937,1.7481850732794e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,0.0178737935611498,0.00296915084280165,0.0120542579092586,0.023693329213041,1.78364469546566e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39434,-0.0517701702584606,0.00860792980440702,-0.0686417126750983,-0.0348986278418228,1.84772355800626e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.0578583449090138,0.00962323135926991,0.0389968114448448,0.0767198783731828,1.86812672581428e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,39868,-0.0396756769225777,0.00660727645326345,-0.052625938770974,-0.0267254150741813,1.95653753589405e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.0609321123079314,0.0101472347081145,0.041043532280027,0.0808206923358359,1.96468344335791e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0204145400120068,0.00340026043859521,0.0137500295523601,0.0270790504716534,1.97675005875143e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,0.033766939358478,0.00562559619945802,0.0227407708075403,0.0447931079094157,1.98617943797106e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,0.0305694669245365,0.00509233312818499,0.0205884939932939,0.0405504398557791,1.98814217067743e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,39585,0.0228712565184618,0.00382016024803783,0.0153837424323077,0.030358770604616,2.18411630841079e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,0.0137808212477724,0.00230220499813301,0.00926849945143172,0.0182931430441131,2.20755781380029e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0159071745802592,0.00265888696242845,0.0106957561338994,0.0211185930266189,2.24187105847688e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0359250889326257,0.00600642287931947,0.0241525000891596,0.0476976777760919,2.26343707824546e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.0641612472093928,0.0107379875590332,0.0431147915936878,0.0852077028250978,2.34731054674352e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37437,0.0317326205533823,0.00531645599973037,0.0213123667939107,0.0421528743128538,2.45031798745934e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,0.0466128231674949,0.00781914154040255,0.0312873057483059,0.0619383405866839,2.56354762087279e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0256278752446838,0.00430055466061762,0.0171987881098732,0.0340569623794943,2.59934943515087e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37043,0.0392907568676473,0.00659897930629765,0.0263567574273039,0.0522247563079907,2.68214640103622e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,0.038252796151801,0.00642835944725584,0.0256532116351796,0.0508523806684225,2.72616310639721e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,0.0522119076293063,0.00878000562531379,0.0350030966036912,0.0694207186549213,2.79467902069873e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,39913,0.031124972277381,0.00523642704269339,0.020861575273702,0.0413883692810601,2.84025624749458e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37043,0.0266238517961285,0.00448387835762307,0.0178354502151873,0.0354122533770697,2.96350448906257e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFH,Complement factor H,36763,0.0132859591946236,0.00224135274704703,0.00889290781041144,0.0176790105788358,3.15145887533046e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,-0.0149566855519076,0.00252635644004302,-0.0199083441743919,-0.0100050269294233,3.29420779891267e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,39563,0.0277071826552601,0.00468118014897062,0.0185320695632777,0.0368822957472425,3.30960843755509e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,39585,0.03239047810391,0.00547686647985897,0.0216558198033864,0.0431251364044336,3.40710007848176e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0244700861933779,0.00414292058014966,0.0163499618562845,0.0325902105304712,3.58105914642459e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,39619,0.0237555604434587,0.00402340102004643,0.0158696944441677,0.0316414264427497,3.61319915262687e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0278612451016781,0.00471860586832916,0.018612777599753,0.0371097126036033,3.62503739101981e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39403,0.0475924415961061,0.00807028178646855,0.0317746892946278,0.0634101938975845,3.77283694468654e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40058,0.0277320318228731,0.00470591261914681,0.0185084430893453,0.0369556205564008,3.86726328967458e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39489,0.0378046172453252,0.00642785961403551,0.0252060124018156,0.0504032220888348,4.15189848289419e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,39713,-0.0263979958306629,0.00449134949225993,-0.0352010408354924,-0.0175949508258335,4.24815567832929e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37445,0.0383677542315926,0.00653982164888265,0.0255497037997826,0.0511858046634026,4.54659718216797e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,39881,0.0593467362312717,0.0101423525179511,0.0394677252960875,0.0792257471664559,4.97028694583901e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,0.0237350980693938,0.00405671316411668,0.0157839402677251,0.0316862558710625,4.98593765169494e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,0.015925914010513,0.00272461411536595,0.0105856703443958,0.0212661576766303,5.17619913204634e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0257810982408946,0.00443408291812762,0.0170902957213645,0.0344719007604247,6.22564744132072e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0182139005473424,0.00313336571794565,0.0120725037401689,0.0243552973545158,6.28474185050236e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,39908,0.0159010138830241,0.00274276383523205,0.0105251967659693,0.0212768310000789,6.85987291507715e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0181635004184924,0.00313730990226807,0.012014373010047,0.0243126278269378,7.19108459188637e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37021,0.021530655349889,0.00372438687882339,0.0142308570673951,0.0288304536323828,7.59455807057638e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.059092715653043,0.0102232193778248,0.0390552056725063,0.0791302256335796,7.62308369220031e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,-0.0140999719682708,0.00243991172971367,-0.0188821989585095,-0.00931774497803197,7.65951395085957e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,39862,0.0135900754984932,0.00235297796217686,0.00897823869262661,0.0182019123043599,7.80599373521978e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0246851034996376,0.00427421956968186,-0.033062573856214,-0.0163076331430611,7.84794990161576e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.030589369134266,0.00530372126150415,0.0201940754617179,0.0409846628068141,8.19131027714186e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,0.0414964691655758,0.00720635950329095,0.0273720045391255,0.055620933792026,8.68017674037821e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0359521411125763,0.00624963128407572,-0.0482014184293647,-0.0237028637957878,8.97397969962551e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0181643022144982,0.00315930773672743,0.0119720590505124,0.024356545378484,9.11431980564241e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0304636893891585,0.00530078483994459,0.0200741511028671,0.0408532276754499,9.25151342824849e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,39587,0.0430984619187005,0.00750837472361158,0.0283820474604218,0.0578148763769792,9.6392183758381e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0319467388437264,0.00556520581797204,0.0210389354405012,0.0428545422469516,9.6508253187343e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0273085679572409,0.00475850780448685,0.0179818926604467,0.0366352432540351,9.70031201575533e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,39817,-0.0346057531301696,0.00603000258083549,-0.0464245581886071,-0.022786948071732,9.7007000019628e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0236520527230299,0.00412387395855697,0.0155692597642582,0.0317348456818015,9.90847692301337e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40012,-0.0244673551696907,0.0042663476891586,-0.0328293966404416,-0.0161053136989399,9.92766038844618e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,39866,0.0178370545950335,0.00311207680838872,0.0117373840505916,0.0239367251394754,1.01302955250946e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,0.0248123220738045,0.00432931145846404,0.016326871615215,0.033297772532394,1.01477939874006e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,-0.018172981251617,0.00317581306459723,-0.0243975748582276,-0.0119483876450064,1.06982978812784e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37039,0.0246389216766517,0.00430895834859451,0.0161933633134064,0.0330844800398969,1.10079496340772e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.0147190434432992,0.00257437910449351,0.0096732603984919,0.0197648264881064,1.10379985232048e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.027628097024509,0.00483804287152555,0.0181455329963189,0.0371106610526991,1.14953751892576e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,0.0368452265253643,0.00646216652695934,0.024179380132524,0.0495110729182046,1.20708952848817e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0160433281768721,0.00281859138711533,0.0105188890581261,0.0215677672956182,1.27762524502824e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,0.0365862747989576,0.00643061164204671,0.0239822759805461,0.0491902736173692,1.29715500494966e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37043,0.0488307587062079,0.00858638544090485,0.0320014432420344,0.0656600741703814,1.32037461731308e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,39866,-0.0227610448032991,0.00400700107920808,-0.030614766918547,-0.0149073226880513,1.36780705944342e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOST,Sclerostin,39846,0.0205882368870705,0.0036290095668649,0.0134753781360153,0.0277010956381257,1.42549850656478e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0272076511631152,0.00479846186074549,0.0178026659160541,0.0366126364101764,1.45256367476808e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0297418410478008,0.00524557733181124,0.0194605094774508,0.0400231726181509,1.45838772838063e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,39856,-0.0331899497134169,0.00585462917364867,-0.0446650228937683,-0.0217148765330655,1.46104002868332e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,0.045287952271098,0.00799248928205127,0.0296226732782775,0.0609532312639185,1.48414040075429e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0342244608043855,0.00604210214669808,0.0223819405968573,0.0460669810119137,1.50685785470047e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,0.0644542121837516,0.0113910277365894,0.0421277978200365,0.0867806265474668,1.55946702538514e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,-0.0474216921610274,0.00838753336237981,-0.0638612575512918,-0.0309821267707629,1.59590393309058e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0233897267060437,0.00413956966213694,0.0152761701682553,0.0315032832438321,1.63503321167285e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,0.0482494056469357,0.00854290300303357,0.0315053157609899,0.0649934955328815,1.652002960169e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37021,0.0252298704840012,0.00446964629206481,0.0164693637515542,0.0339903772164483,1.68875087605553e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,0.0485657107448846,0.00860433993351029,0.0317012044752044,0.0654302170145648,1.69147337540853e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39419,0.0367301368180956,0.00650914346354288,0.0239722156295516,0.0494880580066397,1.70170598796756e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37382,0.0306783880816273,0.00543788680631682,0.0200201299412464,0.0413366462220083,1.7185549364841e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.032530763202851,0.00577582187164118,0.0212101523344343,0.0438513740712677,1.80884227956323e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0302097072887924,0.00537131817861092,0.019681923658715,0.0407374909188698,1.89419679484077e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,-0.0150963405301073,0.00268746402691783,-0.0203637700228662,-0.00982891103734835,1.97844165718638e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0152262943964871,0.00271109207353002,0.00991255393236828,0.020540034860606,1.98924124274543e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40058,-0.0209599533532415,0.00373636970608145,-0.0282832379771612,-0.0136366687293219,2.05979593176792e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,0.0238006442800401,0.00424747335560239,0.0154755965030595,0.0321256920570208,2.13636068472967e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0193423323351141,0.003455167653488,0.0125702037342776,0.0261144609359506,2.20401336790849e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOC,Myocilin,39858,-0.0243505225634513,0.00435571656577579,-0.0328877270323718,-0.0158133180945307,2.30150001244638e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0357425913055331,0.00639312620325634,0.0232120639471507,0.0482731186639156,2.30492760570135e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0123305247132424,0.0022073613090147,0.00800409654757359,0.0166569528789112,2.35982829091672e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.0554377248403929,0.00994077086119449,0.0359538139524517,0.0749216357283342,2.48941172409192e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37124,0.0285602281271945,0.00512375047606092,0.0185176771941151,0.0386027790602739,2.53686802452785e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0406187967243773,0.00729168795810537,0.0263270883264907,0.0549105051222638,2.5876617834819e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0303546923044765,0.00545271068675015,0.0196673793584462,0.0410420052505068,2.64371642922913e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,39785,0.0463617314974794,0.00832920121466722,0.0300364971167317,0.0626869658782272,2.64604819694613e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LXN,Latexin,39682,-0.035259375346176,0.00634029465259775,-0.0476863528652676,-0.0228323978270845,2.72329455438777e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.0508077774728329,0.00914776333493446,0.0328781613363613,0.0687373936093044,2.83455299969858e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.0540437322899681,0.00973292915973099,0.0349671911368954,0.0731202734430409,2.86643587895626e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,0.0149619227916048,0.00269760515282415,0.0096746166920695,0.0202492288911402,2.96288031944556e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0139025276118538,0.00251028096262877,0.00898237692510137,0.0188226782986061,3.10345101929522e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37382,0.0312825291779837,0.0056566281135799,0.0201955380753671,0.0423695202806003,3.25719864424654e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.0120348949935431,0.00217796233690244,0.0077660888132143,0.0163037011738719,3.33221496033916e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,39868,0.0125129163778475,0.00226543332772856,0.00807266705549955,0.0169531657001955,3.37662280943232e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37021,0.031174860112873,0.00565924567938015,0.0200827385812879,0.0422669816444581,3.68364371898976e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,39908,0.0455994363765092,0.00827884764177207,0.0293728949986359,0.0618259777543824,3.68626553706899e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37039,0.0257827416688902,0.00468093260787045,0.0166081137574641,0.0349573695803163,3.69661350027031e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0148029528045585,0.00268755502431889,0.00953534495689351,0.0200705606522235,3.69783257623996e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,0.0305909100536264,0.00555599120868012,0.0197011672846133,0.0414806528226394,3.72971516368263e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,39868,-0.0161109779436704,0.00293113160041231,-0.0218559958804786,-0.0103659600068623,3.93313631891365e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37039,0.0219322832376267,0.00399042893547363,0.0141110425240984,0.0297535239511551,3.95225151638866e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,0.0419596746920209,0.00765853826303143,0.0269489396964793,0.0569704096875625,4.34658321575821e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.0767706261542493,0.0140136574169946,0.0493038576169399,0.104237394691559,4.37178976000392e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37376,0.0330592471423857,0.0060351891018855,0.0212302765026901,0.0448882177820813,4.38474756238271e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,0.0422176545073762,0.00771008577856134,0.0271058863813959,0.0573294226333564,4.42546436137882e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,0.0236939064915741,0.00433295174768287,0.0152013210661157,0.0321864919170326,4.6108206665562e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,39776,0.0201616827333293,0.00368766805406259,0.0129338533473666,0.027389512119292,4.63754194892675e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0155863513509865,0.00285295013846054,-0.0211781336223691,-0.00999456907960381,4.74479244599448e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39344,0.0396830333484193,0.00726643966752413,0.0254408116000721,0.0539252550967666,4.80380995433035e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0178186288631728,0.00326383808755235,0.0114215062115702,0.0242157515147754,4.84866816676232e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0244298105649353,0.00447486058815102,0.0156590838121593,0.0332005373177113,4.86304195402143e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,0.0120105650995502,0.00220311104404018,0.00769246745323147,0.016328662745869,5.06388859833504e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,0.0177568813865686,0.00325782281197702,0.0113715486750936,0.0241422140980435,5.09743152017683e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37043,-0.0220545515143847,0.0040468429125822,-0.0299863636230458,-0.0141227394057236,5.13280407489154e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.023144529758725,0.0042541502457653,0.014806395277025,0.031482664240425,5.39277429965068e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,39858,0.0127869713222448,0.00235120145903881,0.00817861646252874,0.0173953261819609,5.45242492532871e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37021,0.0346790511114385,0.00637625105166244,0.0221815990501801,0.0471765031726969,5.46036816897374e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.0446404650497993,0.00821540659553183,0.0285382681225569,0.0607426619770417,5.61589575549149e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.0372567026568411,0.00686089777955633,0.0238093430089107,0.0507040623047715,5.72517733456819e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0217017141642959,0.00399779039399143,0.0138660449920727,0.0295373833365191,5.78296586793241e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,-0.0321086959166186,0.00591708342749146,-0.0437061794345019,-0.0205112123987354,5.85132182500689e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,0.0456045090734975,0.00840523544170866,0.0291302476077486,0.0620787705392465,5.87378521419536e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,39808,0.053314991538137,0.0098300332007836,0.0340481264646012,0.0725818566116729,5.92333188885759e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40003,0.0309799049104392,0.00572077919733232,0.0197671776836679,0.0421926321372106,6.20506642930835e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,0.0169633553254475,0.00313444825923242,0.010819836737352,0.023106873913543,6.34131013634337e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37388,0.036828269417886,0.00680852701686339,0.0234835564648337,0.0501729823709382,6.44054363560237e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,-0.0237248288661707,0.0043893124483799,-0.0323278812649953,-0.0151217764673461,6.5686520665671e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39489,0.0401624700182247,0.00743527337108934,0.0255893342108896,0.0547356058255598,6.70102905153392e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0316868817222819,0.00587757368669579,0.0201668372963582,0.0432069261482057,7.12163929000459e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,0.0137832925687345,0.00255956907326324,0.00876653718513855,0.0188000479523305,7.34556285311759e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0182817133694257,0.00339823666323158,0.0116211695094918,0.0249422572293596,7.58598785012001e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.0311310340733113,0.00578722945154708,0.019788064348279,0.0424740037983436,7.60689549904462e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0602082271751143,0.0111938017671165,0.0382683757115661,0.0821480786386626,7.60876454464824e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,0.031725219673106,0.00590612598580609,0.0201492127409261,0.043301226605286,7.91674222799565e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.033382852216905,0.00622568869942941,0.0211805023660233,0.0455852020677866,8.3423687423047e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.030108923688522,0.00562069870076728,0.0190923542350181,0.0411254931420259,8.59121019107501e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37162,0.0115243716347806,0.00215330078450897,0.00730390209714303,0.0157448411724182,8.84522934464782e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,39615,0.0379407606643926,0.00709794367399244,0.0240287910633674,0.0518527302654177,9.15159920653024e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,39858,0.0132813517392982,0.00248564897531316,0.0084094797476844,0.018153223730912,9.2563895925323e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,0.0465585136255565,0.00871721735194447,0.0294727676157453,0.0636442596353677,9.39793539560681e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,39749,0.0178679554388268,0.00334973082693012,0.0113024830180438,0.0244334278596099,9.73098797010186e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,0.0351744098024712,0.00659761754349861,0.022243079417214,0.0481057401877285,9.90668537010398e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.047944320319394,0.00900136881693656,0.0303016374381983,0.0655870032005896,1.015782651498e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,39718,0.0228474442074,0.00429719782242614,0.0144249364754448,0.0312699519393552,1.07025199255855e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37368,0.0163857602782568,0.00308249839331826,0.010344063427353,0.0224274571291606,1.07915014787614e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0324270268443305,0.00611179528000023,0.02044790809553,0.0444061455931309,1.13805581784227e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39477,0.0222265406583945,0.00418942056641469,0.0140152763482217,0.0304378049685673,1.13962228144467e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,0.0229017647154324,0.00432463838200963,0.0144254734866935,0.0313780559441713,1.20156138982495e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,39931,0.046665453926124,0.00881715186579532,0.0293838362691651,0.0639470715830828,1.22188997317756e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0212019350493766,0.0040080382538923,0.0133461800717477,0.0290576900270055,1.2436101784834e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0138470488160254,0.00261890654481155,0.0087139919881948,0.0189801056438561,1.2574279569199e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.0427445957166679,0.00809220854222687,0.0268838669739033,0.0586053244594326,1.29360244830192e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,39858,-0.0157857182514588,0.00299043543313242,-0.0216469717003983,-0.00992446480251927,1.31777390287567e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,39559,0.0271272530157491,0.00514670604771724,0.0170397091622233,0.0372147968692748,1.37628844997665e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0339150621668238,0.00643810124303946,0.0212963837304664,0.0465337406031811,1.40194339761124e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37039,0.0405400461818652,0.0076987195690352,0.0254505558265562,0.0556295365371742,1.41761982393378e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37368,0.0243191600286038,0.00461950421282641,0.0152649317714641,0.0333733882857436,1.42762325509609e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40052,-0.0143301196081655,0.00272436376476268,-0.0196698725871003,-0.00899036662923063,1.45898707602258e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,39836,0.0449296002519443,0.00854190224484351,0.028187471852051,0.0616717286518376,1.45988526382945e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,-0.0279135025686585,0.00531397834164539,-0.0383289001182835,-0.0174981050190335,1.51666586835879e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0267959065643416,0.00510496649844791,0.0167901722273837,0.0368016409012996,1.55250529915726e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,39858,0.0361587406782695,0.00689178333027864,0.0226508453509234,0.0496666360056157,1.56869757859575e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.0558645603182135,0.0106505065918334,0.03498956739822,0.076739553238207,1.580508785825e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0323365537887025,0.00616748280688916,0.0202482874871998,0.0444248200902053,1.60370237047216e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,0.0395900623541381,0.00755397818878529,0.0247842651041189,0.0543958596041573,1.61790519582293e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,0.011960757418029,0.00228475919265768,0.00748262940041993,0.016438885435638,1.67054284925407e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,0.0144359533435506,0.0027576253941391,0.00903100757103798,0.0198408991160632,1.67529006917913e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40011,0.0264555884302278,0.00505810135003055,0.016541709784168,0.0363694670762877,1.71310835004715e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,0.0459745627026567,0.00879162197580032,0.0287429836300881,0.0632061417752253,1.72276374446105e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40058,0.0272705497883369,0.0052230044644391,0.0170334610380363,0.0375076385386376,1.79927995532323e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.02476358741823,0.00474274239423094,0.0154678123255373,0.0340593625109226,1.8028483986369e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37388,0.0350878645228411,0.00672387945836125,0.0219090607844531,0.0482666682612292,1.83147887700185e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,0.0315490018274271,0.00605101957744425,0.0196890034556364,0.0434090001992179,1.87259695172117e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0285211552021022,0.00547681603709927,0.0177865957693877,0.0392557146348168,1.94165302359797e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.0388957749674178,0.00747297382827856,0.0242487462639918,0.0535428036708437,1.96598939590847e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.0377969590807637,0.00727560578928643,0.0235367717337623,0.0520571464277651,2.07196254059699e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.0422868871305676,0.00814189614947868,0.0263287706775894,0.0582450035835459,2.09189156701434e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.0525425409565647,0.0101198024381306,0.0327077281778287,0.0723773537353006,2.11053967527595e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37382,0.0163796313700846,0.00315833063172117,0.0101893033319111,0.0225699594082581,2.17765562673376e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0296062299618346,0.00572723818971213,0.0183808431099988,0.0408316168136704,2.37778344420198e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.0410807283171654,0.0079537097696795,0.0254914571685936,0.0566699994657372,2.43889426745492e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,0.0138787980387216,0.00268887475384689,0.00860860352118166,0.0191489925562615,2.47834575513119e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37043,0.0137914793987638,0.00267232976012089,0.00855371306892687,0.0190292457286007,2.49410764877877e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,0.0127570191243608,0.0024721414319064,0.00791162191782427,0.0176024163308974,2.49474643745418e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,0.0142356590551958,0.00276655074402799,0.00881321959690096,0.0196580985134907,2.69848818172602e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37382,0.0385861932156664,0.00750515112211479,0.0238760970163214,0.0532962894150114,2.76660749227596e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,0.0318470902095391,0.00620614005235319,0.0196830557069269,0.0440111247121514,2.90746030572004e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37149,-0.0150071892241535,0.00293124625866176,-0.0207524318911306,-0.00926194655717648,3.10249735943436e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37342,0.0467936653112641,0.00914856546887222,0.0288624769922745,0.0647248536302536,3.18276448959933e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37388,0.045099646880228,0.00882490082445149,0.0278028412643031,0.0623964524961529,3.25688972360994e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,39858,0.0432651691238707,0.00850756545694755,0.0265903408282535,0.0599399974194879,3.70814727238704e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37445,-0.0229987640965152,0.0045260401447814,-0.0318698027802868,-0.0141277254127437,3.79574074181512e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.0474065760180734,0.00933190978097022,0.0291160328473718,0.065697119188775,3.81684185025278e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0227266759649628,0.00447608676730524,0.0139535459010445,0.031499806028881,3.86985564889686e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40011,0.014794170931213,0.00291857343329077,0.00907376700196308,0.0205145748604629,4.043877324728e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,39866,0.023440215896351,0.00462774704103605,0.0143698316959203,0.0325106000967816,4.12624741771301e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37388,0.06602889909498,0.0130350949001316,0.0404801130907221,0.091577685099238,4.12756956443169e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,0.02279518385053,0.00451265838416373,0.0139503734175691,0.0316399942834909,4.44304242963488e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0128357419679795,0.00254215752054777,0.00785311322770591,0.0178183707082532,4.48666887556955e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37039,0.0326278073345449,0.00647360553850942,0.0199395404790665,0.0453160741900234,4.71387347126761e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0244003894968642,0.00484351606084355,0.0149070980176108,0.0338936809761176,4.77135724179487e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,39804,0.0221660604699629,0.00440837794174069,0.0135256397041512,0.0308064812357747,5.00563784911848e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.0523876921104928,0.0104308157859961,0.0319432931699403,0.0728320910510452,5.1577605606673e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0312038242666366,0.0062167355658276,0.0190190225576145,0.0433886259756587,5.24047110052055e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,-0.0151197625719633,0.00301355247348405,-0.0210263254199921,-0.00921319972393459,5.29709169809425e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37437,0.0402487106416833,0.00802306221667073,0.0245235086970087,0.0559739125863579,5.32511641658271e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,39587,0.0381854848738796,0.00761359805824971,0.0232628326797102,0.0531081370680491,5.34908117015914e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0173684287957078,0.00346301940259953,0.0105809107666127,0.0241559468248029,5.36123290468609e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40002,0.012800723898608,0.00255274629909763,0.00779734115237663,0.0178041066448393,5.3737873394475e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,36654,0.0587259956167238,0.0117101934796738,0.0357740163965631,0.0816779748368845,5.37589950363834e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0170522409760684,0.00340993753992119,0.0103687633978229,0.0237357185543139,5.77058811037408e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,0.0158697482337873,0.0031754361362251,0.00964589340678609,0.0220936030607885,5.87748378673322e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,0.0285180862268322,0.0057096659124572,0.0173271410384161,0.0397090314152483,5.9551377470178e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37124,0.031796967877183,0.00637480596616365,0.0193023481835022,0.0442915875708637,6.18078695852129e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,39777,0.0134083813834451,0.00268983089303642,0.00813631283309374,0.0186804499337965,6.26643517766257e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.023091217862368,0.00463433676170929,0.0140079178094178,0.0321745179153182,6.34988526344846e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0294476876724469,0.00591896137594767,0.0178465233755895,0.0410488519693044,6.59969660309903e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,0.0227434944854718,0.00457190658718576,0.0137825575745877,0.0317044313963559,6.61773469075579e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,39788,0.0255262027197162,0.00513734437232333,0.0154570077499625,0.0355953976894699,6.80833124132715e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0268709857928577,0.00541910808391178,0.0162495339483906,0.0374924376373248,7.17621539131109e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,39750,0.0310587578842185,0.00626645418744311,0.01877650767683,0.0433410080916069,7.25684096720054e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,0.0274944074002427,0.00554988317496543,0.0166166363773104,0.0383721784231749,7.35606565637386e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.0416636308287772,0.00842062681061812,0.0251592022799657,0.0581680593775888,7.58204323074919e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,0.03576930012556,0.00724139293364161,0.0215761699756224,0.0499624302754975,7.92496140688642e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,39686,0.0235547874164715,0.00477046646811125,0.0142046731389734,0.0329049016939695,7.9884372057799e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,0.0606255820214362,0.012279545182428,0.0365576734638773,0.084693490578995,8.00800628582582e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0422741292190477,0.00856764349766996,0.0254815479636146,0.0590667104744809,8.14779601486542e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0158968018189422,0.00322432213430161,0.00957713043571108,0.0222164732021734,8.29395409004659e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0124116920800585,0.00251927248789632,0.00747391800378166,0.0173494661563353,8.44579252957626e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0179093097682746,0.00363770984066079,0.0107793984805795,0.0250392210559698,8.59924688025219e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0154883442899531,0.00314929314175177,0.00931572973211961,0.0216609588477865,8.82801418934732e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,0.0251732888666177,0.0051224770798587,0.0151332337900946,0.0352133439431407,9.00118662088121e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.039820109817646,0.00810972007639677,0.0239250584679083,0.0557151611673837,9.20609906996053e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37388,0.0175903628599844,0.00358744620055031,0.0105589683069058,0.024621757413063,9.53289358793598e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,39866,0.0310090605558941,0.00632481191766668,0.0186124291972674,0.0434056919145208,9.54237056775705e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.0569214195083182,0.0116556038158193,0.0340764360293123,0.079766402987324,1.05198821586184e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0275645901760536,0.00564480782057598,0.0165007668477247,0.0386284135043825,1.05581459145901e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,0.0373369555632534,0.00765524342572331,0.0223326784488357,0.0523412326776711,1.08574311986825e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37037,0.0198223733016561,0.00406413256370659,0.0118566734767912,0.027788073126521,1.08752401101251e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37043,0.0545555809143937,0.0111898140231711,0.0326235454289783,0.0764876163998091,1.09816039363278e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,36991,0.0297139192198161,0.00610606809093358,0.0177460257615863,0.041681812678046,1.15031675772212e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37249,-0.0144620736698303,0.00297481633729117,-0.020292713690921,-0.00863143364873957,1.17820964094304e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0313618953097701,0.00645116629169666,0.0187176093780447,0.0440061812414956,1.17847315075136e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37388,0.03021470068786,0.00622159253916975,0.0180203793110873,0.0424090220646327,1.20860820650532e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0221093051611057,0.00455671909967129,0.0131781357257499,0.0310404745964614,1.23605324757616e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.039718584465889,0.00818725735295529,0.0236715600540967,0.0557656088776814,1.24068327746749e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39489,0.0236317689720752,0.00487368906833568,0.0140793383981373,0.0331841995460131,1.25376133483717e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.0383319608818895,0.00791601393486106,0.0228165735695618,0.0538473481942172,1.29523456348558e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,-0.0195600227460734,0.00404188784767117,-0.0274821229275089,-0.0116379225646379,1.31487959680073e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0245157139783351,0.00506886337002467,0.0145807417730867,0.0344506861835834,1.33608667343829e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0226903081531144,0.00469286490559909,0.0134922929381402,0.0318883233680887,1.34563296055889e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.022130985869916,0.00458219805548022,0.0131498776811748,0.0311120940586573,1.37982320201202e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,0.0231399853597659,0.00480583243377789,0.0137205537895612,0.0325594169299706,1.48808818801352e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0160322519229803,0.00333303086596485,0.00949951142568915,0.0225649924202714,1.52517398723063e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.0477664503438696,0.00995210214807104,0.0282603301336503,0.0672725705540888,1.6068881244715e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,0.0152708369885256,0.00318900594578255,0.00902038533479179,0.0215212886422594,1.6976747832427e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0165784936123394,0.00346766551298536,0.00978186920688807,0.0233751180177907,1.76109308140511e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,39885,-0.0146693309698263,0.00307242571239897,-0.0206912853661283,-0.00864737657352433,1.81736259650351e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGN,Mimecan,39858,0.0178592532946496,0.00374427864570813,0.0105204671490617,0.0251980394402376,1.8608614724979e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,39901,0.0133203552045176,0.00279360943450722,0.00784488071288342,0.0187958296961517,1.87556236961502e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.033988929807327,0.00712911323399745,0.020015867868692,0.047961991745962,1.88051652815443e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,39857,-0.0265066513770658,0.00556704067284344,-0.0374180510958389,-0.0155952516582926,1.93982761420638e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37437,-0.0103353905385952,0.00217091040658909,-0.0145903749355098,-0.00608040614168054,1.94764053519494e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0304569020440393,0.00640136826447536,0.0179102202456676,0.043003583842411,1.97661325212953e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPART,Spartin,37124,0.035319221945201,0.00742362501024361,0.0207689169251236,0.0498695269652785,1.97896015768715e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0243667372495528,0.00512512085037642,0.014321500382815,0.0344119741162906,2.00778193539905e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,39892,0.0169421054494783,0.00356886578475514,0.0099471285113582,0.0239370823875984,2.08038123438855e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,0.0450908116251407,0.00950762962062671,0.0264558575687124,0.0637257656815691,2.13154376794284e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,0.0309085525937726,0.00651985645254708,0.0181296339467803,0.0436874712407649,2.15230776312697e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0147255185733515,0.00310898513689856,0.00863190770503033,0.0208191294416727,2.19771046168252e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,-0.0645541951002185,0.0136345546134153,-0.0912779221425125,-0.0378304680579245,2.21701431495967e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37021,0.0359034816405889,0.0075940241167101,0.0210191943718371,0.0507877689093407,2.29251239750139e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,0.0222147792816728,0.00470952003013873,0.0129841200226009,0.0314454385407447,2.41825215750924e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0211436052205585,0.00449120891980839,0.0123408357377341,0.029946374703383,2.52984145787801e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0227935437678412,0.00484384035192788,0.0132996166780626,0.0322874708576199,2.55195727768e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37043,0.0231890631750692,0.00493037832855061,0.01352552165111,0.0328526046990284,2.58583058952304e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37043,0.0325656284786511,0.00693013111799088,0.018982571487389,0.0461486854699132,2.63905938064936e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.0481145350464643,0.010254888090461,0.0280149543891608,0.0682141157037679,2.73382895880538e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0242738804447704,0.00518035572265721,0.0141203832283623,0.0344273776611786,2.81236059699634e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,-0.00772594097109433,0.0016495885732758,-0.0109591345747149,-0.00449274736747376,2.84260776695793e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,0.0510690687157485,0.0109046750749913,0.0296959055687655,0.0724422318627315,2.85134684116062e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,0.0420237502668567,0.00898613966411647,0.0244109165251884,0.059636584008525,2.94189327526541e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0296441806128407,0.00633861623101752,0.0172204928000464,0.042067868425635,2.94342153272175e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.0395142414557815,0.00846880573591566,0.0229153822133868,0.0561131006981762,3.10279727693197e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,0.0135094588937407,0.00289732700260286,0.00783069796863906,0.0191882198188423,3.14604388695213e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0287480331239983,0.00617377677317755,0.0166474306485703,0.0408486355994263,3.24731223684985e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37382,0.0456847906243501,0.00983744343777382,0.0264034014863134,0.0649661797623868,3.44996174684398e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,0.0107663750015482,0.00231854040139297,0.00622203581481795,0.0153107141882784,3.4560351689744e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.034160905676166,0.00736657142262009,0.0197224256878306,0.0485993856645013,3.55805001572286e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39456,0.0402715829036405,0.00868991648625527,0.0232393465905802,0.0573038192167008,3.61066321748215e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37124,0.0144035574764924,0.00310888768068863,0.0083101376223427,0.0204969773306421,3.63787906001359e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0154665791053635,0.00334074819732457,0.00891871263860737,0.0220144455721197,3.69189448081665e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37043,0.0133574320301096,0.00289421386352515,0.00768477285760035,0.0190300912026189,3.96384123228041e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,0.028520230302541,0.00618392165978487,0.0163997438493626,0.0406407167557193,4.02473762982249e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0109046280917794,0.00237553246724186,0.00624858445598539,0.0155606717275735,4.45766182563426e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,39788,-0.0126642557872877,0.00276005908315702,-0.0180739715902754,-0.00725453998429989,4.5006318486997e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37368,0.0178431073546016,0.00388958244389809,0.0102195257645614,0.0254666889446419,4.52815817177068e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,0.0558366894490787,0.0121866504897679,0.0319508544891336,0.0797225244090237,4.64489899870554e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0200479706767887,0.00437868226716793,0.0114657534331396,0.0286301879204379,4.72516278619549e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,0.00836733206611533,0.00182759633741485,0.00478524324478223,0.0119494208874484,4.72874866507423e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,0.0242559264934105,0.00529921589114634,0.0138694633467636,0.0346423896400573,4.74634756414412e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,0.0200658559776882,0.00438837862161118,0.0114646338793303,0.0286670780760461,4.8556999576579e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37411,0.0332242326014387,0.00729076069699005,0.0189343416353382,0.0475141235675392,5.23347829239924e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0189002516789473,0.00415309314453813,0.0107601891156525,0.027040314242242,5.38864686130041e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37388,0.0118187217717026,0.00259756721152949,0.00672749003710478,0.0169099535063004,5.4133377744206e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0303640795129671,0.00668859643693692,-0.0434737285293635,-0.0172544304965707,5.68261780659052e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0163583220622475,0.00360502763246872,0.00929246790260883,0.0234241762218862,5.73759441976904e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.0503221697115835,0.0111041549254065,0.0285580260577869,0.0720863133653802,5.88995583497755e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40009,0.0107710709711525,0.00237717540567275,0.00611180717603391,0.0154303347662711,5.91155101725379e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,39810,0.0174315535581406,0.0038508723368095,0.00988384377799393,0.0249792633382872,6.03592861537991e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0171687060315683,0.00379540273931125,0.00972971666251826,0.0246076954006184,6.13255780365616e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,0.0398953184848749,0.00883778260755147,0.022573264574074,0.0572173723956758,6.40243698315904e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.0167921509038373,0.00372219987238529,0.00949663915396217,0.0240876626537125,6.48780710299677e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,36962,0.0242207665307111,0.00536911350865896,0.0136973040537396,0.0347442290076827,6.50439383430048e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37021,-0.017728423525669,0.00393474665293505,-0.0254405269654216,-0.0100163200859163,6.67534798574094e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,-0.0133010995717452,0.00295734483149884,-0.0190974954414829,-0.00750470370200743,6.92960104309193e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0211884013798332,0.00471151330367958,0.0119538353046212,0.0304229674550452,6.94399598824583e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39477,0.0221845485852338,0.00493564967087347,0.0125106752303218,0.0318584219401458,7.01499641317208e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37124,0.0316724815153483,0.007062720079218,0.017829550160081,0.0455154128706156,7.37126195841359e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0191866262528933,0.00428646689772067,-0.0275881013724258,-0.0107851511333607,7.65446064706039e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40030,0.0182302826499136,0.00407481759438805,0.010243640164913,0.0262169251349142,7.73333448850275e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0225930981387854,0.00506076943903013,0.0126739900382863,0.0325122062392844,8.0958243288227e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,-0.0381280391970156,0.00854895741165947,-0.0548839957238682,-0.021372082670163,8.26541888258841e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.0109768012918847,0.00246150160659901,-0.0158013444408187,-0.00615225814295061,8.28729152334874e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,0.0296959653829008,0.00667317428937342,0.0166165437757289,0.0427753869900727,8.64446906427741e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,-0.0118720297800887,0.00266861463437594,-0.0171025144634655,-0.00664154509671184,8.6946858352258e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,0.0252050236052437,0.00566622584589692,0.0140992209472858,0.0363108262632017,8.72476319811447e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37056,0.024349628810416,0.00549436623290731,0.0135806709939177,0.0351185866269143,9.42273316232629e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.01226177403314,0.00276729899056951,0.00683786801162376,0.0176856800546562,9.44446914333805e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00848632713525007,0.00191545486691834,-0.01224061867441,-0.00473203559609013,9.47960413109472e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,0.0133745947835538,0.00302865259115972,0.00743843570488072,0.0193107538622268,1.01329674180926e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37124,0.0232181954652162,0.00525821375552928,0.0129120965043788,0.0335242944260536,1.01524628300998e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,-0.0189799228477354,0.00430054765841505,-0.0274089962582289,-0.0105508494372419,1.02435783141753e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,0.0276812788877588,0.00627427118938727,0.0153837073565597,0.0399788504189578,1.03162064771834e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0127393533645144,0.00289215399928364,0.00707073152591848,0.0184079752031104,1.06701115766637e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39489,0.0197695127903096,0.00448852665041904,0.0109720005554883,0.0285670250251309,1.06755026515852e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37039,0.0182647059780547,0.00415286440637671,0.0101250917415563,0.026404320214553,1.10059811539552e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,-0.0250015860380551,0.0056862432614758,-0.0361466228305476,-0.0138565492455625,1.10531535639708e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,39900,0.0209391342142754,0.00476282230399931,0.0116040024984367,0.030274265930114,1.10783439178822e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,39788,0.0247279608893005,0.00562584296606129,0.0137013086758204,0.0357546131027806,1.11272393721102e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,0.00955557387802626,0.00217617655339008,0.00529026783338171,0.0138208799226708,1.13553587986712e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.029150372089761,0.00664007754332565,0.0161358201048427,0.0421649240746793,1.14046480073717e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,39585,0.052541178837638,0.0119885047945572,0.0290437094403058,0.0760386482349701,1.18015130498565e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0116464626199857,0.00265867945475999,0.00643545088865616,0.0168574743513153,1.19298055840558e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0145980034729839,0.00333320086283807,-0.0211310771641465,-0.00806492978182124,1.1982813335123e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,-0.0248942625926331,0.00568495441465372,-0.0360367732453544,-0.0137517519399118,1.20135569606399e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",37453,0.00677796273741237,0.00154789447512169,0.00374408956617386,0.00981183590865087,1.2021150636177e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37088,0.0432103342278417,0.00987240478088825,0.0238604208573007,0.0625602475983826,1.21313286353788e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,0.0168759672544617,0.00385657868587785,0.00931707303014114,0.0244348614787823,1.2170509638974e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,36991,0.0180403217476657,0.00412540119961573,0.0099545353964189,0.0261261080989126,1.23502203584069e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0173392730703021,0.00396806766135858,0.00956186045403934,0.025116685686565,1.25341711669399e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,0.0420052625322097,0.00961433272078029,0.0231611703994804,0.0608493546649391,1.25593293872753e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37169,0.0224462745483065,0.0051405488630084,0.01237079877681,0.032521750319803,1.27199205771653e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,0.0218304174588276,0.00500584350783851,0.0120189641834641,0.0316418707341911,1.30306233943013e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37445,-0.0098964863174394,0.00226934887865712,-0.0143444101196074,-0.00544856251527144,1.30460542244056e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGMN,Legumain,39931,0.0148397345994489,0.00340366659885863,0.00816854806568604,0.0215109211332119,1.30915159398599e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,0.0287844867191691,0.00660293529155517,0.015842733547721,0.0417262398906172,1.3143354374774e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,-0.0242107248156592,0.00555860477487734,-0.0351055901744188,-0.0133158594568996,1.33556235473565e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0134756593735274,0.0030985786367726,0.00740244524545312,0.0195488735016017,1.3761696924397e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0139616698640168,0.0032103140372867,0.00766945435093484,0.0202538853770987,1.37759128317863e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,39831,0.0109075208443852,0.00251070090403571,0.00598654707247521,0.0158284946162952,1.40510453561989e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.0404527189500379,0.00931123144241857,0.0222027053228975,0.0587027325771783,1.4060554771329e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0126996827896937,0.00292447011532262,-0.018431644215726,-0.00696772136366135,1.41811591395064e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0123357550894816,0.00284332965207951,0.00676282897140577,0.0179086812075574,1.4450182814295e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0174689847758658,0.00403334673259982,0.0095636251799701,0.0253743443717614,1.49435513867874e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,0.0228802066184788,0.00528497775057978,0.0125216502273424,0.0332387630096152,1.50701032256607e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.0405656763066172,0.00938068801837281,0.0221795277906065,0.0589518248226279,1.540514296557e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,0.0491991877801307,0.0113812793961487,0.0268918801636792,0.0715064953965822,1.55181784508231e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37388,0.0346401311671754,0.00801499729427067,0.0189307364704049,0.0503495258639459,1.55786390237245e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,39788,0.0120182530845096,0.00278266197822267,0.00656423560719312,0.017472270561826,1.57702425329898e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0104023279529697,0.00241510615672489,-0.0151359360201505,-0.00566871988578895,1.66499796527587e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.0359470415738779,0.00834594297847028,0.0195889933360761,0.0523050898116796,1.66550179806733e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0206890020314172,0.00480398592494069,0.0112731896185334,0.0301048144443009,1.66957600384608e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,0.0269263493815039,0.0062584623726694,0.0146597631310719,0.0391929356319359,1.69967484422528e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,0.0135098896673143,0.00314013855561549,0.00735521809830795,0.0196645612363207,1.70204086746349e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,0.027793914497936,0.00646852886391678,0.0151155979246591,0.0404722310712129,1.74314149355285e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,0.0313352551412121,0.00730265428900442,0.0170220527347634,0.0456484575476607,1.79192095978405e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,0.0169320164425991,0.00395780759650522,0.00917471355344883,0.0246893193317493,1.89584690345929e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.031783264800801,0.00743032768393778,0.0172198225402829,0.046346707061319,1.90295405145644e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0127307303085291,0.0029779807620692,0.00689388801487344,0.0185675726021847,1.92521242671787e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37368,0.026478166977155,0.00621334975783028,0.0143000014518076,0.0386563325025023,2.04439526022513e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40030,-0.0238847041012734,0.0056061044960281,-0.0348726689134885,-0.0128967392890583,2.05140888361714e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0203540812582719,0.00478190671891434,0.0109815440891998,0.029726618427344,2.0907264624262e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,-0.0122448843267646,0.00287734425338648,-0.0178844790634021,-0.00660528959012713,2.09874288447799e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37345,0.0356522985212835,0.00838663650125569,0.0192144909788223,0.0520901060637446,2.14169537284474e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39397,-0.0260789616654542,0.00613503971527737,-0.0381036395073978,-0.0140542838235105,2.14230552405527e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0221938327449356,0.00522509179738007,0.0119526528220707,0.0324350126678006,2.17604924277687e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,0.0242052867531088,0.00569880455574378,0.013035629823851,0.0353749436823666,2.17720431442818e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,-0.0131724384901564,0.00310216602946615,-0.01925268390791,-0.00709219307240272,2.18900845593205e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39489,0.020774958831233,0.00489861283092097,0.0111736776826279,0.0303762399798381,2.2381777748561e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,0.0359999874794099,0.00849206080651479,0.0193555482986409,0.0526444266601789,2.25527329553627e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.0119751501976827,0.00282926717553521,-0.0175205138617317,-0.00642978653363372,2.32569630511557e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0080812285234428,0.00191001616930034,-0.0118248602152715,-0.00433759683161412,2.33971332129934e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.0322553526265968,0.00763489956647169,0.0172909494763122,0.0472197557768813,2.40838975570827e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,0.00797316413632593,0.0018873649256599,0.00427392888203253,0.0116723993906193,2.4104501864066e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0231170933992726,0.00547534464313375,0.0123854178987305,0.0338487688998148,2.43453532543267e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39421,0.0185125352496952,0.00438735811908936,0.00991331333628007,0.0271117571631104,2.46212594825412e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,39585,0.0338907179626071,0.00803578748763689,0.0181405744868388,0.0496408614383754,2.48437769343912e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.0363402506610056,0.00864035348387126,0.0194051578326179,0.0532753434893933,2.61748814870849e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,0.0369461978798053,0.00879612967430505,0.0197057837181674,0.0541866120414432,2.68029155867688e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,0.0237660807971056,0.00566128931149361,0.0126699537465781,0.0348622078476331,2.70724856131239e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,-0.011322983954402,0.0026974921507655,-0.0166100685699024,-0.00603589933890162,2.71520990826355e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,0.0147970646562343,0.00352812455634493,0.00788194052579821,0.0217121887866703,2.75550752224591e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39393,-0.027534392227258,0.00658456094801118,-0.0404401316853599,-0.0146286527691561,2.90976128807806e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0109750500881583,0.00262553905634032,0.00582899353773126,0.0161211066385853,2.93248117549359e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0270002000759748,0.00646046764253682,0.0143376834966026,0.039662716655347,2.93966815611913e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,39812,0.0188418967355039,0.00452009681109494,0.00998250698575778,0.02770128648525,3.0826638182047e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,39793,0.0315679242135265,0.00758726468433367,0.0166968854322325,0.0464389629948205,3.19012726589046e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,0.0325581982332874,0.00783237254023177,0.0172067480544331,0.0479096484121417,3.24609080235528e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,36962,-0.0122569344080977,0.00294940695115618,-0.0180377720323638,-0.00647609678383157,3.26312351642866e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39344,0.0235984273713736,0.00568326588467491,0.0124592262374108,0.0347376285053364,3.30963513344584e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,39858,0.0253800790851777,0.00611574506465473,0.0133932187584544,0.0373669394119009,3.34257746957971e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37043,0.0090466674747537,0.00218203445632688,0.00476987994035302,0.0133234550091544,3.40482881604078e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,39749,-0.0130237626045215,0.00314724823719027,-0.0191923691494144,-0.00685515605962858,3.51932227663062e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,-0.0102608988287194,0.00248175118475869,-0.0151251311508464,-0.00539666650659233,3.57802135516453e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.0129504806182698,0.00313555948844215,-0.0190961772156164,-0.00680478402092319,3.64284016159007e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,0.0316232622026655,0.00765929148658098,0.0166110508889667,0.0466354735163642,3.66994633817679e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.03572081182448,0.00866472433809438,0.0187379521218151,0.052703671527145,3.76983358253373e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0150703581595363,0.00366034111101079,0.00789608958195519,0.0222446267371175,3.85406659063433e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,39771,0.0219054591926537,0.00532320360673623,0.0114719801234507,0.0323389382618567,3.88978477826239e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40058,0.0251269550848232,0.00610754359691843,0.013156169634863,0.0370977405347833,3.90638967687381e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40058,0.0135256788613166,0.00329901953309244,0.00705960057645538,0.0199917571461777,4.15329310659077e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37124,0.0425665208157737,0.0103857368270103,0.0222104766348335,0.0629225649967139,4.18210605204468e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0238363166075993,0.00582065723162414,0.012427828433616,0.0352448047815826,4.24407483336221e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.0140434218195135,0.00342983462928794,0.00732094594610912,0.0207658976929179,4.25559290188364e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,39858,0.0299684182154116,0.00733044331834031,0.0156007493114646,0.0443360871193586,4.36831631531436e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0264686967113543,0.00647497191360012,0.0137777517606981,0.0391596416620106,4.37572972277741e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,0.0187768383713589,0.0045943267200312,0.00977195800009774,0.02778171874262,4.39243813962025e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,39788,0.0123549157378614,0.00302433148652461,0.0064272260242732,0.0182826054514497,4.42596131254326e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,0.0204972773424808,0.00501821073410215,0.0106615843036405,0.030332970381321,4.43755838761634e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,0.0199754385165399,0.00489124906683198,0.0103885903455492,0.0295622866875306,4.45042649491832e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.0359459141933642,0.00880635906930171,0.0186854504175328,0.0532063779691956,4.49491410890347e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,0.0281375943049819,0.00689850100492756,0.0146165323353239,0.0416586562746399,4.54875774175995e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,39587,0.0257103142525371,0.00630446880837555,0.013353555388121,0.0380670731169532,4.56269256051034e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40052,-0.0103576034900148,0.00254291416383783,-0.015341715251137,-0.00537349172889267,4.66075963499253e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,39587,0.0188053047036506,0.00461774703057369,0.00975452052372612,0.027856088883575,4.67594230198147e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,-0.0106010181526945,0.00260324243164645,-0.0157033733187215,-0.00549866298666747,4.6787287041773e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,-0.0155511899880831,0.00381987997518837,-0.0230381547394523,-0.00806422523671386,4.70148699900644e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.0343915793163835,0.00846463022887643,0.0178009040677857,0.0509822545649813,4.872378981711e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0117325453018511,0.00289462755914494,-0.0174060153177752,-0.00605907528592703,5.08105255484033e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0168675711546084,0.00417374396173097,0.00868703298961571,0.0250481093196011,5.33921705159904e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40052,0.0340937103497186,0.0084413563070396,0.017548651987921,0.0506387687115162,5.39522781196643e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.0328443766589481,0.00813759358968472,0.0168946932231661,0.0487940600947302,5.46389942840363e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAX,Protein max,39489,0.0402797263740755,0.0100113339290638,0.0206575118731106,0.0599019408750405,5.76308828403332e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,37453,-0.00847741680220969,0.00211170687945,-0.0126163622859317,-0.00433847131848769,5.98953755993867e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0255223965399847,0.00637679395840952,0.013023880381502,0.0380209126984673,6.30465252378752e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,39739,0.022039094460757,0.00551113050985946,0.0112372786614325,0.0328409102600815,6.3894551047102e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,39818,0.0152230145748767,0.00380862895423803,0.00775810182457013,0.0226879273251832,6.44440941448359e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCT,Secretin,37039,0.0167970926877817,0.00420291288362205,0.00855938343588246,0.0250348019396809,6.46259876956039e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.0424997159136963,0.0106429543685267,0.021639525351384,0.0633599064760085,6.54768811355297e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37380,0.00968261348929277,0.00242512021242123,0.00492937787294717,0.0144358491056384,6.56892522465336e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37043,0.0196826087909299,0.00494034585433064,0.00999953091644186,0.029365686665418,6.81135541492266e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.0138779996101148,0.00348368716045287,-0.0207060264446025,-0.0070499727756272,6.82129881294903e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,0.0261104823465029,0.00655652295266181,0.0132596973592858,0.0389612673337201,6.85886016718024e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,-0.0105309325695272,0.00264574132943903,-0.0157165855752277,-0.00534527956382671,6.9188067819104e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37021,0.0148440983718943,0.0037305683938587,0.0075321843199312,0.0221560124238573,6.95636712521029e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,39970,0.0226803797270819,0.00570538338705179,0.0114978282884604,0.0338629311657034,7.06092271128776e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0213102341547653,0.00537105596332497,0.0107829644666483,0.0318375038428822,7.29161985377716e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37382,0.0115074364260515,0.00291218959864807,0.00579954481270132,0.0172153280394018,7.80665921570332e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0414211130200199,0.010485388622403,-0.0619724747199299,-0.0208697513201099,7.83691027521501e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0115318837384279,0.00292031887006626,0.00580805875309804,0.0172557087237578,7.88673440173273e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,39866,0.0147887168833828,0.00374720844387608,0.0074441883333857,0.0221332454333799,7.96088727673236e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,-0.0126218051158382,0.00319838789157425,-0.0188906453833238,-0.00635296484835271,7.97671455086296e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,-0.0079123883811736,0.00200537433022553,-0.0118429220684156,-0.00398185469393156,8.00132423260676e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C3,Complement C3,36816,0.0173172598441472,0.00439242037549637,0.00870811590817433,0.0259264037801201,8.10497460008292e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37388,-0.0138556143294664,0.00351717814119424,-0.0207492834862071,-0.0069619451727257,8.2091634632085e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.0271256401381007,0.0068875575127447,0.0136260274131211,0.0406252528630803,8.23891696435323e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPL,Periplakin,37056,0.0119781179089893,0.00305026585319343,0.00599959683673019,0.0179566389812484,8.64819727851009e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.0107643684720636,0.00274147851598669,-0.0161376663633976,-0.00539107058072971,8.66374213292023e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40058,0.0166948989669435,0.00425541951030638,0.00835427672674297,0.025035521207144,8.77380249559411e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39477,0.0216477637461344,0.00552978644281278,0.0108093823182213,0.0324861451740474,9.08800141557142e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,39829,0.0248322140650201,0.00634389594403144,0.0123981780147185,0.0372662501153217,9.1025238864656e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0258191793829855,0.00659839676958132,0.0128863217146061,0.0387520370513649,9.16351464629504e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39489,0.0181446662879344,0.00464046894145376,0.00904934716268506,0.0272399854131838,9.26502044836229e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0179415095669294,0.00459416352331329,0.00893694906123536,0.0269460700726235,9.45723599598777e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.0113480918278274,0.0029102929056541,0.00564391773274537,0.0170522659229095,9.68737510171373e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,0.00984760524316526,0.00253467018187112,0.00487965168669785,0.0148155587996327,0.000102746686520514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,0.013163770493437,0.00339120024614717,0.00651701801098856,0.0198105229758854,0.000104127128653743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,39558,0.0156017830678936,0.00402047492829768,0.00772165220843014,0.023481913927357,0.000104632613069454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.014836959414575,0.00382861955708338,0.00733286508269157,0.0223410537464584,0.000107005925822613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0354785015299824,0.00916430942567219,0.0175164550556649,0.0534405480042999,0.000108656051770867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,-0.0175371671313098,0.00453018603546547,-0.0264163317608221,-0.00865800250179748,0.000108817806369633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCN,Decorin,39585,-0.00796471366636682,0.00205769025906547,-0.0119977865741351,-0.00393164075859849,0.000108959166643755
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40058,0.0285673945690127,0.00738240541075482,0.0140978799639333,0.0430369091740922,0.000109414553399787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,39908,0.00947170165377755,0.00244786636025817,0.00467388358767153,0.0142695197198836,0.000109548200615967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,0.0237799420109186,0.00614552623321196,0.0117347105938232,0.035825173428014,0.000109595955222721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,39821,0.0249156247474693,0.00644053065060889,0.0122921846722759,0.0375390648226628,0.000109911711377187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37056,-0.019731944929883,0.00510157935643194,-0.0297310404684896,-0.00973284939127642,0.000110344112030578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.0347752038913602,0.00899217190600538,0.0171505469555896,0.0523998608271307,0.000110574243029113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0217104182666189,0.00561458733457465,0.0107058270908526,0.0327150094423852,0.000110802857150312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,-0.009877716460303,0.00255550491148517,-0.0148865060868139,-0.00486892683379207,0.000111487341429501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37437,0.0195947473053284,0.0050866012432457,0.00962500886856683,0.02956448574209,0.000117586061956361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,0.0330789130280858,0.00860537773108752,0.0162123726751542,0.0499454533810173,0.000121607173922254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40009,-0.010769629957246,0.00280331212075369,-0.0162641217139232,-0.00527513820056877,0.000122626401167448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLU,Clusterin,37453,-0.0116271027062838,0.0030274712183299,-0.0175609462942104,-0.00569325911835718,0.000123324787248721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,0.0211958856946855,0.00554477881976735,0.0103281192079415,0.0320636521814295,0.000132603746276953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.0362258558947464,0.0094773212686153,0.0176503062082604,0.0548014055812324,0.00013278368893824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0100466701013107,0.00262908218698837,0.00489366901481346,0.0151996711878079,0.000133217502566093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,36991,0.0199923274601757,0.00523248620509827,0.00973665449818314,0.0302480004221683,0.000133627948657153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,-0.010339406356298,0.00270866314684357,-0.0156483861241114,-0.00503042658848463,0.000135502391432626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,-0.00932151811092869,0.00244316579761611,-0.0141101230742563,-0.00453291314760111,0.00013659581278799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,39985,0.0252671176353063,0.00662366043403843,0.012284743184591,0.0382494920860216,0.000136870304410635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,39858,-0.00691744615040861,0.00181585073423551,-0.0104765135895102,-0.00335837871130701,0.000139780410400215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0302222828742975,0.00793391082817807,0.0146718176510685,0.0457727480975266,0.000139905947070636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,-0.00846476161439053,0.00222296777654121,-0.0128217784564113,-0.00410774477236976,0.000140693185554184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,39587,0.0178838078769975,0.00469837176877689,0.00867499921019477,0.0270926165438002,0.000141548067467129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0208011463705372,0.00546910397109111,0.0100817025871986,0.0315205901538758,0.00014325874579705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNC,Tenascin,39931,-0.0169916076343084,0.00447080995759042,-0.0257543951511856,-0.00822882011743113,0.000144898721084038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.021306419560534,0.0056312385484015,0.010269192005667,0.0323436471154009,0.000155232913473294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39238,-0.0110604315140653,0.00292657845868289,-0.0167965252930838,-0.00532433773504686,0.000157860699232239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0124046945732492,0.00328623776554107,0.00596366855278871,0.0188457205937097,0.000160754774352058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,39587,0.0297551245104929,0.0079107959826646,0.0142499643844702,0.0452602846365155,0.000169624223827648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0107159469569262,0.00284908187921767,-0.0163001474401928,-0.00513174647365953,0.000169840944439643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,0.031540568614939,0.0083932709113727,0.0150897576286485,0.0479913796012295,0.000172106847101959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,0.00661787039545551,0.00176271577643568,0.00316294747364157,0.0100727933172695,0.000174508756665872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,39858,0.0186522350984372,0.00497779858490315,0.00889574987202697,0.0284087203248473,0.00017953001779549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,39858,0.0161005124010936,0.00429951013701891,0.00767347253253652,0.0245275522696506,0.000181219633424757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0135636835489156,0.00362292459309998,0.00646275134643965,0.0206646157513916,0.000181985554829784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.00866693936746695,0.00231509781826077,0.00412934764367584,0.0132045310912581,0.000181993708541228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39438,0.0153766559309773,0.00412836992644039,0.00728505087515413,0.0234682609868005,0.000196290958749496
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,-0.0113533680609456,0.00305050291166109,-0.0173323537678013,-0.00537438235408984,0.000198628771824198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.0352592164062582,0.00947755227569632,0.0166832139458934,0.0538352188666229,0.000199800045582924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0227637179811784,0.00614238336417231,0.0107246465874007,0.0348027893749561,0.000211278761636229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,-0.0119303948799598,0.00322653548690341,-0.0182544044342905,-0.00560638532562913,0.0002183859032152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.014128378430805,0.00382089787102222,0.00663941860360148,0.0216173382580086,0.000218482472912995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,0.0170307372237069,0.00460656323699019,0.0080018732792061,0.0260596011682076,0.000218852751295153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0303321951116222,0.00820975453977217,0.0142410762136688,0.0464233140095757,0.00022107697708955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37169,-0.0115755663860022,0.0031362681872647,-0.0177226520330411,-0.00542848073896343,0.000224378043845706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,39617,0.0243501917573329,0.00660447715069291,0.0114054165419748,0.037294966972691,0.000227744920531884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,35640,0.0354174156000203,0.00960576466211235,0.0165901168622801,0.0542447143377605,0.000227843259882211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,39913,0.009921174926591,0.00269255256299311,0.0046437719031245,0.0151985779500575,0.000229749536386998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0145323091599321,0.00394395074874294,-0.0222624526274683,-0.00680216569239595,0.000229882834126881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,-0.0173933110554775,0.00472604492247016,-0.0266563591035191,-0.00813026300743603,0.000233855763452112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0237196753437902,0.00645179863281497,0.0110741500234729,0.0363652006641076,0.00023745279320423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.011017701742443,0.00300019206906257,0.00513732528708035,0.0168980781978056,0.000241130544825303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,0.015490778939656,0.00421851249855305,0.00722249444249202,0.02375906343682,0.000241496848162632
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,39788,-0.00985978754428881,0.00268959253516246,-0.0151313889132072,-0.00458818617537039,0.00024726766075919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0169311788222723,0.00462089088517534,0.00787423268732864,0.025988124957216,0.000249207410673328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.00842901412992927,0.00230471546934426,0.00391177181001451,0.012946256449844,0.000255713671881923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37445,0.0318137078377025,0.00872093823009489,0.0147206689067165,0.0489067467686885,0.000265311175654635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40052,0.0141578533815099,0.00388146123444631,0.00655018936199509,0.0217655174010246,0.000265575668432831
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0255191587406074,0.0069986651640509,0.0118017750190676,0.0392365424621471,0.00026691807979253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,0.0114612631286993,0.00314388150021316,0.00529925538828155,0.0176232708691171,0.000267637714384623
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37411,0.00878070361922355,0.00240865946936867,0.00405973105926095,0.0135016761791862,0.000267898913322186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,39891,-0.00966272671880873,0.00265303861531943,-0.0148626824048348,-0.00446277103278264,0.000271237583815969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.00959697816150337,0.0026358901220831,0.0044306335222205,0.0147633228007862,0.000272552068563733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,0.0246230468113909,0.00676551733117008,0.0113626328422976,0.0378834607804843,0.000274195487553561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,0.0169231877034043,0.00465109571323151,0.0078070401054706,0.0260393353013381,0.00027505016384575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37347,0.00966044601655613,0.0026571027229057,0.00445252467966096,0.0148683673534513,0.000278251488057425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39489,0.0212582606590175,0.00585120074837475,0.00978990719220302,0.032726614125832,0.000280884358235924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,39587,0.0165384012005095,0.00455571463148789,0.00760920052279321,0.0254676018782257,0.000284040997737569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,39585,0.0154466403792947,0.00425666466087731,0.00710357764397514,0.0237897031146142,0.000285629637784244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.0169154246792859,0.00466621186184483,-0.0260611999285018,-0.00776964943007007,0.000289947883042843
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0132498757657894,0.00365624999010741,0.00608362578517892,0.0204161257464,0.000291102023496472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,0.00916198455750015,0.00253454296348627,0.00419428034906707,0.0141296887659332,0.000301436554533439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0218141711700263,0.0060369515333716,0.00998174616461795,0.0336465961754346,0.00030307605590251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,0.0241442474283427,0.0066848969858919,0.0110418493359945,0.0372466455206908,0.000305256922230301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,0.014130986202802,0.00391726801064215,0.00645314090194339,0.0218088315036606,0.000310474023784491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.0104224139376714,0.00289082568894043,-0.0160884322879947,-0.00475639558734818,0.000312713546974211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI3,Elafin,39594,0.0181200175000778,0.0050267073609019,0.00826767107271012,0.0279723639274455,0.000313420216600765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,0.0125268470304004,0.00347615812065825,0.00571357711391023,0.0193401169468906,0.000314940840730805
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0171167881302139,0.00475704069839941,0.00779298836135108,0.0264405878990768,0.00032157025312962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.025122849672625,0.00699651070813509,0.0114096886846803,0.0388360106605698,0.000330891442668323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37287,0.0339658190161923,0.00948918296266814,0.0153670204093628,0.0525646176230219,0.000345565312150981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.0288920014206238,0.00807652319621232,0.0130620159560477,0.0447219868852,0.000348235578262779
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37411,0.0173868193034603,0.00486460433030433,0.00785219481606382,0.0269214437908568,0.000352590128213261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,0.0225860661819125,0.00632183068614674,0.0101952780370649,0.0349768543267601,0.000354343769184302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37095,0.0481248738744054,0.0135024452441862,0.0216600811958004,0.0745896665530104,0.000366308560776828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,39931,-0.0101718738153561,0.00285416641944562,-0.0157660399974695,-0.00457770763324267,0.000366488079541169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0207683973528011,0.00583190459825159,0.00933786434022797,0.0321989303653742,0.000370508789853565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,0.0223692790336762,0.00628433583408271,0.0100519807988741,0.0346865772684783,0.000372624400135046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,0.0262859472040032,0.00739613771294346,0.011789517286634,0.0407823771213724,0.000380497426997722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.00812455169086227,0.00228608348382835,0.00364382806255871,0.0126052753191658,0.000380639031194107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,39749,0.0488008093171606,0.0137400938146292,0.0218702254404874,0.0757313931938338,0.000383846121623477
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,0.0214020201442839,0.00603180152001717,0.0095796891650503,0.0332243511235176,0.000389228415929292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,39788,0.025473030000922,0.0071825710286157,0.0113951907848352,0.0395508692170087,0.000391496923752862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,0.0201546690154033,0.00568666837003451,0.00900879901013563,0.0313005390206709,0.00039493983974678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.01755046479764,0.00495988290011664,0.00782909431341142,0.0272718352818686,0.000403600649504311
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,39725,-0.0164731374895777,0.00466204718320896,-0.0256107499686673,-0.00733552501048818,0.000411330850575183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.0111408960949554,0.00315530508507123,-0.017325294061695,-0.00495649812821575,0.000415397641147909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40052,-0.00784569698886528,0.00222227220459893,-0.0122013505098792,-0.00349004346785137,0.000415951571209754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,0.0197596876099051,0.00561336471457114,0.00875749276934569,0.0307618824504646,0.000432778507880962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.0376534241579949,0.0107056849302251,0.0166702816947538,0.0586365666212361,0.000437456170601123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,-0.0113191375776098,0.00322082853934374,-0.0176319615147235,-0.00500631364049604,0.000442297811672299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.0256414608836716,0.00729714137243609,0.0113390637936968,0.0399438579736463,0.000442820062152609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,39866,0.0216947355640226,0.0061895663853151,0.009563185448805,0.0338262856792402,0.000457770942055424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37021,-0.0104550932450431,0.00298404340051849,-0.0163038183100594,-0.00460636818002688,0.000460423525616504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0246667295495122,0.00705433853663744,0.0108402260177028,0.0384932330813215,0.000472630941726944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37124,0.0123564028082923,0.00353431910290721,0.00542913736659419,0.0192836682499904,0.000473619948989353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,0.0275340298153617,0.00787706654216218,0.0120949793927238,0.0429730802379996,0.000474777994626533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,39490,0.0140038477937964,0.00401225360291205,0.00613983073208881,0.021867864855504,0.000483863045720677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,0.00876489915705328,0.00251255957757259,0.003840282385011,0.0136895159290956,0.000487396959531157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,39858,0.0403971302267681,0.0115858640700066,0.0176888366495552,0.063105423803981,0.000490221077134697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,0.0203174483474057,0.00583587009898878,0.00887914295338765,0.0317557537414237,0.000500224013172017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,39908,0.0192431519356453,0.00553987755383633,0.00838499193012614,0.0301013119411645,0.000514937810541433
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,-0.0136437684027942,0.00392824977913713,-0.021343137969903,-0.00594439883568542,0.000515831099792911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,-0.00866760575464136,0.00250093515119003,-0.0135694386509738,-0.0037657728583089,0.00053016395781369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39455,0.0286072775824619,0.00825455093111481,0.0124283577574769,0.044786197407447,0.00053040004169971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,0.0174738992467479,0.00504696209457375,0.0075818535413833,0.0273659449521124,0.000537340570971536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0157468919380884,0.00455218573996089,0.00682460788776508,0.0246691759884118,0.000543465003753643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0137250690938059,0.00397272912716875,0.00593852000455514,0.0215116181830567,0.000552122285706142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,39585,0.0152202159971622,0.0044088462680433,0.00657887731179728,0.023861554682527,0.000557499157552965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,0.0392084942500488,0.0113642605259344,0.0169345436192174,0.0614824448808803,0.000562001765663862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,-0.00818976167529291,0.00237385283887045,-0.012842513239479,-0.00353701011110682,0.000562317074948151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0236931123765112,0.00686833455008655,0.0102311766583416,0.0371550480946808,0.000562857874933942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37333,0.0114164111264183,0.00331132632557189,0.00492621152829745,0.0179066107245392,0.000567139689320216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,39913,0.020607628202616,0.00598434105896949,0.00887831972703578,0.0323369366781962,0.00057550662347891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0154286289912972,0.00448125714015424,0.00664536499659486,0.0242118929859995,0.000577199309056854
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0119387977141395,0.00346916165456419,0.00513924087119371,0.0187383545570854,0.000580492172075133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,0.0274559783779469,0.00799006911913014,0.0117954429044518,0.043116513851442,0.000591303398513018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37056,0.0383229444483542,0.0111684262688961,0.0164328289613179,0.0602130599353905,0.000602392841653502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0127249592153989,0.00371465450042784,0.00544423639456037,0.0200056820362375,0.000615244412251095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0125088621464382,0.00365382235743319,0.00534737032586918,0.0196703539670073,0.000620033908118485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,0.0105860465435769,0.00310020139720754,0.00450965180505016,0.0166624412821037,0.000640305148051876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40030,0.0140093300156655,0.00410475571381601,0.00596400881658615,0.0220546512147449,0.000644210007523966
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.0311176143875706,0.00912807114066416,0.0132265949518688,0.0490086338232723,0.000653619928226229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37169,-0.0109265481534439,0.00320881761982356,-0.0172158306882981,-0.00463726561858969,0.000663197504659731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,0.0316985571538006,0.00931058118762716,0.0134498180260514,0.0499472962815499,0.000664660009025153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0148539991146166,0.00436727516488543,0.0062941397914412,0.0234138584377921,0.000672885846309298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,39585,0.0162181995679201,0.0047710015744678,0.00686703648196317,0.025569362653877,0.000677193681776524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37382,0.0145995178224486,0.00429754499315939,0.00617632963585623,0.023022706009041,0.000682812588144975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,-0.0351619010594699,0.0103602455916685,-0.0554679824191402,-0.0148558196997996,0.000690955480023017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0120127368001923,0.00354002295725648,0.00507429180396962,0.018951181796415,0.000691965125460892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,0.0155217572735838,0.00457727201234472,0.00655030412938815,0.0244932104177794,0.000698240045810976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,39858,-0.0153159395814242,0.00452271660732675,-0.0241804641317847,-0.00645141503106381,0.000709743640922482
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.00724588272521153,0.00214334047764333,0.0030449353890306,0.0114468300613925,0.000724905314747569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,37453,-0.00877028448871563,0.00259621665756963,-0.0138588691375521,-0.00368169983987916,0.000731928771819255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,0.0132979591387993,0.00394042745804892,0.00557472132102345,0.0210211969565752,0.000740593939176276
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.00841171184560592,0.00249590390885443,-0.0133036835069606,-0.00351974018425124,0.000753286737166455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0184274781968264,0.00547437403424986,-0.0291572513039561,-0.00769770508969671,0.00076447672826978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,0.0235980105497284,0.00704881877848581,0.00978232574389623,0.0374136953555606,0.000816826342157458
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0195316801344108,0.00584460138534995,0.00807626141912486,0.0309870988496967,0.000834586729239499
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0235126617993204,0.00704088225789974,0.00971253257383695,0.0373127910248039,0.000841710133816117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,0.0170399391874372,0.00510303052244964,0.00703799936343594,0.0270418790114385,0.000842521645179731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,39749,0.0105738069044878,0.00317270042369416,0.0043553140740473,0.0167922997349284,0.00086189540731675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0133163218246829,0.00400436152993009,0.00546777322601996,0.0211648704233459,0.000884765157643058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0133891678153593,0.00403834329356257,0.00547401495997664,0.0213043206707419,0.000916786189885851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,36962,-0.0114066094903109,0.00344101112461018,-0.0181509912945468,-0.00466222768607494,0.000919246352080828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.0232011035265054,0.00700274693490447,0.00947571953409259,0.0369264875189181,0.000925021507567302
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,0.0193431622607244,0.0058386628734902,0.00789938302868357,0.0307869414927651,0.000925695964492655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37368,0.0120729506206981,0.00364635855336226,0.00492608785610804,0.0192198133852881,0.000932199425768055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,36962,-0.0112261638961388,0.00339275706075097,-0.0178759677352107,-0.00457636005706689,0.000939287000934655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0189019122178891,0.0057151940914814,0.00770013179858554,0.0301036926371926,0.00094406020721843
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,0.0271930145602658,0.00822621060801386,0.0110696417685587,0.043316387351973,0.000950061478406958
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,0.0117140844165918,0.00355005473483299,0.00475597713631912,0.0186721916968644,0.000970026959017668
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37430,0.0118240137739131,0.0035832791718347,0.00480078659711709,0.0188472409507091,0.00097011859112168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,36962,-0.0146348327318123,0.00444916320024566,-0.0233551926042938,-0.00591447285933078,0.00100685770049013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0138048102558733,0.00420137350740204,0.00557011818136533,0.0220395023303813,0.00101964603800887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,39826,0.00819972240028317,0.00249987006162133,0.00329997707950536,0.013099467721061,0.00104007529394417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,-0.00487513373165786,0.00148687513193965,-0.00778940899025957,-0.00196085847305615,0.00104477440011607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,0.0137514274733052,0.00419439691559685,0.00553040951873533,0.021972445427875,0.00104579925553734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,0.0109249637730775,0.0033380039809583,0.00438247597039926,0.0174674515757558,0.00106720314108573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37039,0.0154776014584642,0.0047339907987425,0.00619897949292886,0.0247562234239995,0.00108028663835452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.0254342955113367,0.00778185265098432,0.0101818643154074,0.040686726707266,0.00108381120573909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,39779,0.00900278654527085,0.00275757772169133,0.00359793421075584,0.0144076388797859,0.00109794220677497
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,39585,0.0160172397665041,0.00491213352937171,0.00638945804893558,0.0256450214840727,0.00111354383454811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,39731,-0.0088685655180318,0.0027280858626185,-0.014215613808764,-0.00352151722729954,0.00115305233401171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,39788,0.0255988165927835,0.0078823495242591,0.0101494115252356,0.0410482216603313,0.00116618520859231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40030,0.00764234787026021,0.00236111785553077,0.00301455687341991,0.0122701388671005,0.00121142779214517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37021,-0.0112346989385719,0.00347207108869992,-0.0180399582724238,-0.00442943960472008,0.00121630191995551
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.0101634086432824,0.00314163373266771,-0.0163210107593111,-0.00400580652725374,0.00121860546218073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37021,0.0190082215456702,0.00588127969438428,0.00748091334467705,0.0305355297466634,0.00123235019382031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,0.0289696893840099,0.00897662941332991,0.0113754957338832,0.0465638830341365,0.00125244541232534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,39715,0.0216193439050286,0.00669956827034662,0.00848819009514927,0.034750497714908,0.00125360156633781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37021,-0.0106958835754481,0.00332001914246389,-0.0172031210946774,-0.00418864605621891,0.00127772213729407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00974621451050057,0.00303385815707129,0.00379985252264084,0.0156925764983603,0.00131900981530905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37073,0.0200445698338452,0.00624983973633417,0.00779488395063026,0.0322942557170602,0.00134346850512657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSPN,Persephin,39866,0.0286687707021324,0.00894398496322882,0.011138560174204,0.0461989812300609,0.00135154210829928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,0.00839120803079566,0.00261862545435082,0.00325870214026805,0.0135237139213233,0.00135641692324133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,0.0080968836376888,0.00253446036326322,0.00312934132569289,0.0130644259496847,0.00140238619145663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37169,-0.00882219544807984,0.00276197433169864,-0.0142356651382092,-0.00340872575795051,0.00140563801710443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0142530183319813,0.00446749134418975,0.00549673529736943,0.0230093013665933,0.00142354886478241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRELP,Prolargin,39862,-0.00670706935598934,0.00210259424913769,-0.0108281540842992,-0.00258598462767947,0.00142595522598086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,0.0137846353479989,0.00432186473101277,0.00531378047521389,0.022255490220784,0.00142838616980197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.026608789382823,0.00834891127747931,0.0102449232789636,0.0429726554866825,0.00144046785019356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00928106001871519,0.00292170649646757,-0.0150076047517916,-0.00355451528563875,0.00149362235347591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40030,-0.0133456970038824,0.00420261703635831,-0.0215828263951447,-0.00510856761262009,0.00149824017830713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,0.0171796894643827,0.00540997152027729,0.00657614528463922,0.0277832336441262,0.00149836129059177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRN,Progranulin,39787,0.00743801358488786,0.002342762797715,0.00284619850136645,0.0120298286684093,0.00150178820589769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,-0.0112503766829353,0.00354512410664366,-0.0181988199319569,-0.00430193343391373,0.00150970339581126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37437,0.0217172143447597,0.00684576021265493,0.00829952432795606,0.0351349043615634,0.00151542303968179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,0.0152017270103774,0.00480572313269515,0.00578250967029487,0.0246209443504599,0.00156370362365565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,39868,0.0116091050109639,0.00368051462314967,0.00439529634959053,0.0188229136723372,0.00161232487370844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,0.00656728433544705,0.00208272821935967,0.0024851370255021,0.010649431645392,0.00161837276818381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37187,0.00748957941068057,0.00237881954766994,0.00282709309724749,0.0121520657241137,0.00164504526672399
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0142876725946719,0.00453845435331424,-0.0231830431271678,-0.00539230206217596,0.00164682106011813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,0.0155985807436727,0.00496174693405486,0.00587355675292521,0.0253236047344203,0.00167089151150705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,0.0143486541924362,0.00456601903500247,0.00539925688383134,0.023298051501041,0.00167827376916983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,0.0123973540967383,0.00394593224359397,0.00466332689929408,0.0201313812941825,0.00168280828944584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,39788,-0.00447277451216258,0.0014277794555724,-0.00727122224508447,-0.00167432677924068,0.00173532772780191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.00689854241120731,0.00220279603167821,0.00258106218911803,0.0112160226332966,0.00174100924719577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,0.00699759015368242,0.00223460697625734,0.00261776048021803,0.0113774198271468,0.00174253674730504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,0.014404988878276,0.00460267702610019,0.00538374190711961,0.0234262358494324,0.00175308230137329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37021,-0.0141948582678964,0.00453968592118533,-0.0230926426734197,-0.00529707386237317,0.0017708275507259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40042,0.00958753562826869,0.0030714236512596,0.00356754527179987,0.0156075259847375,0.00180231753646181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37368,0.0125138153473181,0.00401044617031487,0.00465334085350094,0.0203742898411352,0.00181044380716773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,0.0228981947201553,0.00734802601661081,0.00849606372759816,0.0373003257127125,0.00183568081725764
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.00999701161378796,0.00321545320952196,-0.016299299904451,-0.00369472332312491,0.00188089925388544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0218509209284457,0.00703625272283303,0.00805986559169296,0.0356419762651984,0.00190377785849927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37106,-0.0106935208295595,0.00344454161101751,-0.0174448223871538,-0.00394221927196518,0.00191013742313643
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,0.00831369146289735,0.00267810415024414,0.00306460732841884,0.0135627755973759,0.0019111858201919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.012607140023395,0.00406147475849349,0.00464664949674772,0.0205676305500422,0.00191276249616284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,39868,0.0203960700017686,0.00658117435863611,0.00749696825884185,0.0332951717446954,0.00194410791580516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39456,0.0182781700114683,0.00589894847803091,0.00671623099452771,0.0298401090284089,0.00194817766289581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0237933109896553,0.00768106361287056,0.00873842630842902,0.0388481956708816,0.00195402097012372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,39866,0.0169517176169028,0.00547742227285877,0.00621596996209957,0.0276874652717059,0.00197262110906195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39480,0.0326166578724147,0.0105489342432216,0.0119407467557004,0.0532925689891289,0.00199204156463403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37056,0.015400127098557,0.00498287611277605,0.00563368991751592,0.025166564279598,0.00200161568620934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,0.0165435476343075,0.0053566648923205,0.00604448444535932,0.0270426108232557,0.00201642682987417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0137871196194633,0.00448979800812644,-0.0225871237153911,-0.00498711552353545,0.00213869156804435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,-0.00822598874396737,0.00268031357661146,-0.0134794033541258,-0.00297257413380892,0.00215185927820873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37021,-0.0206945871330418,0.00674857031934386,-0.0339217849589557,-0.0074673893071278,0.00217009725551063
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,39836,0.0257624877216563,0.00841592164796996,0.00926728129163512,0.0422576941516774,0.002208468017351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37382,0.0104427862933207,0.00341268285043035,0.00375392790647726,0.0171316446801642,0.00221775562586853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,39788,0.0121308109258013,0.00396512331575757,0.00435916922691645,0.0199024526246861,0.00222165632880567
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,-0.0121741243687382,0.00398881971725391,-0.0199922110145559,-0.00435603772292056,0.00227727137587891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,-0.0106977174406691,0.0035058536157351,-0.0175691905275099,-0.00382624435382833,0.00228235146971884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.027397951093005,0.00901379691918863,0.00973090913139524,0.0450649930546147,0.00237310615499402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.00903852275688032,0.00297703928158105,0.00320352576498147,0.0148735197487792,0.00240144979152671
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,-0.00885504163703974,0.00291670908247957,-0.0145717914386997,-0.00313829183537978,0.00240148497192619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00767394974001119,0.00253507291472375,0.00270520682715264,0.0126426926528697,0.00247297082703681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39489,0.011206653228495,0.00370913750836857,0.00393674371209263,0.0184765627448974,0.00252045983627219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,-0.016605876634671,0.00550295564412065,-0.0273916696971474,-0.00582008357219448,0.00255159815634216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,0.0151418730656131,0.00501912544071089,0.00530438720181979,0.0249793589294065,0.00255913054950606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37208,0.00791725710553297,0.00262522365817297,0.00277181873551395,0.013062695475552,0.00256749775083713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39489,0.0191229661847741,0.0063489092548573,0.0066791040452538,0.0315668283242944,0.0025994072329392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0115926599389354,0.00385199602426552,0.004042747731375,0.0191425721464958,0.00262077872701693
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRL,Prolactin,40009,0.0216222566463815,0.00719019982169469,0.00752946499585992,0.0357150482969031,0.00264085510662512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.0123361985193956,0.00410563329207417,-0.020383239771861,-0.00428915726693021,0.00266341599306219
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.00913603462867511,0.00304119590954374,0.00317529064596937,0.0150967786113808,0.00266859835201145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.011014937895721,0.00367131498997819,0.00381916051536376,0.0182107152760783,0.00270230517636105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37056,-0.00975712244460379,0.00325603199112385,-0.0161389451472065,-0.00337529974200105,0.00273489549421111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.00822249089850366,0.0027478069333922,0.00283678930905494,0.0136081924879524,0.0027722592457543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0187163188786881,0.00625496204343623,0.00645659327355311,0.0309760444838231,0.00277364771723739
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,0.0248944288395225,0.00832029718530016,0.00858664635633423,0.0412022113227108,0.00277658281675637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,-0.00737431051689212,0.00246548399560624,-0.0122066591482804,-0.00254196188550388,0.00278564926850221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,-0.0113209519455559,0.00380292820561155,-0.0187746912285545,-0.00386721266255724,0.00291610997202227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0187545150445514,0.00630347286163147,0.00639970823575372,0.0311093218533491,0.00293249937723672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,0.0110717558939403,0.00372703974229567,0.00376675799904077,0.0183767537888398,0.00297686537731999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,36931,-0.0114246082145679,0.00385113752156712,-0.0189728377568394,-0.00387637867229631,0.00301702125674686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0106481769495569,0.00359655312500364,0.0035989328245498,0.0176974210745641,0.00307526574984044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37056,0.0120308246186798,0.00406412357404826,0.00406514241354519,0.0199965068238143,0.00307935407122014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37382,0.0196871979886502,0.00667087008119168,0.00661229262951448,0.0327621033477859,0.00317065681243109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0118680480066663,0.00402339923610316,0.00398218550390409,0.0197539105094285,0.00318569262642504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,39868,0.021474007701326,0.00728174409074979,0.00720178928345645,0.0357462261191956,0.0031924435264425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0275663345423345,0.00937087699502709,0.00919941563208141,0.0459332534525876,0.00326981903946588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0330797869568809,0.0112730650598252,0.0109845794396235,0.0551749944741382,0.00334744904405664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37021,-0.00986720267879875,0.00336453643273363,-0.0164616940869567,-0.00327271127064083,0.00336598893402962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0192354561681352,0.00655951049442255,0.00637881559906705,0.0320920967372034,0.00336860294057298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.0280353428766158,0.00956127142345791,0.00929525088663834,0.0467754348665934,0.0033707114019234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.0333442668985512,0.0113733743393418,0.0110524531934412,0.0556360806036612,0.00337498361286057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,0.0152414062208167,0.00522581067029609,0.00499881730703632,0.025483995134597,0.00354493612602304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37388,-0.0103328320501789,0.00354365304219148,-0.0172783920128742,-0.00338727208748361,0.00355280450226546
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,39749,-0.00339870619264927,0.00116642536317338,-0.00568489990446909,-0.00111251248082944,0.00357579949543649
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,39856,0.0108746524920756,0.00373353337017719,0.00355692708652836,0.0181923778976229,0.0035881730539391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.0143043163917757,0.00492455988041362,-0.0239564537573864,-0.00465217902616505,0.00368229611422646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.00818973101345598,0.00282128521563857,0.00266001199080439,0.0137194500361076,0.00370300902767132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,37453,0.00713325297907262,0.00245763274686218,0.00231629279522274,0.0119502131629225,0.00370804568105359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,-0.0166413393384286,0.0057357324147336,-0.0278833748713065,-0.00539930380555078,0.00372181566642994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39477,0.0187522306534977,0.0064734918785018,0.00606418657163421,0.0314402747353612,0.00377547048500801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.0119460504212356,0.00412449603079068,-0.0200300626415853,-0.00386203820088587,0.00378115562442062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0139246092242363,0.004811630381826,0.00449381367585732,0.0233554047726152,0.00380943245837536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,0.00870520887937179,0.00300859427346289,0.00280836410338453,0.0146020536553591,0.00381552282057095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00737067806513587,0.0025476144134804,0.00237735381471428,0.0123640023155575,0.00381900047734366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0109945352428097,0.00380262231703931,0.00354139550141269,0.0184476749842068,0.00384176486759658
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.0349839387266886,0.0121044285871954,0.0112592586957855,0.0587086187575916,0.00385636303905389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37056,0.0135649292788857,0.00469370279411039,0.00436527180242935,0.0227645867553421,0.00385836073001035
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,0.00694089744047854,0.00240600755328543,0.0022251226360391,0.011656672244918,0.00392154656785267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37445,-0.00621512124189842,0.00215483752990405,-0.0104386028005104,-0.00199163968328647,0.00392945689172871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLC,Galectin-10,39841,-0.0181996777536757,0.00632154330999822,-0.0305899026412722,-0.00580945286607919,0.00399476802632752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39477,0.0202064328821724,0.00702615182337275,0.0064351753083618,0.033977690455983,0.00403436278048335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39477,-0.022908794798949,0.00796743196002585,-0.0385249614405996,-0.00729262815729829,0.00404183275430748
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37437,-0.00824938556310654,0.00287290978920031,-0.0138802887499391,-0.00261848237627393,0.00409239661144452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,0.0213551657321401,0.00743821489042244,0.00677626454691213,0.0359340669173681,0.00409701772229892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37021,-0.0125757814568458,0.00438772337500688,-0.0211757192718593,-0.00397584364183234,0.00416183591334356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.0278517318037214,0.00975227489266792,0.00873727301409229,0.0469661905933505,0.00429791657364445
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37021,-0.0147000538782497,0.00514822935374798,-0.0247905834115957,-0.00460952434490365,0.00430551512966932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,36991,0.0229073899642764,0.00804664564621256,0.00713596449769976,0.038678815430853,0.00442261359930211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,36991,-0.0129357812475456,0.00454533059457141,-0.0218446292129055,-0.00402693328218558,0.00443478026173814
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,0.00958532717758135,0.00336962528306157,0.00298086162278067,0.016189792732382,0.00445192795131018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,0.0130734849106067,0.00459752848323345,0.00406232908346914,0.0220846407377443,0.00446755798790453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,0.00972767734138359,0.00342745589299307,0.00300986379111716,0.01644549089165,0.00454437930053718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,0.0237219009979197,0.00836385560511257,0.00732874401189911,0.0401150579839404,0.00457051984595345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,0.00660337988922069,0.00232884650239406,0.00203884074452833,0.0111679190339131,0.00458255308916569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0789679944013806,0.0278759156223857,0.0243311997815047,0.133604789021257,0.00461942110598994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0103303503006498,0.00365233071614377,0.00317178209700804,0.0174889185042916,0.00468369125716934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40030,-0.012186497642827,0.00431535684925247,-0.0206445970673619,-0.00372839821829219,0.00474887937619818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.00743545383649177,0.00263482420854587,-0.0125997092852417,-0.00227119838774186,0.00477970486588431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,39866,0.0182813229723509,0.00648708667816084,0.00556663308315561,0.0309960128615461,0.00483665121147903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,0.0324602870639222,0.0115251383259994,0.0098710159449635,0.055049558182881,0.00486257788493079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0160501364339747,0.0057046726501253,0.00486897803972909,0.0272312948282203,0.00490655435064171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,-0.00670788850603452,0.00239001825720704,-0.0113923242901603,-0.00202345272190873,0.00501231318121106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37420,-0.00951421380840716,0.00339047075632145,-0.0161595364907972,-0.00286889112601713,0.00502067786774553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,39903,-0.0145408765128099,0.00518750371189495,-0.024708383788124,-0.00437336923749583,0.00506812243290755
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,0.0255313066530051,0.00911247916480871,0.00767084748998003,0.0433917658160302,0.00508926561533737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.00953325948300208,0.00341259305540313,0.00284457709441195,0.0162219418715922,0.00522076199902839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0197102268879203,0.00706761438455886,0.00585770269418493,0.0335627510816557,0.00529662223669232
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,0.00798829519617789,0.00286698383988827,0.00236900686999687,0.0136075835223589,0.00533752457158752
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0250872607570609,0.00900790076075216,0.0074317752659867,0.0427427462481352,0.00535864419634949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,-0.00721083722565295,0.00258940734215661,-0.0122860756162799,-0.002135598835026,0.00536321573506275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0393602599127421,0.0141697656584469,0.0115875192221863,0.067133000603298,0.00547981287348129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0100691320325719,0.0036360319266045,0.00294250945642703,0.0171957546087167,0.00562481015368275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,-0.00976350538280483,0.00352708876386258,-0.0166765993599755,-0.00285041140563418,0.00564421891330613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0090050131470244,0.00325596798081633,0.00262331590462438,0.0153867103894244,0.00568679433878908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,39830,-0.0206620807443338,0.00749014407011117,-0.0353427631217517,-0.00598139836691589,0.00581210715132254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.00639189848108784,0.0023288488407334,-0.0109564422089253,-0.00182735475325038,0.00606550965592371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,0.025128294392167,0.00916632649180373,0.00716229446823164,0.0430942943161023,0.00612639248824179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,36962,-0.0114663781864611,0.00418286699875734,-0.0196647975040255,-0.00326795886889677,0.00612847203382373
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37311,-0.0187719678761616,0.00684936397417697,-0.0321967212655485,-0.00534721448677476,0.00613916618373599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.01592914065259,0.00581358692507636,0.00453451027944029,0.0273237710257396,0.00615112959979023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.0176368943183022,0.00643829153089601,0.00501784291774601,0.0302559457188584,0.00616390225921337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,0.0106627931334276,0.00389872429261831,0.00302129351989576,0.0183042927469595,0.00624608607815758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37437,0.0172896642182406,0.00632622026141847,0.00489027250586044,0.0296890559306208,0.00628384276612057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.016826158091056,0.00615786909219985,0.00475673467034429,0.0288955815117677,0.00629454142794791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,36874,0.0209898637559089,0.00768542392908375,0.00592643285490475,0.036053294656913,0.00632032958521893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0184357238351539,0.00675826239590075,0.00518952953918846,0.0316819181311194,0.00638253451069026
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,0.0102080095122404,0.00375211736335453,0.00285385948006548,0.0175621595444152,0.0065234644498508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37220,0.00854991560634675,0.00314286887992187,0.00238989260169988,0.0147099386109936,0.00652838882816061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,0.00579277768525988,0.00213348694042892,0.0016111432820192,0.00997441208850056,0.00663133363257515
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39489,0.0188601685788972,0.00694711059803816,0.00524383180674239,0.032476505351052,0.00663841999785988
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37021,-0.0110587144401367,0.00407863991171171,-0.0190528486670917,-0.00306458021318179,0.00670921460304505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0114208352656562,0.00421385222211956,0.00316168491030191,0.0196799856210106,0.00673057324517961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.0120607713016202,0.00445031143396171,0.0033381608910553,0.0207833817121852,0.00673371134400071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,0.0274390284572561,0.0101357003412546,0.00757305578839713,0.047305001126115,0.00679454143857033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37021,-0.0133596440769323,0.00493774407902893,-0.023037622471829,-0.00368166568203555,0.00682654440510769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0213532291102341,0.00789448449620815,0.00588003949766616,0.0368264187228021,0.00684118896667507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40058,0.0216004495766558,0.00799503623194419,0.0059301785620452,0.0372707205912664,0.00690510327572308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0188353934266802,0.00697143996521308,0.00517137109486261,0.0324994157584979,0.00690521792868646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,0.0195379466131732,0.00724629221322205,0.00533521387525801,0.0337406793510885,0.00701952476589012
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.0307139052789839,0.0114391611476888,0.00829314942951377,0.0531346611284539,0.00726088325484413
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,0.0194992122060528,0.00726382563447227,0.00526211396248715,0.0337363104496185,0.00727309415591715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0103396514716634,0.00385874548563374,0.00277651031982131,0.0179027926235056,0.00738134391908063
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39477,0.0206183205387706,0.00769561848327681,0.00553490831154802,0.0357017327659931,0.00738693373257816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0123721579010263,0.00463582259647144,0.00328594561194223,0.0214583701901103,0.00761958554926297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.00794738307974421,0.00297785061026834,0.00211079588361827,0.0137839702758701,0.00762085964798599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37437,0.00663793184258209,0.0024896726394103,0.0017581734693379,0.0115176902158263,0.00768079668626091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,0.0158213653213051,0.00594457960858774,0.00416998928847308,0.027472741354137,0.00778761840827404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,-0.00901870303988198,0.00339169909251671,-0.0156664332612147,-0.00237097281854923,0.00784532157955108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,0.013486402275424,0.00507597477622886,0.00353749171401541,0.0234353128368325,0.00789534866117544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0180149385586295,0.00678339526561262,0.00471948383802873,0.0313103932792302,0.00792287364262754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,39868,0.00685053433159629,0.00258102653108067,0.00179172233067817,0.0119093463325144,0.00795776773485474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,0.0116498350540917,0.00439494439503086,0.00303574403983123,0.0202639260683522,0.00803951427147344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0135792742294056,0.00512455318041156,0.00353514999579896,0.0236233984630123,0.00806081202481103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,0.00732311507105519,0.00276837094077585,0.00189710802713452,0.0127491221149759,0.00817024747416502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,39587,-0.00830809190909286,0.00314370553536384,-0.014469754758406,-0.00214642905977973,0.0082312250743689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40030,0.00675156362023232,0.00255601918679676,0.00174176601411068,0.011761361226354,0.00826345718571577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.00952029518662154,0.00360935603525325,-0.0165946330157179,-0.00244595735752517,0.00835758104747171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,0.0127935303035635,0.00486192595536235,0.00326415543105326,0.0223229051760737,0.00851248429179767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.0140481066972226,0.00534061076957505,-0.0245157038055897,-0.00358050958885552,0.00853764880544791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,-0.0114789938891568,0.00436641361349206,-0.0200371645716013,-0.0029208232067124,0.00857359335864521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0189459140992618,0.00721574011183292,0.00480306348006933,0.0330887647184544,0.00865843802056592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,0.00712185515253493,0.00271666167317938,0.00179719827310335,0.0124465120319665,0.00876160616850233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAT,Catalase,37252,0.013161743673241,0.0050244540329888,0.00331381376858297,0.0230096735778991,0.00881484724313272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37411,0.00912148317669854,0.00348223355529481,0.00229630540832071,0.0159466609450764,0.00881737751771441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0219505311260771,0.00840002427714261,0.00548648354287756,0.0384145787092766,0.0089797071052165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0100641011430673,0.00385195747169845,0.00251426449853829,0.0176139377875962,0.00899098892215722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.016196764398913,0.0062119793040695,0.00402128496293679,0.0283722438348892,0.00913339064661638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.0107148933512173,0.00411016377623609,-0.01877081435264,-0.00265897234979454,0.00914593428689086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,0.0192584500549414,0.00739970262588884,0.00475503290819931,0.0337618672016835,0.00926078184734948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37056,0.0156616387008157,0.00602137405029504,0.00385974556223742,0.027463531839394,0.00930541390246887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0119386894263249,0.00459566693646326,0.00293118223085693,0.0209461966217929,0.00939235556412072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37056,-0.0144896466168067,0.0055927199005487,-0.0254513776218821,-0.0035279156117312,0.00958570762509045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,0.0119426751494435,0.00462965059742832,0.002868559978484,0.021016790320403,0.00990013121791922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,0.0310609804077659,0.0120455955092426,0.00745161320965045,0.0546703476058813,0.00993033955535527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37021,-0.0082611462653756,0.00321619373582021,-0.0145648859875832,-0.00195740654316799,0.0102216643762526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37411,0.0151567749364215,0.00590199736500389,0.00358886010101392,0.0267246897718292,0.0102371056014746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,0.0155568525904301,0.00606160760844574,0.00367610167787647,0.0274376035029838,0.0102833521169597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.0215062010936815,0.00839596458520885,0.0050501105066722,0.0379622916806909,0.0104333017668154
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,39866,0.0128613436152894,0.00503669733039926,0.00298941684770682,0.0227332703828719,0.0106729815299887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.00772472019516285,0.00303437615459887,0.00177734293214907,0.0136720974581766,0.0109142256793181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,39868,0.0163751753558732,0.00643300431053846,0.0037664869072178,0.0289838638045286,0.010921611714174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.011134972062883,0.00437568056272043,0.002558638159951,0.0197113059658151,0.0109469053109999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0172640310076524,0.00678547388226629,0.00396450219841047,0.0305635598168943,0.0109618351792175
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,-0.00985522024225352,0.00387603321651679,-0.0174522453466264,-0.00225819513788062,0.0110123037364218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,0.0110421225106369,0.00434511430044122,0.00252569848177213,0.0195585465395017,0.0110563343100908
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,0.0172328264918941,0.00678276255153936,0.00393861189087694,0.0305270410929112,0.0110749849015222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0145469579143411,0.00573424600581373,0.00330783574294615,0.025786080085736,0.011196722986647
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00913012307064209,0.00359903516087522,-0.0161842319859575,-0.00207601415532666,0.0111977301904121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,0.0575078021496079,0.0227131503335714,0.012990027495808,0.102025576803408,0.0113553171809047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,0.0128156853669911,0.00506256045780302,0.00289306686969718,0.022738303864285,0.0113702842508005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0176109435705066,0.00696519829405582,0.00395915491415718,0.031262732226856,0.0114673568579664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37043,0.00731254876504362,0.00290093041968688,0.00162672514245734,0.0129983723876299,0.0117218768027927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,-0.00665080842960957,0.00263877061028664,-0.0118227988257714,-0.00147881803344776,0.011733205561119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,0.0100940823849549,0.00400575942922231,0.00224279390367918,0.0179453708662306,0.0117504959264282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37056,0.00936461530324855,0.00371913059179822,0.00207511934332403,0.0166541112631731,0.0118154698393896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.00722749811053911,0.00287061268129081,0.00160109725520912,0.0128538989658691,0.0118201559830231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0137653451217332,0.00548092160844553,0.00302273876917994,0.0245079514742864,0.0120318719848907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,0.00517032592291411,0.00206139671668812,0.00112998835820539,0.00921066348762283,0.0121458110704993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,0.00790216723227553,0.00315066382711232,0.00172686613113538,0.0140774683334157,0.0121481824532404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,0.00841943360182548,0.00335798745990882,0.00183777818040419,0.0150010890232468,0.0121778407410255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,36962,-0.0107125852125547,0.00427614310535123,-0.0190938256990431,-0.00233134472606631,0.0122503232900811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37424,-0.0034664636116133,0.00138458001129843,-0.00618024043375822,-0.00075268678946838,0.0123046168458119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0111822859468228,0.00447089335919304,0.00241933496280446,0.0199452369308412,0.0123899261734896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0144906727089873,0.00580892347449129,0.00310518269898434,0.0258761627189902,0.0126237015983575
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F3,Tissue factor,39931,-0.00642440459748183,0.00257736184940079,-0.0114760338223074,-0.00137277537265629,0.0126901464828783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00818049764072701,0.00328973265712887,-0.0146283736486996,-0.00173262163275443,0.0129066224191238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,0.0259113988466361,0.0104222225900969,0.00548384257004618,0.0463389551232261,0.0129228407861982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0119356114702914,0.00482403455915137,-0.0213907192062281,-0.00248050373435474,0.0133661204252659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37411,0.0189905029281908,0.00767880447858229,0.00394004615016948,0.034040959706212,0.0134065855521898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00664902943363993,0.00269111794879754,0.00137443825399676,0.0119236206132831,0.0134941548958396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37178,0.00848356170601084,0.00343558346058044,0.00174981812327319,0.0152173052887485,0.0135493849852363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,0.0108194195606949,0.00439143121038844,0.00221221438833358,0.0194266247330563,0.0137614797305401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,0.00831481832344664,0.00337902917581636,0.00169192113884658,0.0149377155080467,0.013876895923968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37088,-0.00720925593717936,0.00293118466569547,-0.0129543778819425,-0.00146413399241622,0.0139256762734871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,-0.0184803932703117,0.00751837553354955,-0.0332164093160688,-0.00374437722455459,0.0139830276008596
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0114626946960593,0.00467599250738696,-0.0206276400105377,-0.00229774938158085,0.0142410569570808
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,-0.0100862096788683,0.00412429937807351,-0.0181698364598924,-0.00200258289784427,0.014475845057721
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,0.0202251816121772,0.00828062953872137,0.00399514771628328,0.0364552155080711,0.0145979181698434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37437,0.0123354545096454,0.00506185105089941,0.00241422644988259,0.0222566825694083,0.0148246720822613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0135090021318328,0.00554646117092072,0.00263793823682816,0.0243800660268374,0.0148778394784172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37368,0.011692095724693,0.00480945378081112,0.00226556631430325,0.0211186251350828,0.0150674256033501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0102260933342414,0.00420733636222912,0.00197971406427237,0.0184724726042105,0.0150873657544481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,-0.0080421744210576,0.00330902388926952,-0.0145278612440259,-0.00155648759808934,0.0150939271147524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,36962,-0.0137555439800221,0.00566901829526819,-0.0248668198387478,-0.00264426812129649,0.0152610901184853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37169,-0.00972934452018498,0.00401640388992389,-0.0176014961444358,-0.00185719289593416,0.0154315502383848
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,-0.0128332581277482,0.00529882534848969,-0.023218955810788,-0.00244756044470845,0.0154524102051885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40030,-0.00664532593130305,0.0027503189856937,-0.0120359511432627,-0.00125470071934341,0.0156943673937549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39489,0.00978409489364207,0.00405492986617978,0.0018364323559297,0.0177317574313544,0.0158380814685003
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40058,0.0138687519649881,0.00578444304048628,0.00253124360563497,0.0252062603243412,0.016514349839294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0133416259996497,0.00556716250637809,0.00242998748714866,0.0242532645121508,0.0165646401605992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.023242131683571,0.00970539450737865,0.0042195584491089,0.0422647049180332,0.0166425661515784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,0.0224999404704221,0.00941551008157395,0.00404554071053713,0.040954340230307,0.0168772357962777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.0256569647965485,0.010764226190781,0.00455908146261776,0.0467548481304793,0.017158619911457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0113803460866343,0.00478767624343909,0.0019965006494937,0.0207641915237749,0.0174678825171308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00728884296376341,0.00306800396760505,-0.0133021307402693,-0.0012755551872575,0.0175270853239595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0138219091743342,0.00583189161759695,-0.0252524167448243,-0.00239140160384422,0.0177997611615531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,-0.00955394018956988,0.00403131665256172,-0.0174553208285909,-0.0016525595505489,0.0178033489347102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0126834118705834,0.00537217169922336,-0.0232128684010612,-0.00215395534010563,0.0182428693876912
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00574946939927458,0.0024367510865812,-0.0105255015289737,-0.000973437269575419,0.0183150722586711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37072,0.00980694910098762,0.0041602066166202,0.00165294413241203,0.0179609540695632,0.0184217490989333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0135997109814833,0.00577337846110824,0.00228388919771117,0.0249155327652555,0.0185078051742237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,36962,-0.0109423958332126,0.00465132907453125,-0.0200590008192938,-0.00182579084713133,0.0186608437120394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,39703,0.0101383938984443,0.00431122849730834,0.00168838604371994,0.0185884017531686,0.0187037709425143
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0150669972071984,0.00641814310670737,0.00248743671805197,0.0276465576963449,0.0189113719344443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,39815,0.0132724146149413,0.00565732689719625,0.00218405389643667,0.024360775333446,0.0189853487019684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,-0.0142533984721029,0.00607837433422316,-0.0261670121671803,-0.00233978477702555,0.0190451916754448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0129772721105639,0.00554335271350849,0.00211230079208728,0.0238422434290406,0.0192421132622894
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.00901389939689904,0.0038664820127547,0.00143559465189984,0.0165922041418982,0.0197529346216993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,0.00560011822954649,0.00241081891847674,0.000874913149332073,0.0103253233097609,0.0201989723207492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37388,-0.00667336587250642,0.0028739872236392,-0.0123063808308393,-0.00104035091417359,0.0202483141285018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.00618349423569492,0.00266479592141999,0.000960494229711749,0.0114064942416781,0.0203323690155798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37043,0.0189727252961885,0.00819750549592207,0.00290561452418122,0.0350398360681957,0.0206582826674891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,39918,-0.0085789785454549,0.00371296310199301,-0.0158563862253612,-0.00130157086554859,0.0208704567856337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37021,-0.0108337330121797,0.00469175918331644,-0.0200295810114799,-0.00163788501287946,0.0209535388163212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,-0.011246289194781,0.00488916321399734,-0.0208290490942158,-0.00166352929534621,0.0214493253132448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37299,-0.00621569678547241,0.00270269534358475,-0.0115129796588985,-0.000918413912046306,0.0214740076312775
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.015184075491526,0.00660280117588133,-0.0281255657962535,-0.00224258518679865,0.0214841524745625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,39868,0.00863773364696903,0.00377087146541303,0.00124682557475948,0.0160286417191786,0.021996802227708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALLD,Palladin,37056,-0.00886260965935025,0.00387143713724545,-0.0164506264483513,-0.00127459287034916,0.0220817169609803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,0.0117797350063458,0.00515210987599341,0.00168159964939876,0.0218778703632929,0.0222444245903086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39315,0.00750410330226369,0.00329231224056487,0.00105117131075654,0.0139570352937708,0.0226639629546574
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,0.0113516592959408,0.00498219278776194,0.00158656143192738,0.0211167571599542,0.0227159176619813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0089415625691464,0.00392487963405021,0.001248798486408,0.0166343266518848,0.0227320833070978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,-0.00713959449216736,0.00314098700569224,-0.0132959290233242,-0.000983259961010567,0.0230392201905619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.00984472247025027,0.00433312523079372,0.00135179701789458,0.018337647922606,0.0231044566619911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,-0.0235173669060257,0.0103511929089037,-0.043805705007477,-0.00322902880457437,0.0231062861159217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0145710141714518,0.00641486067671242,0.00199788724509549,0.0271441410978082,0.0231356103246487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,0.00781314198986245,0.00344197627485443,0.00106686849114776,0.0145594154885771,0.0232262966415411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,39587,-0.0102073115799778,0.00450518888691812,-0.0190374817983373,-0.00137714136161827,0.0234845836212641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.0126701160530193,0.00561053176067387,-0.0236667583039401,-0.00167347380209853,0.0239421731731004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,0.0122607812168919,0.0054307658696922,0.00161648011229518,0.0229050823214886,0.0239836319797035
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,36962,-0.0128308879390792,0.00568607764188427,-0.0239756001171724,-0.00168617576098608,0.0240529526360507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,0.0199872444466618,0.00890445420398468,0.00253451420685179,0.0374399746864717,0.0248050889481155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,0.00596869392181914,0.00265975371777059,0.00075557663498878,0.0111818112086495,0.0248409601732096
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.00999036858519059,0.00446061034529867,0.0012475723084052,0.018733164861976,0.0251253212262955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,-0.00568671276160749,0.00254191494648004,-0.0106688660567084,-0.000704559466506607,0.0252883851717743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,39913,0.00458662117070083,0.00205327953732961,0.000562193277534785,0.00861104906386687,0.0255097820424176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,0.0205268865645794,0.00919958941530271,0.00249569131058612,0.0385580818185728,0.02567914366221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPS,Colipase,39836,-0.0146232483496778,0.00656718924858584,-0.0274949392769061,-0.00175155742244957,0.0259803191052971
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37411,0.00633036214895594,0.00285623716788479,0.00073213729990176,0.0119285869980101,0.0266855022630194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0107768987913503,0.00486335532469173,0.00124472235495448,0.0203090752277461,0.026710041157713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37021,-0.00851433285278966,0.00384389835177523,-0.0160483736222691,-0.000980292083310208,0.0267753725432703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,0.0238245752622976,0.0107593036183221,0.00273634017038622,0.0449128103542089,0.0268234936015924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,0.00985312081037395,0.00445343798490705,0.00112438235995613,0.0185818592607918,0.0269482646533394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,39885,0.00494315490980624,0.00223867298797955,0.000555355853366321,0.00933095396624616,0.0272532448821588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,0.00661526152034446,0.00299726729022951,0.000740617631494622,0.0124899054091943,0.0273214471241216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00771184212656187,0.00349497888334289,-0.0145620007379139,-0.00086168351520982,0.0273627647354535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37039,-0.00726113131756772,0.00329460104696465,-0.0137185493696184,-0.000803713265517007,0.0275451855376924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,-0.00720914847705278,0.00328893153520197,-0.0136554542860486,-0.00076284266805691,0.0283980183550507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-0.00512444499415811,0.00233953639171097,-0.00970993632191161,-0.000538953666404602,0.0285119570392266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,0.00530868876191469,0.00242375656833087,0.000558125887986182,0.0100592516358432,0.0285214472146667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,39749,-0.0116152641854111,0.00530685752424214,-0.0220167049329257,-0.00121382343789647,0.0286311666064773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00809731209622441,0.00370126766925583,-0.0153517967279658,-0.000842827464482986,0.0287078918961145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37391,-0.00494328677092958,0.00226126186179066,-0.00937536002003929,-0.00051121352181988,0.0288272343986674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,0.00627024500394036,0.00286964241801689,0.00064574586462726,0.0118947441432535,0.0289014854337983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,-0.00658202683655293,0.00301415960722467,-0.0124897796667133,-0.00067427400639258,0.0289988676458142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,-0.00681590432038012,0.00312730704918433,-0.0129454261367814,-0.000686382503978828,0.0293137485879831
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,36962,0.0151565832113714,0.00696410088277844,0.00150694548112569,0.0288062209416172,0.0295440857529688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,0.0138822051011475,0.00640258848568367,0.00133313166920752,0.0264312785330875,0.0301570781177285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,36962,-0.00862671782643369,0.00398210331228103,-0.0164316403185045,-0.000821795334362883,0.0303007283849609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0129103414160695,0.00597151524105592,-0.0246145112885392,-0.00120617154359995,0.0306370772865174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,0.00981539063484886,0.00455326057674871,0.000890999904421399,0.0187397813652763,0.0311234752560428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37056,-0.00551002822296785,0.00255681251588629,-0.010521380754105,-0.000498675691830713,0.0311768901979891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00834073836601067,0.00387752914913759,-0.0159406954983203,-0.000740781233700998,0.0314908635052847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,0.00561123591042911,0.00260912630083133,0.000497348360799703,0.0107251234600585,0.0315239368838711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,39844,0.0254567527369274,0.0118423554566777,0.00224573604183911,0.0486677694320156,0.0315989856391395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0111536327022792,0.00519493257469145,0.000971564855883978,0.0213357005486745,0.0318068960442233
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2,Brorin,39684,0.00784482093514023,0.00365549777258447,0.000680045300874677,0.0150095965694058,0.0318854630558591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00519578814298583,0.00242263300024969,-0.00994414882347522,-0.00044742746249643,0.0319956197520837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39489,0.00914211147164156,0.00426307585488167,0.000786482796073488,0.0174977401472096,0.0320092458804253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.0107309095573625,0.00500943893933864,-0.0205494098784662,-0.00091240923625875,0.0322007996804354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.00421007976731431,0.00196660184982442,0.000355540141658445,0.00806461939297018,0.0323061865277725
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,0.00874284763538268,0.00409138226773301,0.000723738390625974,0.0167619568801394,0.0326220506460347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,39868,0.00679957980936508,0.0031820084361591,0.000562843274493233,0.0130363163442369,0.0326226203490484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37056,-0.00698047854568452,0.00326970325079402,-0.0133890969172408,-0.000571860174128238,0.0327878191298028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00676876540572645,0.00317912041874313,-0.012999841426463,-0.000537689384989925,0.0332618935950135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0124661783857919,0.00586096007062977,0.000978696647357594,0.0239536601242263,0.0334392473908174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39489,0.0143263052678033,0.00674469341705627,0.00110670617037299,0.0275459043652336,0.0336786549314523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,39885,0.00599018216539083,0.00282234072793773,0.000458394338632868,0.0115219699921488,0.0338180816031394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,0.00729244158487792,0.00343746991811762,0.000555000545367379,0.0140298826243885,0.0339016099661677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37445,-0.0123564542775961,0.00583726944900671,-0.0237975023976492,-0.000915406157542927,0.0342931748988444
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,39998,0.00822146732416605,0.00388488456565691,0.000607093575478505,0.0158358410728536,0.0343370602135998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.00737174383613998,0.00349452246065338,0.000522479813259347,0.0142210078590206,0.0349185891941627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40009,0.00597856173132804,0.00284048941159243,0.000411202484606868,0.0115459209780492,0.0353272084132738
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,39564,-0.0107442735592142,0.00512426547975576,-0.0207878338995355,-0.000700713218892915,0.0360321862989871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37056,-0.00521104930281764,0.00248815135149988,-0.0100878259517574,-0.000334272653877884,0.0362482134880747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0172013127441,0.00822084784675867,0.001088450964453,0.033314174523747,0.0364218253211667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37437,0.0196168449145064,0.00938528563894619,0.00122168506217192,0.038012004766841,0.0366210640986114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00492562492343195,0.00235845321009146,0.000303056631652688,0.00954819321521121,0.0367715022239192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,39775,0.00664964816465662,0.00318473180184981,0.000407573833030994,0.0128917224962822,0.0368157282395589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,39866,0.00614718856801292,0.0029574682027557,0.00035055089061174,0.0119438262454141,0.037676394395269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,39967,-0.00807132111394928,0.00388460272133643,-0.0156851424477687,-0.000457499780129873,0.037746109938053
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37056,-0.00939455417549799,0.00452498245633731,-0.0182635197899191,-0.000525588561076873,0.0378991510616457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,0.00828964274645996,0.00399432763382208,0.000460760584168683,0.0161185249087512,0.0379725827078852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.00719187587808191,0.00347542800718507,0.000380036983999166,0.0140037147721647,0.0385322546548535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.00345628926160516,0.00167334100976902,0.000176540882457883,0.00673603764075243,0.0388944335791205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,0.0167432533695471,0.0081074511448119,0.000852649125715733,0.0326338576133784,0.0389265560577869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.0110150177337698,0.0053409933068661,-0.0214833646152274,-0.000546670852312263,0.0391936911687251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.00677746751804389,0.00328775136683246,0.000333474839052273,0.0132214601970355,0.0392783170025224
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39489,0.00694574661125312,0.00336964150079535,0.000341249269694235,0.013550243952812,0.0392936301969042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00720673077101082,0.00350053212126654,-0.0140677737286932,-0.000345687813328397,0.0395375484465777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0109969837385123,0.00535622167502779,0.000498789255457856,0.0214951782215668,0.040080339331877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.0120368876122907,0.00587879296460254,-0.0235593218229117,-0.000514453401669737,0.0406278406524576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.00920653297851231,0.00451476153863946,0.000357600362778978,0.0180554655942456,0.0414462056922556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37382,0.0116832518538717,0.00573032620151879,0.000451812498894828,0.0229146912088485,0.0414848212767507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,0.00849499302164378,0.00417654032730138,0.000308973980133086,0.0166810120631545,0.0419706211103476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,0.00522770420240931,0.00257252077556435,0.000185563482303189,0.0102698449225154,0.0421566300524544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,0.0125393659184913,0.00617080046721713,0.000444597002745732,0.0246341348342369,0.0421687339222419
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTN,Titin,37021,0.0132000437591124,0.00649969512912612,0.000460641306025175,0.0259394462121996,0.0422881200831588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,-0.0203146868427951,0.0100239767559858,-0.0399616812845273,-0.00066769240106292,0.0427218677793487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,36991,-0.0185440042771929,0.00915764066075943,-0.0364929799722814,-0.000595028582104404,0.0428900031110735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,0.00904022585995577,0.00446604814541212,0.000286771494948013,0.0177936802249635,0.0429653740085021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,0.0165932752912734,0.00819914632596122,0.000522948492389454,0.0326636020901574,0.0430093680060778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,-0.00894358175415232,0.0044277602771585,-0.017621991897383,-0.000265171610921667,0.043415131044833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37382,0.0117700035230844,0.00583616129374533,0.000331127387343599,0.0232088796588253,0.0437426750049649
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37437,-0.0095622475702771,0.00474251914599033,-0.0188575850964181,-0.000266910044136044,0.0437903363644678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,0.00805230871393386,0.00399608680223229,0.000219978581558575,0.0158846388463092,0.0439196104958293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0137727242082905,0.00684075721406304,0.00036484006872696,0.0271806083478541,0.0440996720462513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.00624752199961973,0.00311092005112171,-0.0123449252998183,-0.000150118699421171,0.0446365516513899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRTN,Neurturin,39587,0.00945656958797716,0.00471323558684516,0.000218627837760641,0.0186945113381937,0.0448321763180005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,-0.00891742854300467,0.00444688965577888,-0.0176333322683313,-0.000201524817678066,0.044948843555234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,-0.00628172059939733,0.00314191931339066,-0.012439882453643,-0.000123558745151639,0.0455936277912691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,0.00837075469766103,0.00418959690681568,0.000159144760302299,0.0165823646350198,0.0457387520946867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0100077885554456,0.00501079714989827,0.000186626141644957,0.0198289509692462,0.0458191203352303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40030,0.00386832656242075,0.00194268440487403,6.06651288676562e-05,0.00767598799597384,0.046472681719853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00867709839356537,0.00436211757930079,-0.0172268488489949,-0.000127347938135822,0.0467003984639109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37056,0.00314178291986589,0.00158210655795688,4.08540662704027e-05,0.00624271177346137,0.0470736870502527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0223255328050466,0.0112559453907677,0.000263879839141935,0.0443871857709513,0.0473349694554715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,-0.00778189888343864,0.00393016355973323,-0.0154850194605158,-7.87783063615106e-05,0.0477187850757709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,0.00827614741856606,0.00418116033581677,8.10731603651926e-05,0.0164712216767669,0.0477892156325932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGN,Cingulin,37039,0.00730890034614766,0.0036992308542111,5.84078718939033e-05,0.0145593928204014,0.0481994832427035
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0122333459697807,0.0061978906607413,8.54802747277759e-05,0.0243812116648337,0.0484224334575063
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,0.00873716642356416,0.00442817096337174,5.79513353555546e-05,0.0174163815117728,0.0485059057228622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.0156302075331549,0.00792837836196964,9.05859436943594e-05,0.0311698291226153,0.0486924195496802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,-0.0092950049904573,0.00472028702814118,-0.018546767565614,-4.32424153005966e-05,0.0489555541768678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00869880291839427,0.00442283141519188,-0.0173675524921704,-3.00533446181799e-05,0.0492272612784757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,-0.00545471188871096,0.00277738220496071,-0.0108983810104339,-1.10427669879785e-05,0.0495538396300147
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37437,-0.00943879815357089,0.00481384476013902,-0.0188739338834434,-3.66242369840945e-06,0.049927345646426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,36991,-0.00811002546193042,0.00413863097539232,-0.0162217421736994,1.69124983851951e-06,0.0500646964078589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,-0.00669570347932757,0.00341862740297291,-0.0133962131891545,4.80623049933793e-06,0.0501778082125756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.00684287411836457,0.00350177099074964,-0.0137063452602339,2.0597023504724e-05,0.0507077903707818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0114328478812629,0.00586670124264186,-0.0229315823168409,6.58865543151452e-05,0.0513442372355127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37021,0.00954043294452633,0.0048957018836627,-5.51427474525645e-05,0.0191360086365052,0.0513481207128423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,-0.00586220846515496,0.00302235226610171,-0.0117860189067143,6.16019764043928e-05,0.0524440074784628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.00876674407035451,0.00452140660386263,-9.52128732162431e-05,0.0176287010139253,0.0525261781617652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,0.00862920297462754,0.00446365343235557,-0.00011955775278937,0.0173779637020444,0.0532310709977247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2,Complement C2,39908,0.00434267860723184,0.00224643203235252,-6.03281761790923e-05,0.00874568539064277,0.0532359204138677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.00965316079130439,0.00499622340731705,-0.000139437087037031,0.0194457586696458,0.0533690989642942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,39587,-0.00523411758882526,0.00270924488039972,-0.0105442375544087,7.6002376758184e-05,0.0533839852757903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,39546,0.0132192812745891,0.00685488097785072,-0.000216285441998323,0.0266548479911765,0.0538174555877206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39173,0.00385796297797884,0.00200660114625743,-7.49752686857201e-05,0.0077909012246434,0.0545443458796271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.00870973912219793,0.00453374371896724,-0.000176398566977863,0.0175958768113737,0.0547378506386844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,-0.00905585635012085,0.00471895672854818,-0.0183050115380753,0.000193298837833582,0.0549973120853125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37169,-0.00726241333973646,0.00378485894390161,-0.0146807368697836,0.000155910190310701,0.0550301447566324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.0079217704488055,0.00413760247333108,-0.0160314712965344,0.000187930398923406,0.0555678578519826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0085558635168506,0.00447619154407582,-0.000217471909538003,0.0173291989432392,0.0559694441518533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00870312116498729,0.00455320703131014,-0.0176274069463552,0.000221164616380587,0.055971416055274
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00838552344774248,0.00439167685199149,-0.0169932100776458,0.000222163182160839,0.0562306956466438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37056,-0.00778399319521388,0.00408458214443751,-0.0157897741983114,0.000221787807883627,0.0567106887594562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40030,-0.00559819320514397,0.00294148496407772,-0.0113635037347363,0.000167117324448368,0.0570340108521252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFP,Properdin,37453,-0.00418124906388822,0.00220115194087737,-0.00849550686800787,0.000133008740231422,0.0575103082572437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,36962,-0.00744770666206855,0.00392093901723723,-0.0151327471358535,0.000237333811716423,0.0575246261030884
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00532457033855931,0.00281383752760723,-0.000190551215550858,0.0108396918926695,0.0584716299364937
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,0.00496605110255607,0.00262769690825048,-0.000184234837614874,0.010116337042727,0.0587910801609872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,-0.00607619632578529,0.00323200641316371,-0.0124109288955862,0.000258536244015589,0.0601291743152437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00600309930475669,0.00319421619184887,-0.0122637630407805,0.000257564431267098,0.0602167971318297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,39585,0.0134043549112464,0.00713447845876777,-0.000579222867938446,0.0273879326904312,0.0602884363542045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37368,0.00779351537150582,0.00415129185692559,-0.000343016668068336,0.01593004741108,0.060488780923645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.00696371263138122,0.00372170766390184,-0.000330834389866394,0.0142582596526288,0.0613482950409087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FN1,Fibronectin,37453,0.00473216789815456,0.0025324758579437,-0.000231484783415081,0.00969582057972421,0.0617008850624736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,-0.00691387603818921,0.00370163334723166,-0.0141690773987633,0.000341325322384847,0.0618134670845207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,39764,0.012007683358656,0.00643039137258429,-0.000595883731609195,0.0246112504489212,0.0618734517223765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,0.0103845615126897,0.00556499094063568,-0.000522820730956251,0.0212919437563356,0.0620563108283695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,39868,0.0136148556975526,0.0072991172088636,-0.000691414031820095,0.0279211254269252,0.0621612469026051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,39587,-0.00714119116266555,0.00383090062936644,-0.0146497563962238,0.000367374070892684,0.0623259396079746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0126745392298958,0.0068090184038803,-0.0260202153015011,0.000671136841709634,0.0627051720753931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39489,0.00515124757505239,0.00277067654149388,-0.00027927844627561,0.0105817735963804,0.0630172805511788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,0.0128422619447239,0.00690797185968821,-0.000697362900265008,0.0263818867897128,0.063038911505361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,39868,-0.00621824515487499,0.00334961861558703,-0.0127834976414256,0.000347007331675584,0.063414365278921
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,-0.0301094810415762,0.0162844983837603,-0.0620270978737463,0.001808135790594,0.0644814397884264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,-0.0078271133492821,0.00423646960261734,-0.0161305937704121,0.00047636707184788,0.0646891277268604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,-0.00394443919487276,0.00214142378467384,-0.00814162981283349,0.000252751423087967,0.0655019063097419
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39520,0.0156193285593745,0.00848557232432512,-0.00101239319630271,0.0322510503150518,0.0656855542857702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.00455149720722044,0.00247511640645507,-0.000299730949431492,0.00940272536387237,0.0659520383650716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.00930488724260865,0.00506109150925548,-0.000614852115532088,0.0192246266007494,0.066009193247064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.021063650651602,0.0114727083221733,-0.00142285765985766,0.0435501589630617,0.0663793123741205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,0.0146326660571449,0.00797011528684801,-0.000988759905077163,0.030254092019367,0.0663851669727254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,-0.00593738077581433,0.00323953580359954,-0.0122868709508694,0.000412109399240774,0.0668560626763041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,39531,0.0103196448630662,0.00563883216859897,-0.000732466187387806,0.0213717559135201,0.0672534910142791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00752436628206175,0.00412209232367647,-0.0156036672364676,0.000554934672344125,0.0679669775446862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,39782,0.00713300721918334,0.00391777075823082,-0.000545823466949077,0.0148118379053158,0.0686742619901196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00843838691452987,0.00465069162824327,-0.000676968676826926,0.0175537425058867,0.0696338474833108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.00628189221329379,0.003470110957824,-0.000519525264041261,0.0130833096906288,0.0702741146399612
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,39985,-0.00516003075102131,0.00285153617521473,-0.0107490416544422,0.000428980152399569,0.0703823902313356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.00672521001087406,0.00372651318712851,-0.000578755835897815,0.0140291758576459,0.0711449791166261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSND,Barttin,36962,-0.00578125910549469,0.00320627362780256,-0.0120655554159877,0.000503037204998322,0.0713941489191599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0131444605364705,0.00729964370040649,-0.00116284111632626,0.0274517621892672,0.0717696339241525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37021,0.0065547758514234,0.00364737606886927,-0.000594081243560366,0.0137036329464072,0.0723393420769631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0037883007525425,0.00211214972220951,-0.000351512702988139,0.00792811420807313,0.0728997884627362
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0118610854099275,0.00662169354219049,-0.00111743393276582,0.0248396047526209,0.0732760929344796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,39868,-0.00770612429517925,0.00430659394007219,-0.0161470484177207,0.000734799827362249,0.0735728636048596
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37056,-0.0172742506010913,0.00969935364495128,-0.0362849837451958,0.00173648254301326,0.074940470831364
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00836851468547672,0.00469932552024725,-0.0175791927051613,0.000842163334207897,0.0749660995438996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESPL1,Separin,36962,-0.00909621586585332,0.00511610366574216,-0.019123779050708,0.000931347319001311,0.0754339908417021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,-0.00914422046912923,0.00515266991136086,-0.0192434534953965,0.000955012557138063,0.0759776901777627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00550556219444168,0.00310610866317585,-0.000582410785382985,0.0115935351742663,0.0763349188739368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0104425214880259,0.00589187890293502,-0.00110556116172671,0.0219906041377786,0.0763581614129744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.011592277681876,0.00655030131269255,-0.00124631289100138,0.0244308682547534,0.0767912953362592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0237660022811702,0.0134329457342048,-0.00256257135787123,0.0500945759202117,0.0768746041806667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37021,-0.0139265807031364,0.00787586207497157,-0.0293632703700807,0.0015101089638079,0.0770404226684334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,-0.00731454812233917,0.00416529672595261,-0.0154785297052063,0.000849433460527948,0.0790993012595603
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37411,0.0115603353953916,0.00659714935854514,-0.00137007734735688,0.0244907481381401,0.0797409290289273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,-0.00421391471684726,0.00240563047362548,-0.00892895044515319,0.000501121011458669,0.0798508535483685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00335741749416111,0.00191954952549074,-0.00711973456412296,0.000404899575800752,0.0802987977165322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,0.00884935002603953,0.00506643991044166,-0.00108087219842611,0.0187795722505052,0.0807159198875864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37388,-0.0119966803376919,0.00688856294811756,-0.0254982637160023,0.00150490304061855,0.0816123995872503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.0106803158284684,0.00613983983721679,-0.0227144019094133,0.00135377025247654,0.0819683864394311
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00487476633569862,0.00281080477905658,-0.0103839437026495,0.000634411031252286,0.0828883465599015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.00917319594133521,0.00529842858667676,-0.00121172408855125,0.0195581159712217,0.0834204647408349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.00908970364165904,0.00525495338903642,-0.00121000500085234,0.0193894122841704,0.0836995287320365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37368,-0.0178071346928348,0.0103195618007301,-0.0380334758222658,0.00241920643659621,0.0844475231572783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,-0.0110609540953018,0.00646303162438285,-0.0237284960790922,0.00160658788848858,0.0870273207988986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39477,-0.00914267059438755,0.00535667354971506,-0.0196417507518291,0.00135640956305396,0.0878825769338071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40018,0.00336381797131357,0.00197388825303344,-0.000505003004631974,0.00723263894725911,0.0883707511897898
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,39862,0.00566566722860529,0.00333654864154213,-0.000873968108817287,0.0122053025660279,0.0895154594081836
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,39892,0.00721073415646257,0.00424859134639666,-0.00111650488247488,0.0155379731954,0.0896771562027726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,39687,0.00925450570863647,0.00545962653414156,-0.00144636229828098,0.0199553737155539,0.0900798483298885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37056,-0.00660205971166706,0.00389559162998271,-0.0142374193064332,0.00103329988309905,0.0901461683367149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,0.00324393723398588,0.00191485060483607,-0.000509169951492827,0.00699704441946459,0.0902709892874355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB1,Calbindin,39788,0.00673453401235703,0.00397997874094852,-0.00106622431990207,0.0145352923446161,0.0906458937606212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00586577639790673,0.00347301106152383,-0.0126728780784934,0.000941325282679972,0.0912508039073686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.00860584186913933,0.00511121692528817,-0.00141214330442548,0.0186238270427041,0.0922560057775176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,39585,0.00775737108110687,0.00460804183974304,-0.00127439092478948,0.0167891330870032,0.0923094115072648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERVV_1,,37021,-0.00769025066657361,0.00457178355619085,-0.0166509464367077,0.00127044510356046,0.0925709025409395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,0.0100189167998757,0.00595882819211874,-0.00166038645667706,0.0216982200564284,0.0927167321759043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,-0.0100337871959973,0.00597886541983165,-0.0217523634188674,0.00168478902687272,0.0933259837480633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37388,-0.00359274841434413,0.00214171050944416,-0.00779050101285468,0.000605004184166427,0.0934652018714448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,39587,0.00688520478509812,0.0041178424492455,-0.00118576641542306,0.0149561759856193,0.0945359683002769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37056,0.00414236074849365,0.00248041442737358,-0.000719251529158557,0.00900397302614586,0.0949376045260448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,0.00398961919028773,0.00240971940485718,-0.000733430843232335,0.00871266922380779,0.0978185686604512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,0.0153220899341751,0.00925551555598129,-0.00281872055554827,0.0334629004238984,0.0978560697835385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.004981987882463,0.00302259982329541,-0.010906283536122,0.000942307771196004,0.0993260503209813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37169,0.0114058294718429,0.00692222063276707,-0.00216172296838056,0.0249733819120664,0.0994352874738107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37083,0.0129664639052539,0.00786988764508977,-0.00245851587912202,0.0283914436896299,0.0994575743639225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,39766,0.00821665631718583,0.00498711779179785,-0.00155809455473796,0.0179914071891096,0.099459430689564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,0.0138078765613209,0.00839715419303548,-0.00265054565702866,0.0302662987796704,0.100126805321712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00649618748092656,0.00395957933139599,-0.0142569629704627,0.00126458800860958,0.100898976725872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.00913733251060297,0.00559375631729936,-0.0201010948925097,0.00182642987130379,0.102390426040424
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,39780,-0.0103767163523659,0.00636443285739283,-0.0228510047528558,0.00209757204812406,0.103031954169355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,0.00627191541881605,0.00387928497940479,-0.00133148314081734,0.0138753139784495,0.105951690093391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00716347737356205,0.00443768562942813,-0.00153438646011709,0.0158613412072412,0.106499951409555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,39791,0.0164637459427444,0.0101996851273901,-0.00352763690694016,0.036455128792429,0.106516310663915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,39587,0.00905673593725533,0.00562924174087186,-0.00197657787485352,0.0200900497493642,0.10766415148007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,-0.00625646887162939,0.00388959508055352,-0.0138800752295143,0.0013671374862555,0.107742333829116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,0.0114491165962274,0.00715073129861975,-0.00256631674906727,0.0254645499415221,0.109376086875017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,0.00960932114976767,0.00600438759910899,-0.00215927854448595,0.0213779208440213,0.10953715022904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,36991,-0.00535268458656776,0.00334546048202005,-0.0119097871313271,0.00120441795819154,0.109626101424815
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37021,-0.00608466052895396,0.00382595084269668,-0.0135835241806394,0.00141420312273153,0.111776442754711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,0.0128358161446378,0.00807418342721622,-0.00298958337270601,0.0286612156619816,0.111918267680824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.00533103448876465,0.00336649698421373,-0.0119293685778236,0.00126729960029426,0.113318893105562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.00810843696236908,0.00513352143985784,-0.00195326505975229,0.0181701389844904,0.114242932993975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,-0.00411681141223078,0.00262393656774232,-0.00925972708500573,0.00102610426054418,0.116680784591476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00318215978628513,0.00203211543763273,-0.00080078647147503,0.00716510604404529,0.117387339076323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.00915006260966261,0.00584490958679292,-0.00230596018045151,0.0206060853997767,0.11749202775982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.00708488478513372,0.00453092402371847,-0.00179572630135448,0.0159654958716219,0.117918361178068
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37388,0.0056318353130075,0.00361229672891167,-0.00144826627565937,0.0127119369016744,0.119002428895183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,0.00697716054566839,0.00448170569297675,-0.00180698261256604,0.0157613037039028,0.119535714603077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37368,-0.00512283862695485,0.00329401176089566,-0.0115791016783103,0.00133342442440064,0.119922483329526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.00440298921164014,0.00283585361316423,-0.00115528387016175,0.00996126229344202,0.120538418309552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.011717704380585,0.00754993888330655,-0.00308017583069588,0.0265155845918658,0.120676157557429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.0107187815913762,0.00690857982359703,-0.00282203486287399,0.0242595980456264,0.120797557624044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00922473174759471,0.00595547599731077,-0.0208974647023238,0.0024480012071344,0.121417630147675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,0.00759248004742133,0.00491370860705396,-0.00203838882240443,0.0172233489172471,0.122330885871195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,-0.00862228796806673,0.00558280420637148,-0.0195645842125548,0.00232000827642137,0.122506566700109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,-0.00614745009203993,0.00398080995038325,-0.0139498375947911,0.00165493741071124,0.122546041474838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,0.00411305460920097,0.00266386995017784,-0.00110813049314759,0.00933423971154954,0.122608100124851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,-0.0102559901401747,0.00665252488144207,-0.0232949389078011,0.00278295862745179,0.123174008419075
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00840379928955731,0.00546055648678372,-0.00229889142453879,0.0191064900036534,0.123827556961901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00503402790554968,0.0032842895318726,-0.01147123538802,0.00140317957692062,0.12535901454088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,39720,-0.00455149830556376,0.00297291199385721,-0.0103784058135239,0.00127540920239636,0.125791827602555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40009,0.00959974087762582,0.00627897027622449,-0.00270704086377418,0.0219065226190258,0.126315802912726
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,-0.00419119223580263,0.00274381292152225,-0.00956906556198623,0.00118668109038097,0.126659095709853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,-0.00518670386239827,0.00340343333579645,-0.0118574332005593,0.00148402547576278,0.127538253084874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00571338192593303,0.00375507341553019,-0.00164656196850614,0.0130733258203722,0.128155166534586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,-0.0075971931112155,0.00499419760258081,-0.0173858204122739,0.00219143418984287,0.128232460924524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37039,0.0133702501090057,0.008800489387309,-0.00387870909011994,0.0306192093081314,0.128720520408264
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37056,-0.00444464489702633,0.00292586066804861,-0.0101793318064016,0.00129004201234894,0.128763868238459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00689672813455073,0.00455956722696646,-0.00204002363030354,0.015833479899405,0.130408771840193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,39952,-0.00564124997690042,0.00374515176194571,-0.012981747430314,0.00169924747651317,0.132014748128061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39489,-0.00458550305914315,0.00304732254593835,-0.0105582552491823,0.00138724913089601,0.132404818309398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.00539345724691142,0.00359528813058965,-0.0016533074890443,0.0124402219828671,0.133600501334873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,-0.00463745725258503,0.00309134753932769,-0.0106964984296673,0.00142158392449724,0.133601824494963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.00664955704677536,0.00444306104484461,-0.00205884260112007,0.0153579566946708,0.13451270894944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,-0.0107120316248242,0.00715787713441168,-0.0247414708082711,0.00331740755862271,0.134537674837548
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0124376520123792,0.00832870979749486,-0.00388661919071072,0.0287619232154691,0.135369766433624
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00935475399003217,0.00626568014461896,-0.0216354870734853,0.002925979093421,0.135457358377046
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,39913,0.00414903744810053,0.00278757987795162,-0.00131461911268464,0.0096126940088857,0.136664743335391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.0122655560774816,0.00824772238531649,-0.0284310919527019,0.00389997979773875,0.137000305296478
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,-0.00396866156106602,0.00266907786115229,-0.00920005416892451,0.00126273104679247,0.137059788460137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_DRA,,39799,-0.00500667845739757,0.0033692373254085,-0.0116103836151982,0.00159702670040309,0.137299543707613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,39866,0.00912286816722569,0.00614785536676404,-0.00292692835163183,0.0211726646860832,0.137852311999138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,-0.0129545875265618,0.00873166716340684,-0.0300686551668392,0.00415948011371562,0.137930372406518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,0.010295223566885,0.00694284010866129,-0.00331274304609116,0.0239031901798611,0.138136197859642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,36991,0.00601158219395568,0.00405444615260947,-0.00193513226515888,0.0139582966530702,0.138174535163561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39456,0.00501864219090044,0.00339756286661509,-0.00164058102766513,0.011677865409466,0.13966097273396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37021,0.00944827922241398,0.00640718425489631,-0.00310980191718279,0.0220063603620108,0.140333734935262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.00541517801696441,0.00367540426675835,-0.00178861434588196,0.0126189703798108,0.140678411868847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCIN,Adseverin,36991,0.0103722317046173,0.00704137888915777,-0.00342887091813195,0.0241733343273665,0.140764259844335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37368,0.00555464333185081,0.00377415631031511,-0.00184270303636681,0.0129519897000684,0.141109636094273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37039,0.00921688723400107,0.00626299845238134,-0.00305858973266636,0.0214923642006685,0.14114164178327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,-0.00988176806148501,0.00672828225485042,-0.0230692012809918,0.00330566515802182,0.141936078723678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,-0.00288895991616195,0.00197697491705559,-0.00676383075359092,0.000985910921267011,0.143951958635553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0117825591447141,0.00808028765212013,-0.0276199229428696,0.00405480465344131,0.144813252268092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00601742447153856,0.00412675591328757,-0.0141058660615822,0.00207101711850507,0.144823375376586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,0.00830296383016317,0.00570696386079102,-0.00288268533698723,0.0194886129973136,0.145724860009778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,-0.00301096918091861,0.00207530317742441,-0.00707856340867045,0.00105662504683323,0.146843313920176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40052,0.00267061882213231,0.00184217518001483,-0.000940044530696764,0.00628128217496139,0.147158918799532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.00604889653732156,0.00417249373228248,-0.00212919117795211,0.0142269842525952,0.14716359432093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00746322535995695,0.0051492416174552,-0.0175557389301691,0.00262928821025524,0.147254101653038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.00968282147228989,0.00670542391104903,-0.00345980939336621,0.022825452337946,0.148750462066946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.0111771195924263,0.00774257965869233,-0.00399833653861068,0.0263525757234633,0.148877920547368
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00675896762892038,0.00469371651960365,-0.0159586520073435,0.00244071674950278,0.149886146279577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37368,0.0110111557878631,0.00765751604940094,-0.00399757566896275,0.0260198872446889,0.150470273674174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,-0.0175879982153805,0.0122382761811793,-0.0415750195304918,0.00639902309973093,0.15070033099538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00475226013296478,0.00331070578226488,-0.00173672320027439,0.0112412434662039,0.151189884648868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,0.00658743515783995,0.00459580132090177,-0.00242033543112751,0.0155952057468074,0.151778868596591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,0.00533968562792645,0.00373516982350226,-0.00198124722613798,0.0126606184819909,0.15286422838977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,-0.00532874968607726,0.00374016471057415,-0.0126594725188026,0.00200197314664808,0.154256413182795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00446319231092293,0.00313384497663152,-0.0106055284651207,0.00167914384327485,0.154411002181527
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,-0.00510181931941248,0.00359040840663641,-0.0121390197964198,0.00193538115759487,0.155349296400268
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,36991,-0.00716699268759748,0.00504639067562255,-0.0170579184118177,0.00272393303662271,0.155566939506604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0083436865929215,0.00587742435856344,-0.00317606514986284,0.0198634383357058,0.155743197243313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,0.003759482151454,0.00265904336907481,-0.00145224285193264,0.00897120715484064,0.157429658214585
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,39913,0.00507888842898809,0.00359701992573433,-0.0019712706254512,0.0121290474834274,0.157977833838586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,-0.00959779672719236,0.0068063154087855,-0.0229381749284119,0.00374258147402721,0.158524621018274
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0112538836389023,0.00798686338950354,-0.00440036860452458,0.0269081358823293,0.158840509314005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00551129330035294,0.00391222647155885,-0.0131792571846083,0.0021566705839024,0.158936943083351
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.00495964151498375,0.00352130371698742,-0.0019421137703116,0.0118613968002791,0.159016150556439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,-0.00402908473178547,0.00286140456219986,-0.00963743767369719,0.00157926821012626,0.159127335576824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37124,0.00449784569825021,0.00320100938543798,-0.00177613269720824,0.0107718240937087,0.160004987269434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.00347106671821987,0.00247541344567348,-0.00832287707173988,0.00138074363530015,0.160874014427999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.00373217988619427,0.00267090433726685,-0.00896715238723731,0.00150279261484876,0.162328791092003
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,-0.00760236191282806,0.00544335536928575,-0.0182713384366281,0.00306661461097201,0.162547340049924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00588368255603112,0.00421951722367949,-0.0141539363144429,0.00238657120238068,0.163221000247947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2,Prothrombin,37453,-0.00194315517200804,0.00139639154553215,-0.00468008260125106,0.000793772257234978,0.164080065880092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,0.00878879118787683,0.00632546618149564,-0.00360912252785463,0.0211867049036083,0.164725567716197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,36991,-0.00641453355811558,0.00463046045585207,-0.0154902360515856,0.00266116893535448,0.165987143736685
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,39858,-0.00442998203477681,0.00320138575897014,-0.0107046981223583,0.00184473405280465,0.166448153161429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.011058233452208,0.00799558532651509,-0.0267295806921776,0.00461311378776155,0.166674703907933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0117456338015816,0.00852438524569507,-0.00496216127998077,0.0284534288831439,0.168261634556545
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.00313289064471263,0.00227416209162275,-0.00132446705486796,0.00759024834429322,0.168348899468989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00712074885005591,0.0051690996789483,-0.0172521842207946,0.00301068652068275,0.168362475002296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.00391560397787467,0.0028480199458335,-0.00166651511595899,0.00949772307170834,0.169197268819733
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.00579827474397809,0.00422349915506492,-0.00247978359994915,0.0140763330879053,0.169814812179217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,39858,-0.00306567749989372,0.00223417315722287,-0.00744465688805055,0.00131330188826311,0.170028073004972
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0148423255938257,0.0108605928215765,-0.00644443633646419,0.0361290875241156,0.171766525246051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,39866,0.00729719225364797,0.00534111204692735,-0.00317138735832964,0.0177657718656256,0.171885699115534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,-0.00436981134667078,0.00319973257614095,-0.010641287195907,0.00190166450256548,0.172062675839494
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,-0.00463628744525965,0.00339680952467568,-0.011294034113624,0.00202145922310468,0.172308797493875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,39587,0.00805613549847926,0.00590817494083796,-0.00352388738556314,0.0196361583825217,0.172726433276305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0108513610301633,0.00798987002073147,-0.00480878421047036,0.026511506270797,0.174442328298701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,-0.00537822822625918,0.00396283030321493,-0.0131453756205604,0.00238891916804209,0.174751074023313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37039,-0.00466906930750533,0.00345359153316678,-0.0114381087125122,0.00209997009750155,0.176415786619056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.00917445003763935,0.00680075362069305,-0.0225039271341977,0.00415502705891902,0.177349204573809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C5,Complement C5,37453,0.00195176032982072,0.00144679917073928,-0.000883966044828276,0.00478748670446971,0.177353165951574
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00436756922321511,0.00326424791538136,-0.00203035669093236,0.0107654951373626,0.180914781227284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37388,0.0122421784003404,0.00915450021187342,-0.00570064201493148,0.0301849988156123,0.181152017344876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40030,-0.00761731959351998,0.00570797159643593,-0.0188049439225344,0.00357030473549444,0.182057030629245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00611826899876074,0.00458982324436921,-0.0151143225577244,0.0028777845602029,0.182552455843189
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.00782825018683788,0.005877202255448,-0.00369106623384021,0.019347566607516,0.182889737044958
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,-0.0112914016827156,0.00850383988855979,-0.0279589278642928,0.00537612449886154,0.184262952981052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00617891876480216,0.00465740927090151,-0.0153074409357691,0.00294960340616479,0.184635709720427
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,0.00720345350987771,0.00543430970217234,-0.00344779350638007,0.0178547005261355,0.185007230421914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,-0.00691007521218009,0.00525203542518789,-0.0172040646455483,0.00338391422118817,0.188295375710196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,39889,-0.00367838330789861,0.00280266734843637,-0.00917161131083389,0.00181484469503667,0.189384425559786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00430462411742138,0.00328103786250942,-0.0107354583279398,0.00212621009309708,0.189553130279141
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARTN,Artemin,39587,0.00557926017828331,0.00425458876282474,-0.00275973379685319,0.0139182541534198,0.18975827442659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,36962,0.00893099250007291,0.00681491921648085,-0.00442624916422956,0.0222882341643754,0.190047688783522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37021,-0.00799954590299497,0.00612063662128629,-0.0199959936807161,0.00399690187472615,0.191242547066355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,39866,-0.00732624502386467,0.00561241390372446,-0.0183265762751646,0.00367408622743527,0.19178757519337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.0151840996510164,0.0116361740262579,-0.007622801440449,0.0379910007424819,0.191944017190741
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.0036774164306482,0.00282347196908914,-0.00185658862876651,0.00921142149006291,0.192787101013425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,-0.00724199119670985,0.00556242083458628,-0.018144336032499,0.00366035363907927,0.192956476819834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,39657,0.0130298890079664,0.0100308791888405,-0.00663063420216104,0.0326904122180938,0.193970519948727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37368,-0.00556714687623712,0.00428648391767204,-0.0139686553548743,0.00283436160240007,0.194045831078935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_A,,37411,0.00398181298125064,0.00307435043484446,-0.00204391387104449,0.0100075398335458,0.195282923508717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,-0.00284372023373873,0.00219641019144281,-0.00714868420896663,0.00146124374148917,0.195438153994402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39478,0.00686229177952123,0.00530052303313794,-0.00352673336542913,0.0172513169244716,0.195462112643222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00737793207095551,0.00571812188937877,-0.0185854509741379,0.00382958683222688,0.196978873432183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37039,-0.0059695169628029,0.00462855437534341,-0.015041483538476,0.00310244961287018,0.197172189543939
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,0.00753794691480974,0.00586661647483257,-0.00396062137586209,0.0190365152054816,0.198850240546454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37289,0.00527952432903741,0.0041114073330132,-0.00277883404366847,0.0133378827017433,0.199123490723422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,36962,-0.00870875267186619,0.00678731543968822,-0.0220118909336551,0.00459438558992272,0.199482411145682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,-0.00417853108128484,0.00326648749804419,-0.0105808465774515,0.00222378441488178,0.200844597138323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,39587,0.00380696018692648,0.00298116384281381,-0.00203612094498858,0.00965004131884154,0.201619447347925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,39587,0.0109024120357253,0.00857097347058236,-0.00589669596661609,0.0277015200380668,0.20338638156332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.00582410734935218,0.00459550063672252,-0.00318307389862396,0.0148312885973283,0.205051977651784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,0.00530775919950276,0.0041884834760594,-0.00290166841357367,0.0135171868125792,0.205092581529777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,-0.00569799626220819,0.00450367822318997,-0.0145252055796605,0.00312921305524414,0.205826662943656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,-0.00602666045587734,0.00476630429860629,-0.0153686168811457,0.00331529596939099,0.206097947908399
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00483898321380148,0.00382963450986294,-0.00266710042552988,0.0123450668531328,0.206409420112692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.0056404347429148,0.00449603561247391,-0.0144526645433637,0.00317179505753406,0.209669834154689
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.0075439397486711,0.00605019969310481,-0.0194023311471565,0.00431445164981433,0.212459644527244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37124,0.0111044717067572,0.00891234711973681,-0.00636372864792691,0.0285726720614414,0.212799287299182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37021,0.00699280658307143,0.0056134555227239,-0.00400956624146742,0.0179951794076103,0.212888548897665
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00651113215628206,0.00524100217721187,-0.0167834964236173,0.00376123211105321,0.214131424711925
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,0.00359527576761209,0.00289478593264165,-0.00207850466036554,0.00926905619558973,0.214261362609243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,0.00512905247920479,0.00413606487747293,-0.00297763468064215,0.0132357396390517,0.214967862257686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37368,0.00948496031699813,0.00765373354868231,-0.00551635743841919,0.0244862780724155,0.215271024961493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,-0.00372556688392764,0.00300976317024769,-0.00962470269761312,0.00217356892975783,0.21580220149756
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,36991,-0.00554813704592709,0.00448968680590996,-0.0143479231855106,0.00325164909365644,0.216573067749928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,36962,-0.00351348305830603,0.00285256097846769,-0.00910450257610271,0.00207753645949065,0.218085410708564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.00816458605851826,0.00665229918495796,-0.00487392034399934,0.0212030924610359,0.219715957918225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,-0.00463080077807468,0.00377588865392196,-0.0120315425397617,0.00276994098361237,0.220065053649869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39477,-0.0191144855226319,0.0155999228635547,-0.0496903343351991,0.0114613632899353,0.220483100748245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.00498909128505838,0.00407905312737426,-0.0129840354147119,0.00300585284459518,0.221313748273144
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,39984,0.00714200401420439,0.00585133137428981,-0.00432660547940364,0.0186106135078124,0.222263840622298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,0.00400022148506199,0.00328636646010561,-0.002441056776745,0.010441499746869,0.223542818893128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.00756715071395653,0.00623578617261425,-0.00465499018436739,0.0197892916122805,0.224959009359703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37411,0.0181252381806006,0.0149607306088542,-0.0111977938127536,0.0474482701739548,0.225716945912256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,-0.00419505906718595,0.0034834002483599,-0.0110225235539714,0.00263240541959945,0.228491227133117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,0.00690475350045591,0.00574956656308439,-0.00436439696318949,0.0181739039641013,0.229801399663978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37249,0.00693992399154259,0.00578819880826659,-0.00440494567265992,0.0182847936557451,0.230557654765848
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,0.00371044279716905,0.00310070873995116,-0.00236694633313522,0.00978783192747332,0.231463709794493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0105362741450199,0.00881551053912052,-0.0067421265116563,0.0278146748016961,0.232031597256359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37021,0.00542252516234528,0.00453744196556084,-0.00347086109015397,0.0143159114148445,0.232084281938322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37382,0.0128868799816535,0.0108206552539704,-0.00832160431612842,0.0340953642794354,0.233693371580359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00828088404421707,0.0069822466615447,-0.0219660875008447,0.00540431941241054,0.235647180732432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00706790851781486,0.00596113829537216,-0.0187517395767443,0.00461592254111457,0.235776376249522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00468677449139737,0.00395532322197308,-0.0124392080064646,0.00306565902366987,0.236063695064869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,39585,-0.00363612932195444,0.00307356365734627,-0.00966031409035313,0.00238805544644426,0.236813685402923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.0054473033771641,0.0046167430883478,-0.0144961198303258,0.00360151307599758,0.238060705034868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00545972045572231,0.00464623755191428,-0.00364690514602969,0.0145663460574743,0.239978813390349
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37411,-0.0039270058597416,0.00335394025766535,-0.0105007287647657,0.00264671704528249,0.241674281653508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.00327827782850533,0.00282453500897814,-0.00225781078909183,0.00881436644610249,0.245804453512385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00322215196171868,0.00278312322058227,-0.00223276955062257,0.00867707347405994,0.246984462391786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,0.00875209746088831,0.00758421992428986,-0.00611297359071982,0.0236171685124964,0.248526209193169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00816579819665873,0.00708409033786885,-0.0057190188655642,0.0220506152588817,0.249053082107539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00298099189741483,0.00259011984392128,-0.00805762679150054,0.00209564299667088,0.249786852386237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,0.00649603606459079,0.00564793362652421,-0.00457391384339666,0.0175659859725782,0.25009828752913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.00243211182206415,0.002116929283461,-0.0017170695735194,0.00658129321764771,0.250622956967948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,0.00246111847680088,0.00214309019030717,-0.00173933829620118,0.00666157524980294,0.250824969529781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.00323568423324899,0.00281896311504389,-0.00228948347223704,0.00876085193873502,0.251060615542555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,0.00862953980741447,0.00754021244641654,-0.00614927658756195,0.0234083562023909,0.252449422158655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,0.00407829460444117,0.0035792120990097,-0.00293696110961784,0.0110935503185002,0.254540214744452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.00286062914138645,0.00253140765252325,-0.00210092985755912,0.00782218814033201,0.258470085599833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,0.00822409067656591,0.00730398699150707,-0.00609172382678794,0.0225399051799198,0.260197509851569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,0.00638768110767677,0.00568853664357919,-0.00476185071373844,0.017537212929092,0.261495370677185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37100,0.00606144071264448,0.00540407706847711,-0.00453055034157066,0.0166534317668596,0.262034957137256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00313062420887317,0.00280352192783343,-0.00236427876968035,0.00862552718742668,0.264153461446015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,-0.00815777929935126,0.00731885359387634,-0.0225027323433489,0.00618717374464636,0.265031354634322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,-0.00432658372184267,0.00388263436813791,-0.011936547083393,0.00328337963970763,0.265152806267312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00579755769158174,0.00520425734057456,-0.0159979020791079,0.00440278669594439,0.26529838433661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37021,0.00452238524108513,0.00406409608854161,-0.00344324309245642,0.0124880135746267,0.2658295516012
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,39868,0.0079074949783265,0.00710828516885134,-0.00602474395262213,0.0218397339092751,0.265968486968036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,-0.00267153506230951,0.00240376140948783,-0.00738290742490565,0.00203983730028663,0.26641367524008
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37056,-0.00519332296359337,0.00467556905913552,-0.014357438319499,0.00397079239231225,0.266702231493599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00341029383651836,0.00308752593618623,-0.00946184467144337,0.00264125699840665,0.269379490336822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,0.00484781980070979,0.00441135540982616,-0.00379843680254948,0.013494076403969,0.271813857015111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,0.00536327799600245,0.00488622381363011,-0.00421372067871257,0.0149402766707175,0.272385054840521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,-0.00411257269103122,0.00375695423567559,-0.0114762029929554,0.00325105761089294,0.273686805327149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00644709195070243,0.00590035634702812,-0.00511760648947269,0.0180117903908775,0.274558788171581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.00139785213142392,0.00128348063124498,-0.00391347416866408,0.00111776990581625,0.276124833617256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37437,0.0081012640983123,0.00744061016747436,-0.00648233182993744,0.022684860026562,0.27626570045345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,0.00488244273520269,0.00449573468100123,-0.00392919723955972,0.0136940827099651,0.277488386958731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37445,0.0026347427275421,0.00243926836516114,-0.00214622326817374,0.00741570872325793,0.280100587851468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,39866,0.0087641786487455,0.00812411710029939,-0.00715909086784131,0.0246874481653323,0.280699675966324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40009,-0.00315601283238111,0.00293708040525188,-0.0089126904266748,0.00260066476191257,0.282596407366713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,-0.0050495174497297,0.00470747099018514,-0.0142761605904926,0.00417712569103317,0.283442604488899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37021,0.00770973599483426,0.00719056221553319,-0.00638376594761079,0.0218032379372793,0.283648921980812
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,-0.00274158849859186,0.00256120893244195,-0.00776155800617808,0.00227838100899436,0.284443015946095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,0.00365670795686774,0.00341763332072738,-0.00304185335175793,0.0103552692654934,0.284656762640684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37056,-0.00353385505991553,0.0033051707029083,-0.0100119896376158,0.00294427951778474,0.285003675969713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,36818,-0.00397425632565634,0.00371786456785897,-0.0112612708786599,0.00331275822734725,0.285106658758786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,0.00471914236581661,0.00441576502957671,-0.00393575709215373,0.013374041823787,0.285223059669218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,-0.00584262310550765,0.00546876906370236,-0.0165614104703643,0.00487616425934898,0.285373603001533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,0.00302661211461702,0.00283400432617965,-0.0025280363646951,0.00858126059392914,0.285556170678522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,-0.00284743487542343,0.00267319666848312,-0.00808690034565034,0.00239203059480348,0.286810675349391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.00388579713834241,0.00365133605451353,-0.0032708215285041,0.0110424158051889,0.287251959609826
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37043,0.001796640947653,0.00169867021286794,-0.00153275266956816,0.00512603456487416,0.290223035480915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00647550175721681,0.00613630912045324,-0.00555166411887154,0.0185026676333052,0.291315276470414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.00340049450790141,0.0032235672373472,-0.00971868629310193,0.00291769727729911,0.29149388981216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.00397540730081481,0.00378527336787007,-0.0113945431018402,0.00344372850021053,0.293628559579547
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.0115400556425576,0.011012880069896,-0.0100451892944385,0.0331253005795538,0.294717654898171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.00265495979795655,0.00254247578970611,-0.00232829274986744,0.00763821234578053,0.296392068850022
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37021,0.00595711552605994,0.00572120134543279,-0.00525643911098834,0.0171706701631082,0.297785586289066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.00857809344658002,0.00828067273058355,-0.00765202510536374,0.0248082119985238,0.300259685180635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,36991,0.00373854918508614,0.00361041791270571,-0.00333786992381705,0.0108149682939893,0.300459521002872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00842412542862004,0.00816341855672946,-0.0244244257998098,0.00757617494256969,0.302120855181303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,-0.00610176578547416,0.00592080834840143,-0.017706550148341,0.00550301857739264,0.302764750658366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00524153298672327,0.00510339321877388,-0.00476111772207353,0.0152441836955201,0.304406713956978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.00653301072735201,0.00636309401788791,-0.00593865354770829,0.0190046750024123,0.304578836140986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,0.00627054041745938,0.00612221104444501,-0.00572899322965284,0.0182700740645716,0.305746387164816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,0.00709055897262999,0.00692800923620934,-0.00648833913034032,0.0206694570756003,0.306104675034746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,0.00719417100505818,0.00704166341070679,-0.00660748927992713,0.0209958312900435,0.306958104628887
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,-0.00329240429063999,0.00322463237221265,-0.00961268374017678,0.00302787515889679,0.307265221169198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,-0.00180803932024063,0.00177118858971727,-0.00527956895608649,0.00166349031560522,0.307364694045192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,-0.00265091070493502,0.00259970196796829,-0.00774632656215286,0.00244450515228283,0.307886980608119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37039,0.00580768217838669,0.00570085319256049,-0.00536599007903188,0.0169813544358053,0.308345534732961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,0.00758585588893404,0.00744785188028388,-0.00701193379642237,0.0221836455742905,0.30844463393347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,39587,0.00501962337190363,0.0049286094685323,-0.00464045118641968,0.0146796979302269,0.308472005502847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,-0.00332637549723654,0.00326622941439898,-0.00972818514945855,0.00307543415498546,0.308496462041948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37235,-0.00331062953826856,0.00325178259244391,-0.00968412341945862,0.0030628643429215,0.308650358566059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,-0.00459960325004906,0.00451829832793853,-0.0134554679728086,0.00425626147271045,0.308699240352464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00245025084752139,0.00240896692144331,-0.00717182601355028,0.00227132431850749,0.309106162867213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,0.00448428399490228,0.00441119795952994,-0.0041616640057764,0.013130231995581,0.309374590804084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39415,0.00291960763372938,0.00287303224594428,-0.00271153556832141,0.00855075083578017,0.309544615262358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00350087130005868,0.00345293320207278,-0.0102686203761213,0.00326687777600396,0.310657049682592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,0.00448076875575965,0.00443428941569349,-0.0042104384989996,0.0131719760105189,0.312283090968131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39489,-0.00425899938950241,0.00422812288825368,-0.0125461202504796,0.00402812147147482,0.313804951306323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIM,Vimentin,39585,0.0111821931437219,0.0111061921936524,-0.0105859435558368,0.0329503298432807,0.314025664192473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37169,-0.00339276388021733,0.00337564322869431,-0.0100090246084582,0.00322349684802352,0.314880541304417
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.00288739593245425,0.00287750675258427,-0.00275251730261093,0.00852730916751942,0.315665730418299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,-0.0088724744055008,0.00885097436190086,-0.0262203841548265,0.00847543534382489,0.316154766520208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.0033914725260503,0.00340817049228897,-0.0100714866909367,0.00328854163883608,0.319705605212492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,39699,-0.00637648586441358,0.00641285537083227,-0.0189456823912448,0.00619271066241766,0.320078078623255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37169,0.00269886772880266,0.00271705730689224,-0.00262656459270612,0.00802430005031145,0.320579199246566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,36991,-0.00890009785800286,0.00897513108131463,-0.0264913547773795,0.00869115906137381,0.321391503120843
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,39788,0.0175215990493663,0.0176697912786168,-0.0171111918567227,0.0521543899554553,0.321401289567875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.0053421703991481,0.00541863018847668,-0.00527834477026618,0.0159626855685624,0.324202251037452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.00325821455536186,0.00331110210300242,-0.00974797467724661,0.00323154556652289,0.325117380111859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37021,-0.0039567816070623,0.00403095331497974,-0.0118574501044226,0.00394388689029799,0.32631525619311
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00660928505722671,0.00676022598121445,-0.0066407578659536,0.019859327980407,0.328254417473698
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.00282417129429414,0.00290776616460671,-0.00852339297692329,0.00287505038833502,0.331437855676882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37039,0.00456516918552791,0.00470376146818285,-0.00465420329211049,0.0137845416631663,0.331797270254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,0.00592783008102106,0.00611319145289661,-0.00605402516665629,0.0179096853286984,0.33222458502861
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37169,0.00209478220597375,0.00216360613882354,-0.00214588582612039,0.00633545023806789,0.33296699438452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,36991,0.0102589457819641,0.01060363020858,-0.0105241694268526,0.0310420609907808,0.33331509106464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,39585,-0.0049092500251357,0.00508931671710579,-0.014884310790663,0.00506581074039165,0.334750668342102
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.00489867704542665,0.00508106235897953,-0.00506020517817322,0.0148575592690265,0.335010602274715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.00643580552659028,0.00669695569453638,-0.00669022763470101,0.0195618386878816,0.336567291141979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,39587,-0.00444713009689647,0.00463603030632334,-0.0135337494972902,0.00463948930349727,0.337445605544929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39489,0.00552588484647493,0.00576516400648426,-0.00577383660623423,0.0168256062991841,0.337827691065383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,0.00517824907505352,0.00541197802628831,-0.00542922785647157,0.0157857260065786,0.338676622296842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,0.00378614781965968,0.00396505342338127,-0.00398535689016761,0.011557652529487,0.339655777636242
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00698978973954525,0.00735816432134796,-0.0214117918093873,0.00743221233029676,0.342161399653672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,0.00356597725279792,0.00375530701818837,-0.00379442450285128,0.0109263790084471,0.342338351450134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37388,-0.00242171399744805,0.00255211283210231,-0.00742385514836858,0.00258042715347247,0.342685608884222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37039,-0.00596071299046182,0.00628189186561501,-0.0182732210470672,0.0063517950661436,0.34270297884825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37039,0.00539969196038824,0.00572105592485108,-0.00581357765231987,0.0166129615730963,0.345274924069438
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40012,-0.00260653613067154,0.00277549438182268,-0.008046505119044,0.00283343285770092,0.347680618879146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37021,0.00980708071707837,0.0104877540025287,-0.0107489171278779,0.0303630785620346,0.349754810001408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,-0.00713971378911986,0.00764676823600519,-0.02212737953169,0.00784795195345032,0.35048084524584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37368,0.00332870365580918,0.00357549879047072,-0.00367927397351344,0.0103366812851318,0.35188260313168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.00240628312321681,0.00258915893529696,-0.00266846838996522,0.00748103463639885,0.352712426607696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39524,-0.0041080225189004,0.00445144215701574,-0.0128328491466512,0.00461680410885045,0.356098526203557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,39868,0.0100239156744069,0.0109354648354003,-0.0114095954029776,0.0314574267517914,0.359343630305203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37169,0.00376111254164537,0.00410557016657657,-0.00428580498484471,0.0118080300681355,0.359631083117994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37056,-0.00913342031110213,0.00998464600766319,-0.028703326486122,0.0104364858639177,0.360341424006772
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39123,0.00241179311246834,0.00266677333142407,-0.00281508261712283,0.0076386688420595,0.365804904868183
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00484590203581928,0.00536243010596769,-0.00566446097187739,0.0153562650435159,0.366183581376273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00374228366480791,0.00414555536907023,-0.00438300485856973,0.0118675721881856,0.36668984185646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,-0.00311251470252068,0.00345895639952342,-0.00989206924558658,0.00366703984054523,0.368220710539842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.00371361054737619,0.00412698720548421,-0.00437528437537286,0.0118025054701252,0.368224096570384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIT,Vitrin,37437,0.0031340973323588,0.00349588422431686,-0.00371783574730224,0.00998603041201984,0.36999600631913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,-0.00637107719520558,0.00715453382890091,-0.0203939634998514,0.0076518091094402,0.373216422537599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,0.00528112688858662,0.00597155064407143,-0.00642311237379339,0.0169853661509666,0.37650661812075
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00147347407633281,0.00166864391933655,-0.00179706800556683,0.00474401615823244,0.377229620255671
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37056,-0.00481300120223169,0.00546153564231525,-0.0155176110611696,0.0058916086567062,0.378196301794998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,-0.00490131500682112,0.00556435380429255,-0.0158074484632345,0.00600481844959227,0.378419398078078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40052,-0.0026730877496891,0.00303732372884742,-0.00862624225823004,0.00328006675885184,0.378829055290208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00426854134017394,0.00485161401637089,-0.0137777048122609,0.00524062213191301,0.378973350907166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,36703,-0.00583492352750133,0.00666237860533826,-0.0188931855939643,0.00722333853896166,0.381154141947718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37437,-0.00390019239260855,0.00445635035787441,-0.0126346390940424,0.0048342543088253,0.38148123953188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37039,-0.00491168274794129,0.00563323648027284,-0.0159528262492761,0.00612946075339347,0.383272632382161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00420295892777687,0.0048282355143949,-0.0136663005359909,0.00526038268043715,0.384045368710226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.00998581004417324,0.0115053220022347,-0.0125646210802068,0.0325362411685533,0.385446091938634
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37056,-0.00313888603794431,0.00362990788840186,-0.0102535054992119,0.00397573342332333,0.387203355016714
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,39587,0.0038749917049303,0.00448319694380367,-0.00491207430492489,0.0126620577147855,0.387416130966271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.00208871864813381,0.00242321037941719,-0.00266077369552388,0.00683821099179151,0.388722884326766
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,-0.00674960288023146,0.00787870164962324,-0.022191858113493,0.00869265235303009,0.391632007814422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,39754,0.00418654070517638,0.00490630338739068,-0.00542981393410935,0.0138028953444621,0.393506720259511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37411,-0.00363614179433259,0.00426136446816253,-0.0119884161519311,0.00471613256326596,0.39351851609946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,36962,-0.00747485744161041,0.00876997967044691,-0.0246640175956864,0.00971430271246553,0.394050292866777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,0.00271669820237953,0.00318907896185859,-0.0035338965628633,0.00896729296762236,0.394295895664688
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,0.00282036499386952,0.00332119966433377,-0.00368918634822467,0.00932991633596371,0.395782645182718
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,0.00273366257392654,0.00323258834048108,-0.00360221057341638,0.00906953572126945,0.397756541991813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37169,-0.00460490422922869,0.00545906623275176,-0.0153046740454221,0.00609486558696477,0.398945402676984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00331897968679864,0.00395617624963892,-0.0110730851360909,0.00443512576249364,0.401520149352157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,0.00289759635197778,0.00347626401513566,-0.00391588111768812,0.00971107382164367,0.404556795180216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00396491852972099,0.00476682365158036,-0.0133078928868185,0.00537805582737651,0.405551852443589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,-0.00586885030117969,0.00707311810920901,-0.0197321617952294,0.00799446119286998,0.406700580289432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,-0.00945453253828118,0.0114231433991457,-0.0318438936006068,0.0129348285240445,0.407873063511994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39489,-0.00413093013559051,0.00500055427802291,-0.0139320165205154,0.0056701562493344,0.408763125996087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.00720513772447937,0.00872255009792758,-0.00989106046745868,0.0243013359164174,0.408798792783994
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,-0.0029121091377327,0.00353216744404107,-0.0098351573280532,0.00401093905258781,0.409696722138458
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00294681581243986,0.00358180206286113,-0.00407351623076795,0.00996714785564767,0.410680408693033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,-0.00490707611870726,0.00596898509796132,-0.0166062869107114,0.00679213467329692,0.41103744196667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37056,-0.00596321256691795,0.00726461214766696,-0.0202018523763452,0.00827542724250928,0.411742175732942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00565663437688388,0.0068971187783265,-0.0191749871824038,0.00786171842863605,0.412148395891316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,0.00567635838478624,0.00693618028860083,-0.00791855498087138,0.0192712717504439,0.413161010136107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEB,Nebulin,37021,0.00291794531350723,0.00356807163857923,-0.00407547509810807,0.00991136572512252,0.413489991896803
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37056,-0.00460352570297367,0.00565089101005207,-0.0156792720826757,0.00647222067672838,0.415284612323891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENG,Endoglin,40052,-0.00130960306873678,0.00160816558750785,-0.00446160762025215,0.0018424014827786,0.415458792057114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00511686472402139,0.00628645089273117,-0.0174383084737745,0.00720457902573171,0.415687624029843
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,-0.00502764287183106,0.00619500799881143,-0.0171698585495015,0.00711457280583935,0.417054378550062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00305908038049872,0.00377266599174501,-0.0043353449633215,0.010453505724319,0.41746432336946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.0021274759325214,0.00263003526649425,-0.00728234505485013,0.00302739318980732,0.418575860893408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,39720,-0.00959262698460254,0.0119174677249391,-0.0329508637254832,0.0137656097562782,0.420876998924099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,-0.00244318161918264,0.00303608730359178,-0.00839391273422253,0.00350754949585725,0.420999300952192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,0.00353184606669744,0.00439771620851658,-0.00508767770199506,0.01215136983539,0.421925999282522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,-0.00505684354841072,0.00632233245652431,-0.0174486151631984,0.00733492806637693,0.423818999141354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.00493505767784188,0.00617349644136889,-0.00716499534724114,0.0170351107029249,0.424075843781676
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,-0.00348603484521743,0.00438287020480215,-0.0120764604466296,0.00510439075619478,0.426408118829172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,-0.00202465943416368,0.00254627089597597,-0.00701535039027658,0.00296603152194921,0.426541976670687
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37056,-0.00208212302607482,0.00262091447825633,-0.00721911540345722,0.00305486935130759,0.426961665993602
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.014088272207427,0.0177355624158712,-0.0206734301276806,0.0488499745425345,0.427002603183909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.00211534333907137,0.00266375590959565,-0.00733630492187885,0.00310561824373611,0.42713702019446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39477,-0.00708382595767293,0.00892583767018327,-0.0245784677912321,0.0104108158758863,0.427422045536073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00343434778650708,0.0043277891308286,-0.00504811890991697,0.0119168144829311,0.427465288568392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00434833184252882,0.00548830795346942,-0.0151054154313289,0.00640875174627124,0.428203600334607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37424,-0.00169980454364846,0.00214744429959465,-0.00590879537085397,0.00250918628355705,0.42863830810031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,-0.00344897718627108,0.00436131914706035,-0.0119971627145094,0.00509920834196721,0.429066378475466
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37056,-0.00408339123861384,0.00516762335321448,-0.0142119330109142,0.00604515053368654,0.429432490122968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,39992,-0.00317066585010187,0.00401384064447854,-0.0110377935132798,0.00469646181307607,0.429578411437959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,-0.00354690556446455,0.00451499653584123,-0.0123962987747134,0.00530248764578427,0.432125919545785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37056,-0.00219945398567008,0.00281330500625488,-0.00771353179792965,0.00331462382658948,0.43434361318297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,39587,-0.00230096987410942,0.00295867119951237,-0.00809996542515366,0.00349802567693481,0.436755342253172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37161,-0.00722235787412907,0.00931616509402296,-0.0254820414584141,0.0110373257101559,0.438205674257447
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,-0.00386959364159866,0.00499559398749035,-0.0136609578570797,0.00592177057388243,0.43858879851043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,0.00507239376271761,0.00655230177291263,-0.00777011771219115,0.0179149052376264,0.438862219553234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00247921789544749,0.00322394832195478,-0.00383972081558388,0.00879815660647885,0.44190427310652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,39866,-0.00281811159800724,0.00366940357298744,-0.0100101426010626,0.00437391940504814,0.442496951725865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37039,-0.00197446993613862,0.002572109002491,-0.00701580358102099,0.00306686370874374,0.442711105600703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00558733864462518,0.00728363173745419,-0.0198632568500354,0.00868857956078503,0.443030184813946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,0.00261875527271035,0.00342590850576705,-0.00409602539859306,0.00933353594401376,0.444641849682229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.00615539666900799,0.00805914706496188,-0.00964053157831729,0.0219513249163333,0.445013411446635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.00435378622620754,0.00570268828596329,-0.00682348281428052,0.0155310552666956,0.44520153465717
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,39788,0.00205211417374818,0.0026902087936996,-0.00322069506190304,0.0073249234093994,0.445588899073941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,0.0027854269876296,0.00365236144415126,-0.00437320144290687,0.00994405541816606,0.445693396034553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00389851696435944,0.00513548410924634,-0.0139640658184823,0.0061670318897634,0.447786451592664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.00435590548269304,0.00574745637445401,-0.00690910901123681,0.0156209199766229,0.448533936647477
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7,Complement component C7,37149,0.00231303724621412,0.00305273225716908,-0.00367031797783728,0.00829639247026552,0.448647561934225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,-0.00284536014851951,0.00376879442863094,-0.0102321972286361,0.00454147693159713,0.450275149386746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,0.0024656501049074,0.00326626859631364,-0.00393623634386733,0.00886753655368213,0.450330667993644
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37039,0.00222476823710427,0.00297862883622824,-0.00361334428190308,0.00806288075611162,0.455131097619597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,36991,0.00440541394268768,0.00590213109267426,-0.00716276299895387,0.0159735908843292,0.455432705857509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.00254909268159523,0.00342665554339786,-0.00926533754665502,0.00416715218346457,0.456947261122636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.00176358858581833,0.00237175747755053,-0.00288505607018071,0.00641223324181737,0.457144250434314
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,0.00773947502577486,0.0104187048707377,-0.012681186520871,0.0281601365724207,0.457589203912934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37169,0.00420450787497399,0.00567663265268202,-0.00692169212428276,0.0153307078742307,0.45890700815769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0027545029167742,0.00372827249422486,-0.00455291117190652,0.0100619170054549,0.460032617601221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40052,-0.00512134986984059,0.00693611332258617,-0.0187161319821095,0.0084734322424283,0.460306307783707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.00492996666974492,0.00668509635221217,-0.0180327555200808,0.00817282218059093,0.460858011422571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.00276399084250055,0.0037738779967066,-0.0101607917160455,0.00463281003104438,0.46393495330088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00587461916493027,0.00805762783583185,-0.0216675697231607,0.00991833139330016,0.465966396125768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.0032543824214182,0.00446847977657097,-0.0055038379406609,0.0120126027834973,0.466442607499017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00277780769742585,0.00381528416006945,-0.010255764651162,0.00470014925631028,0.466579098444981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00254182889476406,0.00350516935411185,-0.00432830303929516,0.00941196082882328,0.468363204095907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40009,0.00197700905913327,0.00273423948462698,-0.00338210033073562,0.00733611844900215,0.469655773406388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00576211715100201,0.00799025198494738,-0.00989877673949486,0.0214230110414989,0.470834108871873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTTG1,Securin,37169,-0.00286616123052895,0.0039782656649426,-0.0106635619338164,0.00493123947275854,0.471257574531333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,-0.0052655846728032,0.00731337995066976,-0.0195998093761159,0.00906864003050954,0.471541755356952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.00472697572086583,0.00657012751189873,-0.00815047420245569,0.0176044256441873,0.471864939857486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,39749,-0.00240825778331016,0.00334865524141593,-0.00897162205648538,0.00415510648986507,0.472045765665168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPGN,Epigen,37368,-0.00340796428029342,0.00473988194545738,-0.0126981328933899,0.00588220433280304,0.472154765948291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,-0.00426072591429114,0.00593367438031117,-0.015890727699701,0.00736927587111874,0.472733901760889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,-0.00336052528413771,0.00468024629801684,-0.0125338080282507,0.00581275745997531,0.472755774699226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.00371283035114351,0.0051906324632872,-0.0138864699791864,0.0064608092768994,0.474437839295556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.00990009397196878,0.0138526962073283,-0.0370513785383323,0.0172511905943947,0.474825871194844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,-0.00176700694915314,0.00247955938621172,-0.00662694334612811,0.00309292944782183,0.476087706346228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00529475546182488,0.00743736537773257,-0.00928248067853096,0.0198719916021807,0.476531389342949
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37437,-0.00531408624505971,0.00747181803527137,-0.0199588495941916,0.00933067710407217,0.476961808296652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.0073409609420744,0.0104258296268857,-0.0130936651266215,0.0277755870107703,0.48137523878034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,36991,0.00388685383488242,0.00553385802005467,-0.00695950788442474,0.0147332155541896,0.482456620756661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00498527535315565,0.00711857491743099,-0.0089671314850091,0.0189376821913204,0.483740333404337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00392054263755689,0.00559989218138246,-0.0148963313130665,0.00705524603795274,0.483870777870288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00374263984703378,0.00534724499389416,-0.0142232400350663,0.00673796034099877,0.483990117744936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,0.00268456588092487,0.00384487201796938,-0.00485138327429511,0.0102205150361449,0.485051926795681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNLY,Granulysin,39858,-0.00336699021000348,0.00483549116657161,-0.0128445528964838,0.00611057247647688,0.486246206229681
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37169,0.00350444326518402,0.00503993633098559,-0.00637383194354775,0.0133827184739158,0.486857632319484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,-0.000531995936064369,0.000769007194318991,-0.00203925003692959,0.000975258164800853,0.489077581201379
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37039,0.0049354773132761,0.00713750353418863,-0.00905402961373361,0.0189249842402858,0.489272924392511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,0.00167359859417787,0.00242516595363047,-0.00307972667493786,0.0064269238632936,0.490145332749002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.00421631089257321,0.00611568899806556,-0.0077704395436353,0.0162030613287817,0.490567709497736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,39866,-0.00219827690964717,0.0031961528622751,-0.00846273651970638,0.00406618270041203,0.491595999417771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,-0.00356608413819783,0.00519343511887682,-0.0137452169711964,0.00661304869480072,0.492311989968842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,39587,-0.00347854422821678,0.00506983223489942,-0.0134154154086196,0.00645832695218608,0.492643707157683
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39477,0.00198598235478598,0.00289889686001666,-0.00369585549084667,0.00766782020041863,0.493302281389582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.00207212358126687,0.00302553423077483,-0.0038579235110518,0.00800217067358553,0.493430577568567
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37039,0.0039366557021942,0.0057634428489877,-0.0073596922818217,0.0152330036862101,0.494594264716776
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,0.00168878486517343,0.00247324550470304,-0.00315877632404452,0.00653634605439139,0.494729659957906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,0.0018356541241971,0.00269602452305302,-0.00344855394098682,0.00711986218938103,0.495962904159859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,-0.00258009473343001,0.00379600929549265,-0.0100202729525956,0.00486008348573557,0.496715202059112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,0.00395807154457622,0.00584115434362036,-0.00749059096891969,0.0154067340580721,0.498025480162576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00269849076965855,0.00398347053764697,-0.0105060930234466,0.00510911148412951,0.498150104576453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00437137243665371,0.0064804919692794,-0.0170731366964413,0.00833039182313391,0.499977683618445
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37388,0.00359918653452399,0.00539607517465431,-0.00697712080779845,0.0141754938768464,0.504782989547356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0057967412262186,0.00869082683010302,-0.0228307618132205,0.0112372793607833,0.504786839043816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,36903,-0.00217073015652077,0.00326340660934452,-0.00856700711083602,0.00422554679779449,0.50595157139279
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00179443467734747,0.00270051073530959,-0.00349856636385932,0.00708743571855426,0.506394652874897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.00355829543921391,0.00539715778149751,-0.0070201338125212,0.014136724690949,0.509718826252161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40030,0.00458745342656145,0.00696490644944894,-0.00906376321435847,0.0182386700674814,0.510128284573544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.00282890421724597,0.00430400189183844,-0.00560693949075738,0.0112647479252493,0.511016595490457
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,38832,0.00298865176741956,0.00456597867045665,-0.00596066642667548,0.0119379699615146,0.512768929693571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00254096839359876,0.00388490550753928,-0.0101553831883757,0.00507344640117822,0.513083382747481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00347537838322779,0.00534949915031048,-0.0139603967178363,0.00700963995138074,0.515920455785926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.00204168365576683,0.00314779155681738,-0.0082113551071289,0.00412798779559524,0.516601076060073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,0.00512840555515282,0.00793873041253769,-0.010431506053421,0.0206883171637267,0.518291835240571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00352963304748133,0.00547708637955334,-0.00720545625644321,0.0142647223514059,0.519303861492157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39315,0.00155460350505717,0.00241542090906957,-0.00317962147671918,0.00628882848683353,0.519834032768408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00249040990858106,0.00389872506950543,-0.0101319110448117,0.00515109122764958,0.522978048324082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39489,0.00419875725797126,0.00657866624731746,-0.00869542858677097,0.0170929431027135,0.523327871354288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.00768550775025,0.0120494351303595,-0.0313024006057547,0.0159313851052547,0.523592806424517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.00122008142154635,0.00191436042470706,-0.00253206501087949,0.00497222785397218,0.523918281075138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,-0.00412309675275351,0.00648464618597803,-0.0168330032772704,0.00858680977176342,0.524901874142729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37388,0.00305400583749319,0.00482693329314506,-0.00640678341707114,0.0125147950920575,0.526939567894194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00395055404688791,0.00625477978680765,-0.0162099224290309,0.00830881433525509,0.5276554630856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,-0.00382468218684697,0.00609218005604692,-0.0157653550966989,0.008115990723005,0.530142896719275
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00348930793013959,0.00556682894388983,-0.00742167679988447,0.0144002926601637,0.530797011431323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.00258224684155394,0.00413713704737112,-0.00552654177129345,0.0106910354544013,0.532529816814266
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39477,-0.00235607136942205,0.00377490689385834,-0.00975488888138439,0.00504274614254029,0.532544592855421
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.00315171354826608,0.00505277111203593,-0.00675171783132435,0.0130551449278565,0.532796393027002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,-0.00202084383007275,0.00324358636492685,-0.00837827310532937,0.00433658544518387,0.533276849312877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,39587,-0.00286261365273167,0.00462842462544444,-0.0119343259186028,0.00620909861313944,0.536264291070712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,39783,0.00425784725511382,0.00688503613303512,-0.00923682356563501,0.0177525180758626,0.536307056024213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,-0.00398326774256251,0.00645430231193416,-0.0166337002739535,0.00866716478882845,0.537146957189316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00132494583878597,0.00214873733904753,-0.00288657934574719,0.00553647102331913,0.537496702801554
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,-0.00149137371436285,0.002420764455457,-0.00623607204705856,0.00325332461833287,0.537853396400536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,0.00458320446521827,0.00746744724529507,-0.0100529921355601,0.0192194010659966,0.539385835182413
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.00226153747033549,0.00370890191921491,-0.00500791029132574,0.00953098523199672,0.542029914963299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37380,0.00269299853431115,0.00444590825119202,-0.00602098163802521,0.0114069787066475,0.544707434799299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00150706631338105,0.00248919058747803,-0.00638587986483798,0.00337174723807588,0.544892390600285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.00223221396057263,0.00369189511145781,-0.00500390045788468,0.00946832837902994,0.545436630778901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37382,-0.00655734729250804,0.0109021597719973,-0.0279255804456227,0.0148108858606066,0.547535528126684
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.00574333868353603,0.0095502308001112,-0.0129751136846819,0.024461791051754,0.547595804064761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37169,0.00240030390467416,0.00399222116310055,-0.00542444957500291,0.0102250573843512,0.547686907554816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37031,-0.00398994424600532,0.0066461423096473,-0.017016383172914,0.00903649468090338,0.548290077965785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.00400322508868823,0.00669542395372454,-0.00911980586061187,0.0171262560379883,0.549913551491053
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00187436750813982,0.00317338187228033,-0.00434546096152963,0.00809419597780926,0.554761437066787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,36991,0.00360446992414512,0.00610938944632256,-0.0083699333906471,0.0155788732389373,0.555208466586144
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,36868,-0.0024331225946755,0.00414642586922825,-0.0105601172983629,0.00569387210901187,0.557348237223395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37368,-0.00154424930983906,0.0026324103234035,-0.00670377354370992,0.0036152749240318,0.557462430498587
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.00258548640668098,0.00440907051140986,-0.0112272646090443,0.00605629179568234,0.557615664727615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,0.00585048796958773,0.0100168918059063,-0.0137826199699887,0.0254835959091642,0.559188491152766
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.00272952510358232,0.00467865983876103,-0.0118996983875539,0.00644064818038931,0.559633208479918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,36962,0.00400417000798431,0.00687728628298468,-0.00947531110666566,0.0174836511226343,0.560421041242765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00553599833642058,0.00951813003292307,-0.0131195365281086,0.0241915332009498,0.560828131717795
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,0.00199972321532515,0.00345880326145894,-0.00477953117713437,0.00877897760778468,0.563169346129715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,-0.0021686325123034,0.00376064323735649,-0.00953949325752211,0.00520222823291532,0.564175430724162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00204191213417461,0.00356300105711784,-0.00494156993777635,0.00902539420612557,0.566595069888867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00276591224033548,0.00482827929025124,-0.0122293396492279,0.00669751516855695,0.566751496962864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,-0.00181676468188728,0.00318827100782021,-0.00806577585721488,0.00443224649344033,0.568804108746392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37169,-0.00894341994926779,0.0157151836007278,-0.0397451798066944,0.0218583399081588,0.569301813017285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,0.00214763639224186,0.00377433666950311,-0.00525006347998424,0.00954533626446795,0.569358868579976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,0.00349091169845478,0.00614417711252236,-0.00855167544208905,0.0155334988389986,0.569931954971342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00341590824713515,0.00603592678589559,-0.0152463247474905,0.00841450825322019,0.571451486787909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37021,-0.0032605063227392,0.00579381567185423,-0.0146163850395735,0.00809537239409509,0.573610420770036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37124,0.00193624552912586,0.00344387918297272,-0.00481375766950068,0.0086862487277524,0.573970143123727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,36991,-0.00252840067120349,0.00451458587828096,-0.0113769889926342,0.00632018765022719,0.57545385249667
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00137950772364332,0.00246592880910353,-0.00345371274219959,0.00621272818948624,0.575878044752217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00406651847895707,0.00731138985682809,-0.0183968425983401,0.010263805640426,0.578090773982558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00257112671560631,0.00463964408108932,-0.00652257568332876,0.0116648291145414,0.579475345607029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.00186020747122157,0.00336928276421094,-0.00846400168907501,0.00474358674663188,0.580882174759659
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.00289819648791078,0.00529036884695394,-0.00747092645211894,0.0132673194279405,0.583819608020203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,-0.00146813387186941,0.00268465043262425,-0.00673004871981295,0.00379378097607412,0.584481229009604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,0.00286780289254549,0.00527025951051724,-0.0074619057480683,0.0131975115331593,0.586348600947901
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,0.00218101530807485,0.00405637935821757,-0.00576948823403158,0.0101315188501813,0.59081031207626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37169,-0.00261452972348073,0.00489193753137018,-0.0122027272849663,0.00697366783800482,0.593034395001267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37411,0.00108923460656703,0.00205736134441559,-0.00294319362848752,0.00512166284162158,0.596513912651563
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40009,0.0012746766260191,0.00241789016652925,-0.00346438810037822,0.00601374135241642,0.598072021776186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00389965582236873,0.00741786645817568,-0.0184386740803931,0.0106393624356556,0.599097693610236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.00448719803092325,0.00854483346530907,-0.0122606755610825,0.021235071622929,0.599497607268222
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37411,0.00175961569529716,0.00335235689694859,-0.00481100382272207,0.00833023521331638,0.599668852997618
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.00181422636599818,0.00345755233693953,-0.00496257621440331,0.00859102894639966,0.599790584162243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.00340535569933741,0.00650192204144521,-0.01614912290057,0.00933841150189521,0.600464008051014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,0.00198138537607801,0.00379254746975011,-0.0054520076646322,0.00941477841678822,0.601371563347456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00313103847807004,0.00602760865031189,-0.0149451514326813,0.00868307447654126,0.603455937852503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.0015528344137842,0.00300005218674151,-0.00743293669979756,0.00432726787222916,0.60474273105765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00248619046799931,0.00482998229737491,-0.0119529557708541,0.00698057483485551,0.606742509067905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,39908,-0.00398881265802148,0.00782045516715811,-0.0193169047856514,0.0113392794696084,0.610024388174541
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37437,0.00409613856656509,0.0082112003006413,-0.0119978140226918,0.020190091155822,0.617894747038004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00171557297546964,0.00344686292197325,-0.00847142430253722,0.00504027835159794,0.618688294273072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.0024440369273124,0.0049181934751801,-0.0120836961386654,0.0071956222840406,0.619241117375964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00222433745073215,0.00449333509059486,-0.00658259932683377,0.0110312742282981,0.620586917151511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37039,0.00216764485927194,0.00439224182809623,-0.00644114912379667,0.0107764388423405,0.621655739870202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37039,0.00372876533384494,0.00759035596079376,-0.0111483323493108,0.0186058630170007,0.623257542902062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00167408211657167,0.0034164815738151,-0.00502222176810594,0.00837038600124927,0.624140702940588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00354432364166444,0.00723584482664483,-0.0177265795018883,0.0106379322185594,0.624263383662627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.00173797819266392,0.00356599299849851,-0.008727324469721,0.00525136808439315,0.625998974593941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.00261805730795715,0.00539880747606545,-0.0131997199610454,0.00796360534513114,0.627732321514337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,0.002434941440497,0.00503071360726902,-0.00742525722975027,0.0122951401107443,0.628383229707338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37411,0.00133811006496857,0.00278494532057159,-0.00412038276335174,0.00679660289328888,0.630893995581531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37056,0.00146448708103345,0.00305030548704699,-0.00451411167357865,0.00744308583564555,0.631155990590137
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,0.00299214286870095,0.00624589589363928,-0.00924981308283205,0.0152340988202339,0.631904429861598
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,-0.0040141520439079,0.00839668006946194,-0.0204716449800533,0.0124433408922375,0.632611063825016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,-0.00178840198029788,0.00375429362337908,-0.00914681748212087,0.00557001352152511,0.633824604645234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37039,0.0021823342413308,0.00458856377474371,-0.00681125075716688,0.0111759192398285,0.634365191244839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,0.00269805550693622,0.00567958719078232,-0.00843393538699713,0.0138300464008696,0.634763080413097
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.00466251659714882,0.00982732133706853,-0.0239240664178031,0.0145990332235055,0.635190770035431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,37453,0.000864665395715664,0.00183903725478886,-0.0027398476236705,0.00446917841510183,0.638239069675244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00203163074331133,0.00434319295573587,-0.00648102744993098,0.0105442889365536,0.639954269560874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37043,0.001304050751068,0.00279459856909514,-0.00417336244435848,0.00678146394649448,0.64077048152605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37351,0.00222359296203621,0.0047849465817456,-0.00715490233818516,0.0116020882622576,0.642149574029052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.000903638554557751,0.0019473635102378,-0.00291319392550833,0.00472047103462384,0.64263131894892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37380,0.00139486911802311,0.00301132432989928,-0.00450732656857948,0.0072970648046257,0.643222834148138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,36931,0.00155614566155476,0.00336012357624753,-0.0050296965478904,0.00814198787099992,0.643284949607322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,0.00385984936384781,0.008351953313484,-0.0125099791305808,0.0202296778582765,0.643980697429517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.00175303120275729,0.00379843932225679,-0.00569190986886601,0.00919797227438059,0.644436477219767
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37056,0.00203501842671758,0.00443379621742507,-0.00665522215943556,0.0107252590128707,0.646256956354015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37388,-0.00379286092043334,0.00826841481022192,-0.0199989539484683,0.0124132321076016,0.646444905599461
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,37453,0.000913168751308598,0.00199085772642805,-0.00298891239249038,0.00481524989510757,0.646470543608891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,-0.000948242418877312,0.00207004728029506,-0.00500553508825563,0.00310905025050101,0.646904189425533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,36962,0.0026023875585245,0.00569449825765825,-0.00855882902648567,0.0137636041435347,0.647678388004441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37043,-0.00308170806738405,0.00676149221631622,-0.0163342328113638,0.0101708166765957,0.648560465418974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,36991,-0.00331972952782657,0.00737206699942686,-0.0177689808467032,0.0111295217910501,0.652492991037465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00136680196618751,0.00303959537304377,-0.00459080496497828,0.00732440889735329,0.652958885394108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,0.00355390129455034,0.00790435596655293,-0.0119386363998934,0.0190464389889941,0.65299691910584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37039,-0.00181466543061932,0.0040456080893668,-0.00974405728577824,0.0061147264245396,0.653762271153456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37039,0.00298713547691319,0.00668593182292438,-0.0101172908960186,0.016091561849845,0.655041810038702
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00162878245782462,0.00365956115264757,-0.00554395740136461,0.00880152231701385,0.656272028749713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0032797319847655,0.00742881780992184,-0.0112807509226813,0.0178402148922123,0.658866005687904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.0020914690557536,0.00480555966103198,-0.0115103659913763,0.00732742787986908,0.663410883287852
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,0.00218080349444335,0.00502548870853226,-0.00766915437427987,0.0120307613631666,0.664332843368493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00206403516253314,0.00478660810893638,-0.00731771673098216,0.0114457870560484,0.666322441725327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.0017851105455783,0.00416943119556358,-0.0063869745977263,0.00995719568888291,0.668554353954187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00077804772726157,0.00182176616635946,-0.00434870941332611,0.00279261395880297,0.66932469249106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,-0.00242100780699283,0.00571470530919847,-0.0136218302130218,0.00877981459903616,0.671831448258167
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,39971,-0.0045820350592207,0.0108307141146696,-0.0258102347239732,0.0166461646055317,0.67225759391471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.00393435474289379,0.00942606755335644,-0.0224094471474724,0.0145407376616848,0.676399252630411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.00303263983070611,0.00726708587042038,-0.0112108484753178,0.0172761281367301,0.676457055667968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,39585,0.00425924942625488,0.0102485248058216,-0.0158278591931555,0.0243463580456652,0.677711074251954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39453,0.00135203772823868,0.00327132416799937,-0.0050597576410401,0.00776383309751745,0.679392636519378
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00381732190083561,0.0092691069263523,-0.0143501276748149,0.0219847714764861,0.680468541328687
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00338380838629496,0.00835634936881611,-0.0197622531491745,0.0129946363765846,0.685529154770197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,39587,-0.00107285243031136,0.00267064308780441,-0.006307312882408,0.00416160802178528,0.687895096957248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FST,Follistatin,39908,0.00195544734861357,0.00487935494646429,-0.00760808834645644,0.0115189830436836,0.688602610094064
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.00351134213304273,0.00879404225359291,-0.0207476649500848,0.0137249806839994,0.6896874588374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.00185512248369246,0.00465322700806437,-0.00726520245211371,0.0109754474194986,0.690138579892797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.00136056158137566,0.00343271441996464,-0.00808868184450636,0.00536755868175505,0.691851965226267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.00197993139510844,0.00501493212214447,-0.0118091983545116,0.00784933556429471,0.692991557362771
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.00970844569868259,0.0245904446294383,-0.0384888257750165,0.0579057171723817,0.692992735337196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,-0.00166422772162048,0.00421725883589107,-0.00993005503996698,0.00660159959672603,0.693127299151022
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,0.00187407876285522,0.00475430070055872,-0.00744435061023987,0.0111925081359503,0.693450101013749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,36991,0.0033936674174346,0.00861224746678632,-0.0134863376174666,0.0202736724523358,0.693549554597734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.00219381861652373,0.00557040923823557,-0.00872418349041799,0.0131118207234655,0.693708512829573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.00149773213031403,0.00384639214439384,-0.00604119647269791,0.00903666073332596,0.696996758054412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00179165167401783,0.00462363241898512,-0.007270667867193,0.0108539712152287,0.698393308123485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,-0.00183574517955483,0.00476415269774129,-0.0111734844671278,0.0075019941080181,0.700003201349731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,0.00324030283328853,0.00843231959676227,-0.0132870435763655,0.0197676492429426,0.700783197252459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAG,S-arrestin,36991,-0.00194134291314886,0.00506232816051328,-0.0118635061077549,0.00798082028145716,0.701364055672139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00155253284362374,0.00407268068049248,-0.009534986977389,0.00642992129014152,0.703056081035797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40058,-0.00144961424393128,0.00380791771408908,-0.00891313296354587,0.00601390447568332,0.703442560009285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.000934560706825175,0.002495688001432,-0.0058261091896319,0.00395698777598155,0.70806060708246
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.00324380196669809,0.00869290157994047,-0.0137942851299852,0.0202818890633814,0.709038727755789
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,39587,-0.00104673301319703,0.0028170149066125,-0.00656808223015753,0.00447461620376346,0.710214126392885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00215338548187402,0.00580089124886929,-0.0135231323296578,0.0092163613659098,0.710482423346336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00106153489571125,0.00286003343139414,-0.00666720042124377,0.00454413062982127,0.710523079189692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,0.00180135698020398,0.00486014469913445,-0.00772452663009954,0.0113272405905075,0.710912722612212
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.0018332341248324,0.00495094659590853,-0.0115370894528131,0.00787062120314832,0.711179218818523
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.00201725952684936,0.00546251777391551,-0.00868927531002503,0.0127237943637238,0.711915597857801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0012461640205707,0.00338070951779906,-0.00538002663431547,0.00787235467545686,0.712424036977516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,39858,-0.00659214837385823,0.0179314487471528,-0.0417377879182777,0.0285534911705612,0.71315359500316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,-0.00145730253269147,0.00396928743741943,-0.00923710591003356,0.00632250084465063,0.713517074452867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00188773557564942,0.00521033087028334,-0.00832451293010593,0.0120999840814048,0.717128999174867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,-0.000992131013600597,0.00275774118901646,-0.00639730374407286,0.00441304171687166,0.719029976204936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.00143025799651174,0.00399308366834145,-0.00925670198646099,0.00639618599343751,0.720211345348791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,39585,0.00240877645386039,0.00675364256642805,-0.0108283629763386,0.0156459158840594,0.721348667698508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,-0.00126576768582949,0.00357106725627686,-0.00826505950813213,0.00573352413647314,0.723006695863267
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37039,-0.000752401054386652,0.00215274686315249,-0.00497178490616553,0.00346698279739222,0.726713967438513
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,-0.00103370784298863,0.00297772850365706,-0.00687005571015646,0.00480264002417921,0.728485985582332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,0.001434420341737,0.00416737522121176,-0.00673363509183805,0.00960247577531204,0.730698636804448
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,39587,0.00471257694295047,0.0136999002337845,-0.0221392275152672,0.0315643814011682,0.730861245518883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,0.00129841148924876,0.00377629562042135,-0.00610312792677708,0.0086999509052746,0.730978108230207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,39906,0.00487078912964751,0.0142971817821771,-0.0231516871634197,0.0328932654227147,0.733347627558914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.00123117852912863,0.00368585838179636,-0.00599310389919224,0.0084554609574495,0.738363108909258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37437,-0.00139302282639778,0.00422417083402463,-0.00967239766108605,0.00688635200829049,0.741575622686947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,0.00161877343715163,0.0049464342381094,-0.0080762376695428,0.0113137845438461,0.743475875514639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,39585,0.00117360693617799,0.00361280811734226,-0.00590749697381284,0.00825471084616882,0.745301808782218
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,39585,0.000834632583847969,0.00258986105922391,-0.0042414950922309,0.00591076025992684,0.747253009784891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37056,0.00133319146805879,0.00414883286411,-0.0067985209455968,0.00946490388171438,0.747956828728482
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37348,-0.00175907127689369,0.0055116186956651,-0.0125618439203973,0.00904370136660991,0.749612461141326
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.00251902536758959,0.00795221953947525,-0.0130673249297819,0.0181053756649611,0.751422949681699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37437,-0.00269049255579266,0.00856440853821441,-0.0194767332906929,0.0140957481791076,0.753413395628511
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00146511432392663,0.0046669484241001,-0.0106123332351628,0.00768210458730957,0.753576054720645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39477,-0.00259640560204156,0.00839935611868038,-0.0190591435946551,0.013866332390572,0.757234674078999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,0.00115919731799186,0.00376094059396874,-0.00621224624618687,0.00853064088217058,0.757919000515968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCLN,Nicalin,39587,-0.00153980616774544,0.00500502763091034,-0.0113496603243297,0.00827004798883882,0.758351311740799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00161065933213435,0.00526664923897231,-0.0119332918405201,0.00871197317625138,0.7597445770473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.000974059475267805,0.00319718016448017,-0.00724053259764893,0.00529241364711332,0.760627529268656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.00190983665811036,0.00641964090570445,-0.0144923328332911,0.0106726595170704,0.766090277767151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,0.00178857687138309,0.00605072885881852,-0.0100708516919012,0.0136480054346674,0.767542603171905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,36991,-0.00177809923665995,0.00611827373885095,-0.0137699157648078,0.0102137172914879,0.771345736392109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-0.00110957277906269,0.0038589527992323,-0.008673120265558,0.00645397470743262,0.773709452365293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,-0.00269714337850989,0.00938405774412705,-0.0210898965569989,0.0156956097999791,0.773796294636761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.00150049993133078,0.00522118314481355,-0.0117340188951653,0.00873301903250378,0.773819860737568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,-0.0023301561748485,0.00812326216110984,-0.0182517500106238,0.0135914376609268,0.774231850912682
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.000964477153227882,0.00342769169003923,-0.00768275286570478,0.00575379855924901,0.778424089852783
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.000867691476868993,0.00309588821724088,-0.00520024942892314,0.00693563238266112,0.779272292130541
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,0.00305463120970316,0.0110099388085419,-0.018524848855039,0.0246341112744453,0.781444272629558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,0.000845810242769094,0.00306133420333466,-0.00515440479576685,0.00684602528130504,0.782331144912754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NENF,Neudesin,37368,0.00281346911360779,0.0104282536899196,-0.0176259081186347,0.0232528463458503,0.787323683757858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.00435102513525903,0.0161882206751165,-0.0273778873879693,0.0360799376584874,0.788105215939913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.00122168670580841,0.00459170486592787,-0.010221428243027,0.00777805483141021,0.79019418684255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.000847736555458221,0.00325984022093914,-0.0055415502775825,0.00723702338849894,0.794824936396163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,39931,0.00110515946472008,0.00430873267354297,-0.00733995657542414,0.00955027550486429,0.797573522707449
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000992160689975431,0.00388960364884167,-0.0086157838417051,0.00663146246175424,0.798665173938303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37437,0.00103229205088503,0.00408030597547751,-0.0069651076610509,0.00902969176282095,0.800276846454295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00177084985899494,0.00714177128290878,-0.0157687215734961,0.0122270218555063,0.8041718058518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39405,0.00155647126925183,0.00639694123311507,-0.0109815335476537,0.0140944760861574,0.807764654679103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.00194631603992717,0.00806972450577643,-0.0138703439913946,0.017762976071249,0.809413052025715
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.00118029143893453,0.00501889520815035,-0.0110173260469092,0.00865674316904017,0.814080788794867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,0.000868704752403423,0.00370660430519415,-0.00639623968577711,0.00813364919058395,0.814703926109902
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,36962,-0.00101317947706868,0.00434333792838356,-0.00952612181670045,0.00749976286256309,0.815553780905446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00150811781583072,0.00647688480157289,-0.0111865763952522,0.0142028120269136,0.815884440680044
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.000581547809844606,0.00253016719454881,-0.00554067551116027,0.00437757989147106,0.818215311528099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.00090870369333101,0.00398124944808667,-0.00871195261158089,0.00689454522491887,0.819458659149067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.00111693794740533,0.00490060884697284,-0.00848825539266144,0.0107221312874721,0.819713374116286
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.00290521819674346,0.0127688660268097,-0.0221217592158035,0.0279321956092905,0.82002005648957
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,0.00308287268885123,0.0136925620196587,-0.0237545488696798,0.0299202942473823,0.821866530980427
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39477,-0.00291987550913117,0.0130742866953793,-0.0285454774320745,0.0227057264138122,0.823281895171259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00144785336185151,0.00649925393710709,-0.0141863910785814,0.0112906843548784,0.823716221788744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,-0.00176520699899448,0.0079856632197239,-0.0174171069096533,0.0138866929116644,0.825059218375272
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.000563052256626836,0.00254778304962578,-0.00443060252063969,0.00555670703389337,0.825098151228054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00124921287576348,0.00571852293178011,-0.0124575178220525,0.00995909207052554,0.827081060730405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00114507995249463,0.00530121306529405,-0.011535457560471,0.0092452976554817,0.828987929987582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,39587,0.000694674347354915,0.0032170272573713,-0.00561069907709283,0.00700004777180266,0.829039866207542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37368,0.00121249318393144,0.00565256100309625,-0.00986652638213721,0.0122915127500001,0.830157804789006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37039,0.00122570840791285,0.00573401886638958,-0.0100129685702107,0.0124643853860364,0.830736909283652
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.00123859434919087,0.00584428702998089,-0.0102162082295717,0.0126933969279534,0.832162395179082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00108814019731334,0.00517439978015153,-0.0112299637664103,0.00905368337178365,0.833442200590238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00127908176077918,0.00610123742633592,-0.0132375071163976,0.0106793435948392,0.8339489725029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00143889022615273,0.00687623269247087,-0.0149163063033956,0.0120385258510902,0.834251953362171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37382,0.00503478730250776,0.0241251546920942,-0.0422505158939968,0.0523200904990123,0.83468987071136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.00119332583777919,0.00574880784787929,-0.0100743375440642,0.0124609892196226,0.835561198176294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.000953886990509888,0.00465439111952763,-0.00816871960376427,0.010076493584784,0.837619473968868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.000456250639512739,0.00224105348358198,-0.00484871546733341,0.00393621418830793,0.838678389848611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.000718841615385498,0.00356815310178882,-0.00771242169489159,0.00627473846412059,0.840341685931025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,39749,0.000796481195787618,0.0039909209782644,-0.00702572392161061,0.00861868631318585,0.841816879518312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00122271975828381,0.00613522771240488,-0.0132477660745974,0.0108023265580297,0.842035121892159
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.00147721734789406,0.00741301877890088,-0.0160067341545398,0.0130522994587517,0.842051970315138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.000981250054567149,0.00496411859275323,-0.00874842238722919,0.0107109224963635,0.843307427378629
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.00114716177808416,0.00582210961324666,-0.0102641730638793,0.0125584966200476,0.84380234480034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37169,0.00108748203211348,0.00560783140085178,-0.00990386751355601,0.012078831577783,0.846239895599922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37437,0.000532794540910295,0.00276119992762188,-0.00487915731722858,0.00594474639904917,0.846995052041316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.000906567145120496,0.00470906219737823,-0.0101363290519818,0.00832319476174083,0.847341427992985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.000600176151882516,0.00312618979133423,-0.0067275081428976,0.00552715583913257,0.847758263910836
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39489,0.000860868094660815,0.00449348282584294,-0.00794635824399135,0.00966809443331298,0.848072538573624
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.000416992593417946,0.00221520055906808,-0.00392480050235549,0.00475878568919139,0.850689768938327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00130528285205703,0.00696268681249769,-0.0123415833004384,0.0149521490045525,0.851296357190816
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37056,0.000724022311410964,0.00387107968170736,-0.00686329386473546,0.00831133848755739,0.851637094716231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,-0.000761683182536988,0.00421801077000703,-0.00902898429175076,0.00750561792667679,0.856701004040405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37368,0.000884025577225746,0.0049911717080618,-0.00889867097057538,0.0106667221250269,0.859418480723134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,0.000901392401532436,0.00512634832680666,-0.00914625031900861,0.0109490351220735,0.860425705424972
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37039,0.000695977754486422,0.00398107085043871,-0.00710692111237345,0.00849887662134629,0.861222386644987
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.00104240915973259,0.00606049791299245,-0.0129209850691978,0.0108361667497326,0.863439710105241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.000647270121690992,0.00389578550532426,-0.00828300971212655,0.00698846946874456,0.868044354211538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.000941460469918317,0.00566796325244506,-0.010167747504874,0.0120506684447106,0.868079182430929
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37039,0.000551754890925501,0.00333973904087788,-0.00599413362919513,0.00709764341104614,0.868782028827256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37039,0.0010073349213271,0.00640420600003316,-0.0115449088387379,0.0135595786813921,0.875016574401385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.000800794245172176,0.00517783129260638,-0.0109493435786807,0.00934775508833633,0.877093126239617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.000603851457690404,0.00393282215546171,-0.00710447996701455,0.00831218288239535,0.8779736071571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.000497060289837242,0.00334987807391827,-0.00706282131471705,0.00606870073504257,0.88204388547983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.000528146626505485,0.00362775522219722,-0.00763854686201204,0.00658225360900107,0.88425087785653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MB,Myoglobin,40052,0.000694079940021311,0.00492164067114582,-0.0089523357754245,0.0103404956554671,0.887851053732416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.0013510780643755,0.00984474221542631,-0.0206467728066111,0.0179446166778601,0.890844343738773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.000382689939647031,0.00282622362027901,-0.00515670835609982,0.00592208823539388,0.89229230126032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.000625444302687315,0.00469988813336778,-0.00858633643871353,0.00983722504408817,0.894134654036354
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.000637542526238767,0.00482684061136914,-0.00882306507204475,0.0100981501245223,0.894920844379547
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.000420264560330933,0.00318793943814887,-0.00666862585910273,0.00582809673844086,0.895121143355039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-0.000712752665265329,0.00549574126331562,-0.0114844055413639,0.0100589002108333,0.896812244156867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,36962,0.000668403520631807,0.00517442882342969,-0.00947347697329039,0.010810284014554,0.897221668446377
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.00117374224698105,0.00909400128976639,-0.0189979847749232,0.0166505002809611,0.897306010623415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39489,-0.000578563928311641,0.00478221735298773,-0.00995170994016759,0.00879458208354431,0.903706564651453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37056,0.000335822453511498,0.00278063507884271,-0.00511422230102022,0.00578586720804321,0.90387358295897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.000599984572517133,0.00498287267429361,-0.0103664150141326,0.00916644586909835,0.90416041492961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.000605820736645968,0.00504428045122016,-0.0104926104210375,0.00928096894774555,0.904405291561434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,36962,-0.000452831759478498,0.00387946333294434,-0.00805657989204941,0.00715091637309241,0.907079481229661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,-0.000308247614639102,0.00277283703528412,-0.00574300820379598,0.00512651297451778,0.911485665781621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.000415742802319587,0.00376929833921698,-0.0069720819425457,0.00780356754718487,0.912175360709489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.00105098302854417,0.00964033398588172,-0.0199460376408723,0.017844071583784,0.913188536510636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.000456553468665595,0.00440973757682094,-0.00818653218190344,0.00909963911923463,0.91754122616173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.000583901850182638,0.00569378328039852,-0.0105759133793985,0.0117437170797637,0.918321076142905
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,0.000384498556923443,0.00374986387485895,-0.0069652346378001,0.00773423175164699,0.918332252086986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37021,-0.000457268855045524,0.00446618182327114,-0.00921098522865696,0.00829644751856591,0.918452857281473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,39788,0.000169244572542108,0.0017906706234116,-0.00334046984934462,0.00367895899442884,0.924701549789879
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.000282869329506765,0.0030679296733182,-0.00629601148921044,0.00573027283019691,0.926538711538687
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.000389083931020044,0.00426304178949262,-0.00874464583842559,0.0079664779763855,0.927280136959777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,0.000442276718778667,0.00491890377382984,-0.00919877467792782,0.0100833281154852,0.92835724606847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.000307352530772448,0.00343810341365833,-0.00643133015999788,0.00704603522154278,0.928768597731557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.000451301447389258,0.00527350533620151,-0.0107873719063442,0.00988476901156571,0.93180237253202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37056,-0.000506611695717427,0.00600696780226255,-0.012280268588152,0.0112670451967172,0.932789503159976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.000457332186911464,0.0055947886524818,-0.0105084535719529,0.0114231179457758,0.934852699382521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.000634562060699189,0.00864848509004931,-0.0163164687157975,0.0175855928371958,0.941510712337814
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,39587,-0.000534159311005802,0.00735864027936329,-0.0149570942585579,0.0138887756365463,0.942133782066177
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,39587,0.000245936298874464,0.00371664229298736,-0.00703868259538076,0.00753055519312969,0.947242020008056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,39868,-0.000236154666375295,0.0036108522985415,-0.00731342517151664,0.00684111583876605,0.947855254583648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.000285874064328996,0.00440172419929533,-0.00834150536628984,0.00891325349494783,0.948218038643158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.000160560544550451,0.00255845091592081,-0.00517512433975523,0.00485400325065433,0.949960831656127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,-0.000491689304824388,0.00824913219787495,-0.0166599884126593,0.0156766098030105,0.952471166306181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.000340265742616144,0.00581442649880322,-0.0110560101950382,0.0117365416802704,0.953334543755692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37021,0.000268009554966791,0.00463455939460934,-0.00881572685846751,0.00935174596840109,0.953886125183091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.000475650565127521,0.00836206428068576,-0.0159139954250166,0.0168652965552716,0.954640089973444
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,0.000284384184619697,0.00535610037689371,-0.010213572554092,0.0107823409233314,0.95765671836962
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,0.000299212279170797,0.00568083833399067,-0.0108352308554509,0.0114336554137925,0.957995291323209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.000270441813204837,0.00516999317061446,-0.0104036284276092,0.0098627448011995,0.958282421414134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.000197588680944953,0.00393901879935399,-0.00752288816578887,0.00791806552767878,0.959994129101844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37368,0.000157408192297675,0.00324534831041058,-0.00620347449610707,0.00651829088070242,0.961316320718493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.000288251557252992,0.00605776916296182,-0.0115849760021522,0.0121614791166582,0.962048684042947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00039942139537282,0.0091479556804181,-0.0183294145289923,0.0175305717382466,0.965174201517055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.000287442135689937,0.00662276111795155,-0.0126931696554951,0.013268053926875,0.965381491309427
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,0.000293232935654039,0.00691338348686709,-0.0132569986986054,0.0138434645699135,0.966168311057948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,-0.000130453866831203,0.00334911210707472,-0.00669471359669765,0.00643380586303524,0.968929321056655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.000132012313209439,0.00363370748672915,-0.00725407898719858,0.0069900543607797,0.971019825701729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.00010480360168627,0.00293356988030281,-0.00585460056707977,0.00564499336370723,0.971501677862571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,7.62383428306134e-05,0.00264087091669154,-0.0050998686538848,0.00525234533954603,0.976969796106806
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,0.000316803753421033,0.0110975943828604,-0.0214344812369853,0.0220680887438274,0.977226264317534
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,39585,0.000154897374114254,0.00570951429747484,-0.0110357506489364,0.0113455453971649,0.978356635581239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,5.51859052834491e-05,0.00215395992634817,-0.00416657555035896,0.00427694736092585,0.979560211664976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,36991,-0.000111402513090022,0.00445837054218548,-0.00884980877577357,0.00862700374959353,0.980065496379279
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,6.37814201269262e-05,0.00262221077088186,-0.00507575169080152,0.00520331453105537,0.980594902592508
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00014629546423282,0.00624526832466415,-0.0123870213805746,0.0120944304521089,0.98131160767663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,0.000101320882375433,0.00463965878092536,-0.00899241032823827,0.00919505209298914,0.982577511946238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFD,Complement factor D,37453,3.48281424659711e-05,0.00173613184386531,-0.00336799027151003,0.00343764655644198,0.983995188893153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,8.35632909462187e-05,0.00460034678723833,-0.00893311641204091,0.00910024299393335,0.985507847241168
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-9.26932526629444e-05,0.00531227206549915,-0.0105047465010413,0.0103193599957154,0.986078771927734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,36962,0.000130760712671811,0.0075685156578438,-0.014703529976702,0.0149650514020457,0.98621595338817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,39964,5.20153326840457e-05,0.00316283053822127,-0.00614713252222965,0.00625116318759774,0.986878931619867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.000121040609113305,0.00738406657731366,-0.0143517298824215,0.0145938111006481,0.986921803167028
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-8.96029459139332e-05,0.00564312046282757,-0.011150119053056,0.0109709131612281,0.987331750134392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.000159070175779937,0.0109918866411201,-0.0217031679923752,0.0213850276408154,0.988453957945493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,39866,-7.85128947500729e-05,0.00608416485456716,-0.0120034760097017,0.0118464502202016,0.989704172894359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-2.95442401148868e-05,0.00317527115266569,-0.00625307569933963,0.00619398721910986,0.992576348544075
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,39885,2.77870013248362e-05,0.00302133771836871,-0.00589403492667784,0.00594960892932751,0.992662137443376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,36962,-3.36711933082862e-05,0.00505095629927675,-0.00993354553989072,0.00986620315327415,0.994681202513428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-9.14350724538122e-06,0.00320600987915799,-0.00629292287039505,0.00627463585590428,0.9977244876789
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,6.5305954156862e-06,0.00426969111589757,-0.00836206399174356,0.00837512518257493,0.99877963974344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37056,-5.23759913308558e-06,0.00445464925169108,-0.00873635013244761,0.00872587493418144,0.999061897107048
